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Non-coding RNAs (ncRNAs) and small proteins have both emerged as important regulators of 
gene expression. Dual-function RNAs encode a small protein and have a separate function as a 
regulatory RNA. Although first discovered in bacteria, dual-function RNAs have now been 
identified and characterized in eukaryotes as well. These RNAs allow two activities of a single 
gene to regulate targets at multiple levels. The work described here explores how two novel and 
one synthetic dual-function RNA act and how competition between the components of a dual-
function RNA impacts their functions. AzuCR is a 164-nucleotide E. coli RNA that was 
previously shown to encode a 28 amino acid protein (AzuC). This work demonstrates that the 
AzuC small protein impacts glycerol metabolism, with the small protein increasing activity of 
GlpD, an essential enzyme in glycerol catabolism, while the RNA base pairs with and represses 
galE mRNA, a gene essential for galactose metabolism. The second dual-function RNA studied 
in this work is Spot 42, a 109-nucleotide RNA known to base pair with and repress mRNAs 
encoding proteins involved in the metabolism of non-preferred carbon sources. Although Spot 42 
is a well-characterized base pairing small RNA (sRNA) in E. coli, this work shows it also 
encodes a 15-amino acid protein, SpfP. SpfP was found to bind to cAMP receptor protein (CRP) 
and block activation of some target genes. For both AzuCR and Spot 42, the coding sequence for 
the small protein overlaps the base pairing region, and we have observed that translation 
 
 
interferes with base pairing activity suggesting competition between the sRNA and mRNA 
activities. Finally, a synthetic dual-function RNA was constructed from the Escherichia coli 
sRNA MgrR and the mRNA for the small protein MgtS. Various versions of this hybrid 
molecule are used to probe how the organization of components is important for the proper 
functioning of a dual-function RNA. These three studies highlight the complexities of regulation 
by dual-function RNAs and provide insights into how these molecules coordinate two different 














Dissertation submitted to the Faculty of the Graduate School of the  
University of Maryland, College Park, in partial fulfillment  
of the requirements for the degree of  













NIH Distinguished Investigator Gisela Storz, Chair 
Associate Professor Jiqiang Ling 
Professor Leslie Pick 
Professor Wade C. Winkler 















ã Copyright by 




 I would like to thank Dr. Storz for her critical input, guidance, and support; my 
committee for their critical feedback to improve my research; and the past and present members 
of the Storz Lab. Thank you, Katie, for your support and love. I could not have done any of this 
without you.  
 iii 
 
Table of Contents 
ACKNOWLEDGEMENTS ....................................................................................................................................... II 
TABLE OF CONTENTS .......................................................................................................................................... III 
LIST OF TABLES ..................................................................................................................................................... VI 
LIST OF FIGURES ................................................................................................................................................. VII 
CHAPTER 1 ..................................................................................................................................................................1 
Introduction ...........................................................................................................................................................1 
Small regulatory RNAs in bacteria ..................................................................................................................................... 1 
Small proteins are poorly annotated and characterized ....................................................................................................... 2 
Regulatory RNAs may not be “non-coding” ....................................................................................................................... 2 
Definition of dual-function RNAs ....................................................................................................................................... 3 
Discovery of dual-function RNAs ....................................................................................................................................... 4 
Roles of dual-function RNAs in bacteria ............................................................................................................................ 4 
Dual-function RNAs in eukaryotes ..................................................................................................................................... 9 
Small ORFs in lncRNAs .............................................................................................................................................. 10 
Dual-function RNAs in animal development .............................................................................................................. 11 
mRNAs in which disease-causing mutations lead to aberrant RNA function ............................................................. 13 
Open questions regarding dual-function RNAs ................................................................................................................ 13 
Competition between activities of dual-function RNA ............................................................................................... 14 
Evolution of dual-function RNAs ................................................................................................................................ 14 
Perspectives ....................................................................................................................................................................... 15 
CHAPTER 2 ................................................................................................................................................................18 




AzuC protein and mRNA levels are discordant for cells grown in glucose and low pH glycerol .................................... 23 
AzuC protein is localized to the membrane ...................................................................................................................... 24 
AzuC protein interacts with GlpD ..................................................................................................................................... 26 
AzuC protein increases GlpD activity ............................................................................................................................... 29 
AzuC overexpression causes an increase in cell length .................................................................................................... 31 
AzuC and GlpD protein levels are repressed by the FnrS small RNA ............................................................................. 31 
AzuCR overexpression reduces growth in glycerol and galactose ................................................................................... 34 
AzuR functions as an sRNA to repress cadA and galE ..................................................................................................... 35 
AzuCR RNA association with Hfq and ProQ is not required for cadA repression .......................................................... 37 
AzuC translation and AzuR base pairing activity interfere ............................................................................................... 38 
Discussion ...........................................................................................................................................................40 
AzuCR is a unique dual-function sRNA ........................................................................................................................... 40 
AzuC stimulation of GlpD activity ................................................................................................................................... 41 
AzuR repression of the cadA and the galETKM mRNAs ................................................................................................ 43 
Competition between two AzuCR activities ..................................................................................................................... 43 
Material and Methods ..........................................................................................................................................45 
Bacterial strains and plasmid construction ........................................................................................................................ 45 
Bacterial growth ................................................................................................................................................................ 45 
Immunoblot analysis ......................................................................................................................................................... 46 
Total RNA isolation .......................................................................................................................................................... 46 
Northern analysis ............................................................................................................................................................... 47 
Sub-cellular fractionation .................................................................................................................................................. 47 
Microscopy ........................................................................................................................................................................ 48 
Purification of chromosomally encoded SPA-tagged AzuC ............................................................................................. 49 
Purification of chromosomally encoded HA-His-tagged GlpD ........................................................................................ 50 
Dehydrogenase activity assay ........................................................................................................................................... 51 
β-galactosidase assays ....................................................................................................................................................... 52 
 iv 
Growth curves ................................................................................................................................................................... 52 
GFP reporter assay ............................................................................................................................................................ 52 
Hfq and ProQ co-immunoprecipitation assays .................................................................................................................. 53 
Addendum ...........................................................................................................................................................54 
CHAPTER 3 ................................................................................................................................................................56 
SPOT 42 SMALL REGULATORY RNA ENCODES A 15-AMINO ACID PROTEIN THAT BLOCKS CRP-MEDIATED 




Spot 42 regulatory sRNA encodes a 15 amino acid protein ............................................................................................. 60 
Spot 42 base pairing and protein coding activities can be genetically separated .............................................................. 62 
Histidine 10 is critical for SpfP function ........................................................................................................................... 64 
SpfP associates with Crp ................................................................................................................................................... 66 
SpfP overexpression blocks activation of some Crp-dependent operons ......................................................................... 69 
SpfP blocks Crp-dependent transcription from the galE P1 promoter .............................................................................. 72 
Relative importance of Spot 42 base pairing activity and SpfP protein activity varies with temperature ........................ 73 
Discussion ...........................................................................................................................................................77 
Impact of dual-function RNAs on carbon metabolism ..................................................................................................... 77 
SpfP interaction with Crp .................................................................................................................................................. 79 
Material and Methods ..........................................................................................................................................81 
Bacterial strains and plasmids ........................................................................................................................................... 81 
Bacterial growth ................................................................................................................................................................ 81 
Immunoblot analysis ......................................................................................................................................................... 82 
RNA isolation .................................................................................................................................................................... 82 
Northern analysis ............................................................................................................................................................... 83 
Growth assay ..................................................................................................................................................................... 83 
Purification of scrambled SpfP ......................................................................................................................................... 84 
Reciprocal purification ...................................................................................................................................................... 85 
β-galactosidase assays ....................................................................................................................................................... 85 
Addendum ...........................................................................................................................................................87 
CHAPTER 4 ................................................................................................................................................................89 




Construction of a synthetic dual-function RNA ................................................................................................................ 94 
MgtSR is a functional dual-function RNA ........................................................................................................................ 95 
Translation of MgtS is the dominant activity in the absence of an intervening sequence ................................................ 96 
Truncating the intervening sequence disrupts regulation by each component .................................................................. 98 
Reversing the organization of the components of MgtSR disrupts regulatory capability .............................................. 100 
Discussion .........................................................................................................................................................102 
Elements necessary for dual function activity ................................................................................................................. 102 
Evolution of dual-function RNAs ................................................................................................................................... 103 
Possibility of exploiting dual-function RNAs ................................................................................................................. 104 
Material and Methods ........................................................................................................................................105 
Bacterial strains and plasmid construction ...................................................................................................................... 105 
Bacterial growth .............................................................................................................................................................. 105 
Immunoblot analysis ....................................................................................................................................................... 105 
Total RNA isolation ........................................................................................................................................................ 106 
Northern analysis ............................................................................................................................................................. 106 
β-galactosidase assays ..................................................................................................................................................... 107 
Addendum .........................................................................................................................................................108 
CHAPTER 5 ..............................................................................................................................................................110 
Discussion .........................................................................................................................................................110 
Roles of dual-function RNAs in regulating carbon metabolism ..................................................................................... 110 
 v 
Competition between base pairing and translation ......................................................................................................... 111 
Where do we go from here? ............................................................................................................................................ 115 
Application of what has been learned about dual-function RNAs in E. coli to other bacteria .................................. 115 
Application of what has been learned about dual-function RNAs in E. coli to eukaryotes ...................................... 115 
The search for more dual-function RNAs .................................................................................................................. 117 
Generation of synthetic dual-function RNAs to regulate desired processes .............................................................. 119 
Conclusions ..................................................................................................................................................................... 120 
APPENDICES ...........................................................................................................................................................121 
Appendix 1: Strain List .....................................................................................................................................121 
Appendix 2: Plasmid List ..................................................................................................................................124 
Appendix 3: Northern Probes ............................................................................................................................127 
Appendix 4: Oligonucleotides for Plasmid Construction .................................................................................128 
Appendix 5: Oligonucleotides for Chromosomal Tagging ...............................................................................131 
Appendix 6: Oligonucleotides for Sequencing .................................................................................................132 




List of Tables  
Table 1: Dual-function RNA in bacteria. ........................................................................................ 5 
Table 2. Dual-function RNAs in eukaryotes. ................................................................................ 10 
  
 vii 
List of Figures 
Figure 1. General features of dual-function RNA. ......................................................................... 3 
Figure 2. Stability can dictate competition between components of a dual-function RNA. .......... 6 
Figure 3. Ribosome binding to and conservation of azuC. ........................................................... 21 
Figure 4. AzuC protein synthesis is regulated at a post-transcriptional level. .............................. 23 
Figure 5. AzuC protein is membrane associated. ......................................................................... 25 
Figure 6. Fractionation showing subcellular localization of untagged AzuC and AzuC-SPA co-
purification with GlpD-HA-His6 compared to untagged control strain. ....................................... 26 
Figure 7. AzuC copurifies with GlpD. .......................................................................................... 27 
Figure 8. AzuC increases GlpD activity and affects cell shape. ................................................... 28 
Figure 9. Effect of AzuC overexpression on GlpD levels at pH 5.5 and on GlpD activity at pH 
7.0.................................................................................................................................................. 30 
Figure 10. FnrS sRNA represses synthesis of both AzuC and GlpD. ........................................... 32 
Figure 11. FnrS sRNA represses AzuC expression. ..................................................................... 33 
Figure 12. Growth curves for AzuC and AzuCR overexpression. ............................................... 34 
Figure 13. AzuC and AzuR overexpression leads to different growth phenotypes in different 
carbon sources. .............................................................................................................................. 35 
Figure 14. AzuR represses cadA and galE expression. ................................................................ 36 
Figure 15. AzuCR mRNA and base pairing activities are differentially affected by Hfq and ProQ.
....................................................................................................................................................... 39 
Figure 16. Ribosome binding to and conservation of spf. ............................................................ 60 
Figure 17. Spot 42 is a dual-function sRNA. ................................................................................ 61 
Figure 18. SpfP expression impacts growth on galactose. ............................................................ 63 
Figure 19. SpfP copurifies with Crp. ............................................................................................ 65 
Figure 20. Lack of SpfP-FLAG association in ∆crp mutant background. .................................... 68 
Figure 21. SpfP overexpression leads to downregulation of Crp-activated genes. ...................... 70 
Figure 22. No effect of SpfP overexpression on AzuC or Crp levels and no effect of SpfPH10A 
overexpression. ............................................................................................................................. 71 
Figure 23. SpfP blocks Crp-dependent transcriptional activation. ............................................... 72 
Figure 24. Spot 42 and Spot 42STOP have different effects at different temperatures. .................. 74 
Figure 25. Spot 42 and SpfP have different effects at different temperatures. ............................. 75 
Figure 26. Regulatory activity of the synthetic dual-function RNA. ............................................ 94 
Figure 27. MgtS translation is the dominant activity absent the intervening sequence. ............... 97 
Figure 28. RNA levels of synthetic constructs. ............................................................................ 98 
Figure 29. Analysis of the regulatory contributions of the intervening sequence. ....................... 99 
Figure 30. Reversing the organization of the components produces a nonviable synthetic dual-
function RNA. ............................................................................................................................. 100 





Many organisms employ noncoding RNA (ncRNA) to regulate diverse biological processes and 
respond to environmental stress. These ncRNAs vary in size and complexity to exert important 
regulatory roles in their respective organisms. The majority of ncRNA do not contain open 
reading frames (ORFs) and function through interactions with other target RNA molecules or 
proteins. The discovery of ncRNAs that encode functional small ORFs in addition to binding 
RNA targets illuminated how some RNAs break this mold (Raina, King et al. 2018). Since this 
discovery, only a handful of dual-function RNA have been characterized in bacteria and 
eukaryotes. This is perhaps due to a lack of organized searches for potential dual-function RNA 
throughout the genome and the inherent difficulties in studying these molecules. The reality is 
that these unique molecules have diverse regulatory capabilities and are likely much more 
prevalent than is currently recognized. 
 
Small regulatory RNAs in bacteria 
Small regulatory RNAs (sRNAs) are molecules that are transcribed from DNA but do not encode 
a protein and are involved many cellular processes. One of the first discovered sRNA that 
regulated gene expression was Spot 42 in E. coli (Ikemura and Dahlberg 1973). Since the initial 
discoveries, numerous other ncRNA have been found with a wide variety of functions. These 
regulatory molecules have been found to play an important role in attenuating gene expression in 
response to environmental stresses. For most sRNAs, base pairing with their target mRNA 
blocks access to the ribosome binding site (RBS) and prevents translation by preventing 
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initiation. For other sRNAs, base pairing with their target results in destabilization of the RNA 
target (Frohlich, Papenfort et al. 2013, Papenfort, Sun et al. 2013). Finally, in cases where a 
sRNA base pairs with the 5’ untranslated region (UTR) of a target, an inhibitory secondary 
structure preventing translation of the mRNA can be relieved to permit ribosome binding and 
subsequent translation. The hexameric RNA chaperone Hfq assists in the base pairing between 
sRNA and mRNA and is required by most sRNAs for stability (Updegrove, Zhang et al. 2016). 
 
Small proteins are poorly annotated and characterized 
Some small proteins have been demonstrated to interact with and modulate a larger protein 
partner (Andrews and Rothnagel 2014, Storz, Wolf et al. 2014, Saghatelian and Couso 2015). An 
issue with studying small proteins is that many databases, such as GenBank, do not have 
widespread annotation of small ORFs. This problem is in part due to small ORFs often not 
encoding functional proteins. Biochemical techniques used to characterize proteins are often not 
optimized for small proteins (e.g., co-purification of small proteins may simply run off a gel). 
Despite these issues, in the past decade, small proteins that modulate cell division, enzymatic 
activity, transport across membranes, metabolism, and stress responses have been identified 
(Ramamurthi and Storz 2014, Storz, Wolf et al. 2014, Orr, Mao et al. 2020). 
 
Regulatory RNAs may not be “non-coding” 
Given the bias against characterizing and annotating small proteins there may be numerous 
ncRNAs that actually contain an open reading frame (ORF). Additionally, computational 
searches have predicted that many sRNAs in bacteria contain ORFs between 10-50 amino acids. 
Only a small number of sRNAs contain ORFs, and of these only a fraction have a documented 
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function. An RNA molecule that has RNA specific regulatory capability and also encodes a 
protein is called a dual-function RNA.  
 
Definition of dual-function RNAs 
Regulatory systems in eukaryotes and bacteria can have the same function while their origins and 
steps required for execution can be quite different. As an example, sRNA in bacteria and miRNA 
in eukaryotes can both regulate genes via direct base-pairing interactions, but their maturation 
and the steps involved in actually regulating an mRNA are very different. While only just 
beginning to be understood, in bacteria a dual-function RNA encodes a small protein and directly 
regulates mRNA via base pairing. In eukaryotes, there are many types of ncRNA including the 
21-25 nt regulatory microRNA (miRNA) and the hundreds to thousands of nucleotides in length 
 









Figure 1. General features of dual-function RNA. 
A Bacterial model of a dual-function RNA with general features that are important to many of these 
molecules. The important features indicated are the small ORF, ARN motif (where A = adenine, R = 
adenine or guanine, N = any nucleotide), base pairing region, and rho-independent terminator. 
B Eukaryotic model of a dual-function RNA. Important features of the 5’ cap, ORF, 5’ untranslated region 
(UTR) with noncoding function, and poly-A tail are indicated. 
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long noncoding RNA (lncRNA). Eukaryotic dual-function RNA can have diverse functions 
including RNA that can serve a scaffolding function during development and also contain an 
ORF, or an mRNA that gains additional non-coding function upon mutation (Mayba, Gilbert et 
al. 2014). As is currently understood, the general features of dual-function RNA in bacteria and 
eukaryotes are summarized in Figure 1. Until now, only a limited number of dual-function RNAs 
have been identified and characterized because they tend to be overlooked due to the difficulty in 
distinguishing true translated ORFs from small ORFs that occur by chance. 
 
Discovery of dual-function RNAs 
The identification of most dual-function RNAs has been serendipitous. For example, human 
LINC00948 was thought be a lncRNA until the bioinformatic identification of a 46 amino acid 
ORF, myoregulin (Anderson, Anderson et al. 2015, Nelson, Makarewich et al. 2016). In E. coli, 
RNAIII was originally identified and characterized as an mRNA until a regulatory function was 
found for the RNA (Balaban and Novick 1995, Verdon, Girardin et al. 2009). In contrast, SgrS 
was originally understood to be a ncRNA until the identification of a small ORF encoding SgrT 
(Wadler and Vanderpool 2007). Systematic identification of potential dual-function RNAs would 
be a valuable and interesting addition to the field. 
 
Roles of dual-function RNAs in bacteria 
Once an RNA has been documented to have two functions, the biggest challenges are elucidating 
each function and determining how the functions are coordinated. As each dual-function RNA 
has two functional components that can each have unique regulatory targets, these molecules can 
control two separate pathways or regulate a single system using both components. 
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Dual-function RNAs affecting metabolism 
SgrST is a well characterized dual-function RNA in enterobacteria (Bobrovskyy and Vanderpool 
2014). This 227-nt sRNA was originally identified in a computational screen for sRNAs in E. 
coli and plays a role in the cellular response to glucose-phosphate stress (Wassarman, Repoila et 
al. 2001). SgrS counteracts the accumulation of sugar phosphates in the cell by reducing 
translation of sugar transporters and increasing dephosphorylation of sugar phosphates (Maki, 
Morita et al. 2010). Two of the targets of SgrS are ptsG and manXYZ, important sugar  
Table 1: Dual-function RNA in bacteria. 
Name Organism Protein Name Protein Function RNA Targets 
RNAIII S. aureus hld (delta 
hemolysin) 
Host cell lysis. Inhibits spa, coa, lytM, rot, sbi, 
sa1000, sa2353, sa2093, and ltaS. 
Activates hla, map, and mgrA. 
PSM-mec S. aureus PSMα Lyse erythrocytes and 
neutrophils. 
Inhibits and degrades agrA to 
decrease the high density agr 
response 
SR1 B. subtilis SR1P Binds GapA to prevent 
gapA operon RNA 
degradation. 
Inhibits ahrC to regulate arginine 
metabolism. 
Pel RNA S. pyogenes Streptolysin S Host cell lysis. Activates sic, nga, and emm. 
SgrS E. coli SgrT Blocks activity of PtsG 
glucose transporter. 
Inhibits ptsG, manXYZ, asd, adiY, 
folE, and purR. Activates yigL.  
transporters in the cell. SgrS base pairs near the 5’ end of ptsG RNA in a short region that also 
includes the ribosome binding site (RBS) and prevents translation of PtsG protein (Rice and 
Vanderpool 2011). In addition to functioning as a regulatory sRNA, SgrS also encodes the 43 
amino acid small protein SgrT (Wadler and Vanderpool 2007). This small protein functions to 
inhibit the transport activity of the glucose permease PtsG. Superresolution microscopy 
demonstrated that SgrT binds the EIICGlc domain of PtsG to inhibit the function of this 
transporter (Lloyd, Park et al. 2017). In summary, SgrS and the small protein SgrT work together 
to block sugar phosphate accumulation, and actively reduce intracellular glucose-6-phosphate. 
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SgrS base pairs with target mRNAs to inhibit synthesis of sugar transporters, while SgrT inhibits 
the activity of translated PtsG transporter. 
SgrST was the first dual-function RNA for which researchers explored the possibility of 
competition between the base pairing and small protein components. The base pairing region of 
SgrS is 15-nt downstream of the SgrT ORF making it possible that a translating ribosome could 
interfere with base pairing (Balasubramanian and Vanderpool 2013). Mutations to inhibit sgrT 
translation do not impede or enhance SgrS regulation of mRNA targets, but mutations that 
restrict base-pairing increase SgrT translation. Furthermore, translation of the small protein lags 
behind transcription of SgrS RNA by approximately 30 minutes (Balasubramanian and 
Vanderpool 2013). These observations suggest that the stability of SgrS RNA dictates 
competition between the activities. SgrS transcripts that base pair with target mRNAs are 
unavailable for use as an mRNA, as they are degraded. Once the pool of targeted mRNA has 
 
Co-degradation of both RNA molecules
Translation of the small protein
Dual-function RNA base pairs with target mRNA
Pool of mRNA is degraded, dual-
function RNA is still expressed
Small ORF Base pairing region
Dual-function RNA
mRNA
Figure 2. Stability can dictate competition between components of a dual-function RNA.  
A candidate dual-function RNA base pairs and co-degrades with an mRNA target. Once the levels of the target 




been sufficiently degraded, SgrS is able to function as an mRNA (Balasubramanian and 
Vanderpool 2013).  
 SR1 is the first dual-function RNA identified in B. subtilis. It was discovered through a 
bioinformatic search of intergenic regions for sRNAs. This 205-nt RNA is expressed under 
gluconeogenic conditions and repressed under glycolytic conditions by CcpN, an RNA regulator 
involved in carbon catabolite repression (Licht, Preis et al. 2005). CcpN represses SR1 by 
binding to DNA and inducing a conformational change to reduce transcription. SR1 regulates 
arginine metabolism through base pairing interactions with ahrC mRNA, which encodes the 
activator of the rocABC and rocDEF arginine catabolism operons (Heidrich, Moll et al. 2007). 
The functional outcome of this base pairing is a structural change downstream of the ahrC start 
codon, which inhibits binding of the 30S ribosomal subunit thus blocking translation initiation. 
The decrease in ahrC mRNA expression leads to a decrease in rocABC and rocDEF RNA levels.  
 SR1 RNA was found to encode the 39 amino acid small protein SR1P after researchers 
mutated a potential AUG start codon and noticed that certain overexpression phenotypic effects 
were alleviated (Gimpel, Heidrich et al. 2010). This result was confirmed by detecting the 
product of a small potential ORF with a FLAG tag using immunoblot analysis. This small 
protein was found to directly interact with GapA, one of two glyceraldehyde-3-phosphate-
dehydrogenases in B. subtilis. GapA binds RNase J1 and RNase Y to inhibit the degradation of 
gapA mRNA (Gimpel and Brantl 2016). SR1P binding enhances GapA binding to RNase J1, 
increasing RNase J1 activity. Both SR1 and SR1P are highly conserved, with 23 identified 
homologs in Bacillus, Geobacillus, Anoxybacillus, and Brevibacillus species (Gimpel, Preis et al. 
2012). All of the identified homologs share high structural similarity to B. subtilis SR1 and all 
contain the SR1P ORF.  
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Dual-function RNAs affecting pathogenesis 
In S. aureus, RNAIII is one of the primary effectors of the agr system, a system that is vital for 
pathogenesis. RNAIII was the first dual-function RNA discovered during studies to understand 
the function of the agr quorum-sensing system (Novick, Ross et al. 1993). Almost all S. aureus 
isolates from acute infections produce RNAIII. At the end of exponential growth, RNAIII RNA 
is expressed and begins repressing the translation of early virulence genes and increasing the 
production of secreted factors that are required for late infection (Novick, Ross et al. 1993). This 
514-nt long dual-function RNA has fourteen stem-loop motifs and is implicated in the base 
pairing regulation of 12 different mRNA targets including coagulase (coa), fibrinogen-binding 
protein (SA1000), staphylococcal secretory antigen (SsaA), surface protein A (spa), lipoteichoic 
acid synthase (ltaS), the major cell wall autolysin (lytM), and immunoglobulin-binding protein 
(sbi). RNAIII indirectly controls transcription of many genes through repression of rot mRNA, 
encoding the transcription factor Rot (repressor of toxins) (Boisset, Geissmann et al. 2007).  
RNAIII encodes a small ORF that is translated to produce the 26 amino acid cytotoxic 
peptide δ-hemolysin (hld), which lyses host cells by targeting their membranes (Verdon, 
Girardin et al. 2009). δ-hemolysin is produced during late exponential phase but lags behind the 
increase in RNAIII levels by 1 hour (Balaban and Novick 1995). The ORF for δ-hemolysin is 
located between the 5’ and 3’ base pairing regions of RNAIII and may be sequestered in 
secondary structure that could be responsible for the lag in δ-hemolysin levels (Benito, Kolb et 
al. 2000). Consistent with this hypothesis, deletion of the 3’ end of RNAIII prevents the delay 
between the increase in RNAIII levels and translation of δ-hemolysin (Balaban and Novick 
1995). 
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 Another dual-function RNA that affects pathogenesis is Psm-mec. The function of Psm-
mec RNA was first uncovered when researchers were attempting to understand the genetic 
differences between community-acquired (CA) multi-drug resistant S. aureus (MRSA), which 
infects healthy people outside of hospitals, and hospital-associated (HA) MRSA, which infects 
the immunocompromised patients within a hospital. This study discovered that in HA-MRSA the 
staphylococcal cassette chromosome (SCCmec), the mobile genetic element that normally 
encodes Psm-mec and confers antibiotic resistance, was absent Psm-mec in CA-MRSA (Kaito, 
Saito et al. 2011). The 143-157-nt sRNA inhibits translation by base pairing with agrA mRNA, 
which encodes the AgrA transcription factor that upregulates the accessory gene regulator (agr) 
quorum-sensing system. Psm-mec also destabilizes agrA mRNA in a manner separate from the 
activity inhibiting translation (Kaito, Saito et al. 2013). The regulatory effects of Psm-mec have 
been found to be highly strain dependent (Chatterjee, Chen et al. 2011). 
 Psm-mec also contains a small ORF that translates the 22 amino acid phenol-soluble 
modulin, PSM-mec (Queck, Khan et al. 2009). This is a cytolytic toxin that contributes to S. 
aureus infection and aids in immune evasion of the host response. PSM-mec translation is 
upregulated by AgrA, a transcription factor that is a component of the quorum-sensing system 
(Chatterjee, Chen et al. 2011). Similar to Psm-mec, the expression of the small protein varies 
among MRSA strains.  
 
Dual-function RNAs in eukaryotes 
In eukaryotes, there are several different classes of ncRNAs have been defined: short (~20-30-
nt), silencing RNAs (siRNAs) (Fire, Xu et al. 1998), microRNAs (miRNAs) (Gebert and 
MacRae 2019), PIWI-interacting RNAs (P-element induced wimpy testis or piwiRNA (Iwasaki, 
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Siomi et al. 2015)); small ncRNAs smaller than 200-nt; and long ncRNAs (greater than 200-nt) 
(Burenina, Oretskaya et al. 2017). Long non-coding RNAs (lncRNAs) is a term that broadly 
describes RNA transcripts that are several thousand nucleotides in length and include long 
intergenic ncRNAs (lincRNAs) and enhancer RNAs (eRNAs) (Lam, Li et al. 2014). Given the 
large number of ncRNA types in eukaryotes, it is likely that there will be more diversity in the 
organization and types of dual-function RNA than are present in bacteria.  
 
Small ORFs in lncRNAs 
Perhaps one of the most intriguing potential types of dual-function RNA in eukaryotes are the 
lncRNAs that encode small proteins. However, the regulatory function of lncRNAs has, in most 
cases, not been demonstrated (Mercer, Dinger et al. 2009). Using ribosome profiling and  
Table 2. Dual-function RNAs in eukaryotes. 
examining sequence conservation, some lncRNAs have been shown to contain small conserved 
ORFs (Andrews and Rothnagel 2014, Aspden, Eyre-Walker et al. 2014, Mackowiak, Zauber et 
al. 2015). However, despite evidence to confirm the synthesis of these small proteins their 
cellular relevance remains largely unexplored. An interesting example of one of the small 
proteins that has been well described is the 46 amino acid myoregulin protein which inhibits the 
Sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) pump (Anderson, Anderson et al. 2015, 
Name Organism Protein Name Protein Function RNA function 
Sqt D. rerio Squint Signaling in mesendoderm 
patterning and specification 
of the neural tube.  
The 3' UTR associates with 
scaffolding RNA binding 
proteins and initiation of dorsal 
axis specification. 
Oskar D. melanogaster Oskar Involved in late oogenesis. The 3' UTR associates with 
scaffolding RNA binding 
proteins and regulates early 
oogenesis. 
DMPK H. sapiens DM1 protein 
kinase 
Necessary for maintenance 
of skeletal muscle structure 
and function. 
The CUG repeat expansion in 
the 3' UTR forms a hairpin 
structure that sequesters the 
mRNA and MBNL protein. 
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Anderson, Makarewich et al. 2016, Nelson, Makarewich et al. 2016). Myoregulin forms a 
transmembrane alpha helix and colocalizes with the SERCA pump in the sarcoplasmic reticulum 
membrane to inhibit calcium reuptake (Anderson, Anderson et al. 2015). The Ca2+ pump has 
been demonstrated to be regulated by two other small proteins, phospholamban and sarcolipin, 
raising the possibility that some large transmembrane proteins may be the target of numerous 
smaller proteins that serve to alter their function (Asahi, Kurzydlowski et al. 2002, Asahi, Sugita 
et al. 2003, Shaikh, Sahoo et al. 2016). Given this example, lncRNAs provide an interesting pool 
of potential novel dual-function RNA that remain to be characterized.  
 
Dual-function RNAs in animal development 
Another type of dual-function RNA in eukaryotes are those RNAs that play a structural role in 
embryonic development. Early embryogenesis in many animals relies upon many maternal 
transcripts that are deposited in oocytes and guide the initial stages of development. These 
maternal RNAs are widely believed to be under tight post-transcriptional control in order to 
regulate the spatial and temporal expression of their protein (Bashirullah, Cooperstock et al. 
2001, Tadros and Lipshitz 2005, Bettegowda and Smith 2007, Kugler and Lasko 2009). In the 
last decade, studies in Drosophila and zebrafish have suggested that some of the oocyte localized 
transcripts may have additional roles beyond coding for protein (Kloc, Wilk et al. 2005, Jenny, 
Hachet et al. 2006, Lim, Kumari et al. 2012). For example, Oskar (osk) was originally identified 
as a maternal-effect gene required for antero-posterior patterning in Drosophila embryogenesis 
(Lehmann and Nusslein-Volhard 1986). In early oogenesis, osk mRNA is transported to oocytes 
where it localizes to posterior poles and is translated to give the Osk protein, which is required 
for embryonic patterning and germ cell formation (Ephrussi, Dickinson et al. 1991). Females 
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with osk knockouts failed to lay eggs but could be complemented by nonsense mutant alleles that 
still expressed osk RNA. This led to a series of experiments that ultimately demonstrated that 
expression of osk 3’UTR alone is sufficient to rescue the eggless phenotype of osk-null mutants 
(Jenny, Hachet et al. 2006). The osk 3’UTR was subsequently discovered to include a motif 
recognized by RNA-binding proteins (RBP) that induce the formation of RBP scaffolds that are 
important for embryonic development (Ephrussi, Dickinson et al. 1991, Jenny, Hachet et al. 
2006). The mechanisms underlying the non-coding functions of osk RNA are still being studied. 
 A second example is Squint (sqt) in zebrafish, which encodes a nodal-related signaling 
molecule from the transforming growth factor beta (TGFβ) superfamily with a well-studied role 
in mesendoderm patterning, specification of the ventral neural tube, and left-right axis 
development (Rebagliati, Toyama et al. 1998, Shen 2007, Schier 2009). The protein is also 
involved in embryonic development, playing an important part in germ layer patterning (Shen 
2007). However, sqt RNA is localized to one or two cells by the 4-cell stage and these 
asymmetrically localized sqt transcripts play a role in dorsal axis specification independent of 
mRNA activity (Lim, Kumari et al. 2012). Depletion of sqt RNA using antisense 
oligonucleotides produces embryos with defective dorsal structures (Gore, Maegawa et al. 2005). 
These dorsal defects can be rescued by expressing the sqt 3’UTR. By using mutants of sqt, 
including one with a stop codon in the second codon and the other with a truncation to remove 
the 3’ end of the RNA and the potential ORF, researchers suggest that the 3’ UTR sqt RNA 
contributes to initiation of dorsal axis specification by binding and transporting unknown factors 
(Lim, Kumari et al. 2012). Thus, sqt mRNA is a potential dual-function RNA with an RNA 
function in embryogenesis that is separate from protein coding activity. 
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mRNAs in which disease-causing mutations lead to aberrant RNA function 
A final potential category of dual-function RNA in eukaryotes are mRNAs where an aberrant 
non-coding function arises from acquired mutations. These mutant RNA molecules acquire an 
additional RNA specific function that undermines normal mRNA translation. The autosomal 
dominant inherited disease, myotonic dystrophy (DM), displays multi-system symptoms like 
muscle wasting, myotonia, cardiac defects, and reduced cognitive ability. The mutation 
associated with type 1 myotonic dystrophy is caused by a CUG repeat expansion in the 3’UTR of 
DM protein kinase (DMPK) that is expressed in tissues affected by DM (Mahadevan, Tsilfidis et 
al. 1992). Research has shown that the disease is caused by gain of function from the expanded 
CUG repeats. The repeats form a stable hairpin structure that causes the mutant DMPK mRNA to 
sequester in discrete foci and deplete actively translating DMPK mRNA (Michalowski, Miller et 
al. 1999). This is a scenario in which a mutation in an RNA transcript gives a normal mRNA a 
new function that alters localization and causes disease. 
 
Open questions regarding dual-function RNAs 
The origins of dual-function RNA and how these molecules internally regulate their separate 
components remain largely unanswered questions in both eukaryotes and bacteria. In bacteria, 
only SgrS has had the competition between its components carefully examined but no eukaryotic 
dual-function RNA has been studied in such depth. Furthermore, a better understanding of 
whether these molecules evolve de novo, from a progenitor RNA, or the combination of two 
separate RNA fragments would provide much information on what are the essential elements of 
a dual-function RNA. 
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Competition between activities of dual-function RNA 
Although the study of dual-function molecules has advanced our knowledge about their targets 
and conservation, little is known about the interaction between their two regulatory functions. 
For many dual-function RNAs there is very little, if any, separation between the RNA binding 
site and the ORF. For some, the two components actually overlap. Furthermore, the levels of 
RNA and protein are sometimes independent of one another suggesting that there are conditions 
where the RNA functions and others where the protein is translated. Ribosomal occupancy of an  
mRNA would serve as an impediment for base pairing interactions. Similarly, the base pairing 
necessary for regulation may disrupt translation initiation. It is not difficult to imagine that the 
dual nature of these molecules must somehow be controlled to allow each component to function 
in situations where they are in competition. As of the writing of this dissertation, SgrS remains 
the only dual-function RNA to have the competition between components explored 
(Balasubramanian and Vanderpool 2013). The balance between translation and base pairing 
regulation within dual-function RNA permits for additional layers of regulation. The competition 
within a single molecule is a concept that should be addressed for every dual-function RNA that 
is identified and described. Fortunately, as more of these molecules are characterized our 
understanding of different types of competition will also expand.  
 
Evolution of dual-function RNAs 
Studying how these regulatory molecules evolve would provide important insights into whether 
they are generated de novo or develop from an existing RNA that gains additional functionality. 
Developing an understanding for the evolution of any RNA is greatly aided through phylogenetic 
analysis across species and strains. Evolution of dual-function RNAs is not well understood as 
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there are only a handful that have been characterized. Furthermore, most dual-function RNAs are 
first characterized as either a ncRNA or a small protein until the second function is uncovered. 
SgrS was first understood to be sRNAs until a functional ORF was discovered. However, 
RNAIII and Pel RNA were originally characterized as mRNAs until a base pairing function was 
identified for both. Does a ncRNA evolve to encode a small protein or does the small ORF 
develop base pairing capabilities? The identification of more dual-function RNA will facilitate 
the study of their evolution. 
A dual-function RNA will presumably need to possess at least some of the characteristics 
of a regulatory ncRNA. The evolution of dual-function RNA would presumably have similar 
requirements with the evolution of regulatory ncRNAs. These requirements were recently 
reviewed and include an environmentally-sensitive promoter, a rho-independent terminator, and 
a relatively unstructured seed sequence region to permit base pairing (Updegrove, Shabalina et 
al. 2015). Each of these features levy restrictions on the sequence of the sRNA and thus the 
evolution of the sRNA. Interestingly, these restrictions are apparently not so onerous as to 
prevent significant changes in sRNA sequence (Gottesman and Storz 2011). An investigation 
into the conservation of dual-function RNA across bacterial species would shed much light on 
how these unique molecules develop. Further study of the evolution of dual-function RNA will 
contribute to our understanding of what features are important for their function. 
 
Perspectives 
This work seeks to add to the existing pool of characterized dual-function RNAs, explore the 
features that are important for their function, and further our understanding of how competition 
between components guides the regulatory activity of these molecules. As we have discussed, 
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examples of dual-function RNA are relatively rare in both bacteria and eukaryotes, but more are 
being discovered every year. Despite their scarcity, these molecules can have potent regulatory 
function. For example, Oskar RNA plays a critical role in early embryogenesis of Drosophila, 
and in Staphylococcus aureus RNAIII is the primary effector of the agr quorum-sensing system 
(Balaban and Novick 1995). This dissertation will describe the characterization of two new dual-
function RNA and the creation of a synthetic dual-function RNA in order to more fully examine 
how competition between components impacts the regulation of these interesting RNA 
molecules.  
The first dual-function RNA characterized in my dissertation is AzuCR, which was first 
identified in a bioinformatic search for novel sRNAs in E. coli (Chen, Lesnik et al. 2002). It was 
then discovered to be a potential dual-function RNA when translation of a 28 amino acid protein, 
AzuC, was detected (Hemm, Paul et al. 2008). AzuC levels are induced by low pH, high 
temperature, and hydrogen peroxide (Hemm, Paul et al. 2010). This work demonstrates that 
AzuC interacts with GlpD, the aerobic glycerol 3-phosphate dehydrogenase, leading to an 
increase in GlpD activity. cadA and galE were identified as base pairing targets of AzuCR. 
Interestingly, AzuC translation also disrupts the base pairing base pairing regulation of cadA and 
galE, another example of competition between components of a dual-function RNA.  
The second dual-function RNA I will examine is Spot 42, one of the first sRNAs 
described in E. coli. Spot 42 is repressed by the transcription factor cAMP receptor protein (Crp) 
and regulates numerous targets involved in carbon catabolite repression (De Lay and Gottesman 
2009, Beisel and Storz 2011). Spot 42 is found to encode a small ORF that translates a 15 amino 
acid protein, SpfP, that interacts with Crp to interfere with transcriptional activation of Crp 
targets. As the base pairing region and ORF overlap, the temperature dependent increase in 
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translation also changes the regulatory activity of the sRNA function of Spot 42. As the SpfP 
ORF overlaps the base pairing regions of Spot 42, we seek to understand how translation of the 
small protein both contributes to and interferes with the already characterized functions of this 
RNA. 
Both AzuCR and Spot 42 are examples of dual-function RNA whose components 
overlap. To better study the organization and the competition between components I designed a 
synthetic dual-function RNA. The goal of constructing this synthetic dual-function RNA was to 
gain insight into the functional constraints that govern the organization and design of these 
unique RNA molecules. I used the small protein MgtS and the sRNA MgrR as the functional 
components of a synthetic dual-function RNA MgtSR. MgtS is a 31 amino acid small inner 
membrane protein that is required for the accumulation of MgtA, the Mg2+ transporter. MgrR is a 
98 nt sRNA that negatively regulates eptB (phosphoethanolamine transferase). Various versions 
of this synthetic dual-function RNA were used to examine how organization of components is 
important for the proper function of both activities and eliminates competition between the two 
activities. 
The mysteries behind the structure and function of dual-function RNA can only be 
understood through further study and identification. Searching bacterial and eukaryotic genomes 
for novel dual-function RNA will allow for a greater understanding of these molecules. This 
dissertation focuses on understanding the competition between activities of dual-function RNA. 
The question of when and why translation of the ORF or base pairing can be the dominant 
activity is a persistent and interesting question that I attempt to answer by characterizing AzuCR 






AzuCR RNA modulates carbon metabolism as a dual-function RNA 
 
Abstract 
Bacteria have evolved small RNAs (sRNAs), to regulate numerous biological processes and 
stress responses. While sRNAs are generally considered to be “noncoding”, a few have been 
found to also encode a small protein. Here we describe one such dual-function sRNA that 
modulates carbon utilization in Escherichia coli. The 164 nucleotide RNA was previously shown 
to encode a 28 amino acid protein (denoted AzuC). We discovered the membrane-associated 
AzuC protein interacts with GlpD, the aerobic glycerol 3-phosphate dehydrogenase, leading to 
increased GlpD activity. Overexpression of the RNA encoding AzuC leads to a growth defect in 
glycerol and galactose medium. The defect in galactose medium was still observed for a stop 
codon mutant, pointing to a potential regulatory role for the RNA. Consistent with this 
observation, we found that cadA and galE are repressed by base pairing with the RNA (denoted 
AzuCR). Interestingly, translation of AzuC interferes with the observed repression of cadA and 
galE by AzuCR and base pairing interferes with AzuC translation, showing that the translation 





Bacteria are exposed to rapidly changing environmental conditions, which include variations in 
carbon availability, pH, temperature and osmolarity, to name a few. To survive in these 
fluctuating conditions, bacterial cells utilize fast, flexible, and energy-efficient mechanisms to 
regulate protein amounts and activity. Changes in nutrient availability or stress detected by the 
cell are transduced into changes in the activation or repression of transcription, post-
transcriptional changes to mRNA stability, the modulation of mRNA translation as well as the 
modification of protein stability or activity.  
For carbon source availability in E. coli studied here, the sequence-specific DNA binding 
protein CRP is a key regulator of transcription. When the levels of the preferred carbon source 
glucose are low, the levels of the small molecule cAMP increase. cAMP binds and activates the 
highly conserved CRP transcription factor, which in turn activates genes for the uptake and 
utilization of alternative carbon sources in a process termed carbon catabolite repression (CCR) 
(reviewed in (Soberon-Chavez, Alcaraz et al. 2017)). 
 Small RNAs (sRNAs), which are commonly transcribed under specific environmental 
conditions and modulate the stability or translation of mRNAs through short base pairing 
interactions, are major post-transcriptional regulators in bacteria (reviewed in (Wagner and 
Romby 2015)). In many cases, these sRNAs require RNA chaperones such as Hfq and ProQ for 
their stability and for optimal base pairing with their target mRNAs (reviewed in (Updegrove, 
Zhang et al. 2016, Olejniczak and Storz 2017, Holmqvist, Li et al. 2018)). Several sRNAs 
including GlmY, GlmZ, ChiX and the CRP-repressed sRNAs Spot 42 and CyaR have been 
found to impact carbon metabolism in E. coli (reviewed in (Papenfort and Vogel 2014, Durica-
Mitic, Gopel et al. 2018)). 
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The majority of the base-paring sRNAs are thought to not encode an open reading frame 
(ORF). However, a few sRNAs have been shown to be translated to give small proteins and thus 
are denoted “dual-function sRNAs” (reviewed in (Raina, King et al. 2018)). Computational 
analyses of the genomes of fourteen phylogenetically diverse bacteria predicted that a number of 
other sRNAs contain small ORFs (smORFs) that could encode proteins between 10-50 amino 
acids (Friedman, Kalkhof et al. 2017). However, translation of these smORFs has only been 
documented in a limited number of cases. Even fewer sRNA-encoded translation products have 
experimentally been demonstrated to have a function.  
Small proteins of less than 50 amino acids generally have been long overlooked due to 
many challenges related to their annotation and biochemical detection. The few that have now 
been studied show that small proteins modulate diverse cellular functions ranging from 
morphogenesis and cell division to transport, enzymatic activities, regulatory networks, and 
stress responses by forming complexes with larger proteins (reviewed in (Storz, Wolf et al. 2014, 
Hemm, Weaver et al. 2020)). 
To date, the only dual-function sRNA identified and characterized in E. coli is SgrS, 
which is involved in the regulation of carbon metabolism (Wadler and Vanderpool 2007). The 
SgrS sRNA was first found to protect cells against elevated levels of glucose phosphate by 
regulating the stability and translation of mRNAs encoding proteins involved in glucose 
transport and catabolism (Vanderpool and Gottesman 2004). The sRNA subsequently was shown 
to encode a 43-amino-acid protein, SgrT, which interacts with the glucose importer PtsG to block 
glucose transport and promote utilization of nonpreferred carbon sources to maintain growth 
during glucose-phosphate stress (Wadler and Vanderpool 2007, Lloyd, Park et al. 2017). Thus, 
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both the sRNA and its encoded small protein act together to repress glucose import to relieve 
glucose phosphate stress.  
The 164-nt RNA initially denoted IS092 or IsrB (now denoted AzuCR) was first noted in 
a bioinformatic search to identify 
new sRNA genes in E. coli 
(Chen, Lesnik et al. 2002). 
Subsequently, this RNA was 
found to encode a 28 amino acid 
ORF (Hemm, Paul et al. 2008) 
(Fig 3A). Synthesis of the small 
protein was documented by the 
detection of a tagged derivative 
(Hemm, Paul et al. 2008) and is 
supported by data indicating 
ribosome binding to the RNA 
(Weaver, Mohammad et al. 2019) 
(Fig 3A). While the protein, 
denoted AzuC, is only conserved 
in a limited number of enteric 
bacteria (Fig 3B), expression of AzuC was found to be highly regulated. The levels of the tagged 
small protein were elevated for growth in glucose compared to glycerol due to CRP-mediated 
repression in the absence of glucose (Hemm, Paul et al. 2010). AzuC-SPA levels also were 
shown to be reduced under anaerobic conditions but induced upon exposure to low pH, high 
 
Figure 3. Ribosome binding to and conservation of azuC. 
A) The azuC open reading frame lies within a region that was 
previously reported to encode the IsrB sRNA (Chen, Lesnik et 
al. 2002). Translation is detected by ribosome density on the 
isrB gene for an untreated control (gray) (Weaver, Mohammad 
et al. 2019), and cells treated with the translation inhibitors 
Onc112-treated (blue) (Weaver, Mohammad et al. 2019) or 
retapamulin-treated (red) (Meydan, Marks et al. 2019).  
B) The AzuC amino acid sequences from E. coli K12 and other 
bacterial species aligned with ClustalW (Madeira, Park et al. 
2019). “*” indicates the residues are identical in all sequences 
and “:” and “.” respectively indicate that conserved and semi-
conserved substitutions as defined by ClustalW.  
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temperature, and hydrogen peroxide suggesting an important role in cellular stress responses 
(Hemm, Paul et al. 2010).  
Here we show that AzuC is associated with the membrane and binds GlpD, an essential 
enzyme required for glycerol catabolism, increasing GlpD activity in presence of glycerol. 
Additionally, we document that the transcript acts as a regulatory sRNA, denoted AzuR, 
repressing expression of cadA, a lysine decarboxylase involved in maintaining pH homeostasis, 
and galE, encoding UDP-glucose 4-epimerase, through direct base pairing. Thus, AzuCR has 
mRNA and sRNA activities in two different pathways, and we find that there is inherent 
competition between the two activities. Intriguingly, while the transcript base pairs with other 
mRNAs as a regulator, translation of AzuC itself is repressed by the FnrS sRNA, an sRNA that 
also represses GlpD synthesis.  
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Results 
AzuC protein and mRNA levels are discordant for cells grown in glucose and low pH 
glycerol 
Previous analysis of chromosomally-encoded AzuC, which was C-terminally tagged with the 
sequential peptide affinity (SPA) tag, showed that AzuC-SPA protein levels were elevated in 
cells grown in minimal medium with glucose compared to glycerol as well as in pH 5.5 
 Figure 4. AzuC protein synthesis is regulated at a 
post-transcriptional level.  
A) Diagram of the AzuC RNA and sequence of the 
azuC promoter and coding region.  Boxes and 
text in light blue denote AzuC coding sequence 
and yellow box and highlighted text denote 
region of base pairing with target mRNAs. The 
AzuCR transcript is indicated in bold with the 
+1 site of transcription (position 1988001 of the 
E. coli K-12 genome) in green font and the 3´ 
end of the transcript in red font. The ribosome 
binding site and the start (ATG) and the stop 
codons (TAA) of the AzuC ORF are indicated 
by black boxes. Potential σ70 -10 and -35 
sequences are underlined, the predicted Crp 
binding sites are highlighted in light gray 
(Hemm, Paul et al. 2010) and the region 
targeted by the FnrS sRNA is highlight in dark 
gray. 
B) Immunoblot blot analysis of AzuC-SPA levels 
(top) and northern blot analysis of azuC mRNA 
levels (bottom) for cells grown in with different 
carbon sources. Cultures of the azuC-SPA::kan 
(GSO351) or unmarked (MG1655) strains were 
grown in M63 medium supplemented with 
glucose, glycerol, or galactose at pH 7.0 or 5.5. 
Samples were taken at to OD600 = 0.5 and 1.5. 
α-FLAG antibody was used to detect the SPA 
tag. The membrane was stained with Ponceau S 
stain to control for loading. The azuC mRNA 
and 5S RNA were detected by probes specific 
to each of these transcripts.  
C) Immunoblot blot analysis of AzuC-SPA levels 
in hfq+ (GSO351) and ∆hfq (GSO1007) cells 
grown in with different carbon sources. Strains 
were grown in the same media as in (B) and 
collected at OD600 = 1.5. Immunoblot blot 
analysis also was carried out as in (B). 
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compared to pH 7.5, and decreased under anerobic conditions (Hemm, Paul et al. 2010). The 
decreased levels in minimal glycerol medium and part of the pH-induction were attributed to 
Crp-mediated repression of azuC mRNA transcription.  
To further evaluate the conditions under which AzuC-SPA and azuC mRNAs levels are 
highest, strains were cultured in M63 media supplemented with glucose or glycerol at pH 7.0 and 
5.5, and in M63 galactose at pH 7.0. Cells were collected in exponential (OD600 = 0.5) and 
stationary (OD600 = 1.5) phase (Fig 4B). As observed previously, AzuC-SPA levels were 
significantly higher in glucose compared to glycerol and galactose. A notable exception was the 
elevated AzuC-SPA levels in cells grown to stationary phase in glycerol at pH 5.5. As expected 
for a Crp-regulated transcript, azuC mRNA levels were low for all conditions except for cells 
grown to exponential phase in glucose. The discordance between AzuC-SPA protein levels and 
azuC mRNA levels in glycerol at pH 5.5 raised the possibility that translation and/or RNA or 
protein stability is regulated and that the protein and RNA may have different roles.  
Hfq is a key regulator of posttranscriptional regulation in many bacterial cells (reviewed 
in (Updegrove, Zhang et al. 2016, Holmqvist, Li et al. 2018)). To determine whether Hfq had 
any impact on AzuC, AzuC-SPA levels were compared in wild type and ∆hfq cells grown to 
stationary phase under the same conditions as above (Fig 4C). AzuC-SPA levels were elevated in 
the ∆hfq strain for the cells grown in M63 galactose. This observation is consistent with potential 
posttranscriptional repression by Hfq together with base-pairing sRNAs.  However, before 
delving further into the regulation of AzuC expression, we wanted to learn more about the 
function of the 28 amino acid protein. 
 
AzuC protein is localized to the membrane 
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Information about the subcellular 
localization of proteins can give clues 
about possible interacting partners and 
functions in the cell. Secondary 
structural predictions suggested that 
AzuC has the potential to fold into an 
amphipathic helix (Fig 5A), indicating 
the protein might associate with the 
membrane. To test this, AzuC-SPA 
cells grown in M63 glucose to OD600 
~1.0 were lysed, and cell extracts were 
homogenized and fractionated into 
soluble, inner membrane and outer 
membrane fractions by sucrose 
cushion fractionation (Rhoads, Tai et 
al. 1984, Fontaine, Fuchs et al. 2011). 
Consistent with the secondary structure 
prediction, immunoblot analysis of the 
fractions showed that AzuC-SPA was 
enriched in the inner membrane 
fraction, while the OmpA control protein was enriched in the outer membrane fraction (Fig 5B). 
Similar fractionation of untagged AzuC, expressed from a plasmid and detected by α-AzuC 
antiserum, also showed enrichment in the membrane fraction (Fig 6A).  
 
Figure 5. AzuC protein is membrane associated.  
A) Helical wheel projection generated using NetWheels 
(Mól, Castro et al. 2019) showing amphipathic nature of 
AzuC. Mutations introduced in (C) are indicated. 
B) Fractionation of AzuC-SPA strain. A culture expressing 
AzuC-SPA (GSO351) was grown in M63 medium 
supplemented with 0.2% glucose, and cells were 
fractionated into a soluble, inner membrane, and pellet 
fractions, which were compared to the whole cell lysate. 
The top panel shows AzuC-SPA as detected with a-
FLAG antibody. The bottom panel shows the outer 
membrane OmpA control detected with a-OmpA 
antibody.  
C) Microscopy of AzuC-GFP. AzuC-GFP (GSO1008) and 
AzuC-GFP IL>EE mutant (GSO1009) cells were grown 
in M63 glucose medium to OD600=0.5 to observe 
membrane localization by fluorescent microscopy. Left 
panels are fluorescent images showing GFP labeled AzuC 
and the right panels are the corresponding brightfield 
images.  Insets provide an enlargement of a few cells. 
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The localization of AzuC to the membrane was further confirmed by fluorescence 
microscopy imaging of chromosomally expressed AzuC C-terminally tagged by with GFP (Fig 
5C). While wild type AzuC-GFP showed clear membrane localization, mutations replacing 
hydrophobic residues with charged residues (I6L7 to E6E7) eliminated the membrane localization. 
Taken together, these data support the hypothesis that AzuC is inserted into the membrane as an 
amphipathic helix. 
 
AzuC protein interacts with GlpD 
To further investigate the AzuC role in the cell, we carried out co-purification assays to identify 
interacting proteins. Cells expressing chromosomally encoded AzuC-SPA or previously 
characterized AcrZ-SPA (Hobbs, Yin et al. 2012) as a control were grown in M63 glucose 
medium. Cell lysates prepared from exponentially growing cells were applied to calmodulin 
 
Figure 6. Fractionation showing subcellular 
localization of untagged AzuC and AzuC-SPA co-
purification with GlpD-HA-His6 compared to 
untagged control strain. 
A) AzuC was overexpressed at low levels from the 
arabinose-inducible PBAD promoter on the multicopy 
pAZ3 plasmid derivative of pBAD18 (Kawano, 
Reynolds et al. 2005). After induction with arabinose, 
cell extracts were fractionated into periplasmic, 
cytoplasmic, and membrane fractions. The fractions 
were then examined on immunoblots using 
polyclonal a-AzuC primary antibody followed by a-
rabbit secondary antibody. AzuC expressed from the 
chromosome could not be detected by the polyclonal 
a-AzuC antibody. 
B) AzuC-SPA cells grown in M63 glucose and MG1655 
cells or GlpD-HA-His6 cells grown in M63 glycerol, 
to OD600~ 1 were mixed in a 1:1 ratio. The mixed 
cells were homogenized, cell lysates (L) were applied 
to anti-HA beads and the flow-through (FT) fractions 
were collected. The beads were washed (W), after 
which the bound proteins were eluted (E) and 
examined on immunoblots using either a-HA 
antibodies to detect GlpD-HA-His6 (top panel) or a-
FLAG antibodies to detect AzuC (bottom panel). 
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beads, and the eluants from each column were separated by SDS-PAGE (Fig 7A). Unique bands 
from each of the elutions were sent for mass spectrometric analysis for identification. In two 
independent experiments, a prominent band of ~60 kDa observed only for the AzuC-SPA cells 
was identified as the aerobic glycerol 3-phosphate dehydrogenase (GlpD), which catalyzes the 
oxidation of glycerol 3-phosphate. The most prominent band in the AcrZ sample was AcrB, a 
known interactor (Hobbs, Yin et al. 2012).  
We tested the interaction between AzuC and GlpD, by assessing reciprocal co-
purification of AzuC-SPA with GlpD-HA-His6. Cells with chromosomally encoded AzuC-SPA, 
grown to exponential phase in M63 glucose medium, were mixed with cells with chromosomally 
encoded GlpD-HA-His grown to exponential phase in M63 glycerol medium, a condition where 
GlpD is known to be expressed. The mixed cells were lysed and incubated with dodecyl β-D-
maltoside (DDM) to facilitate mixing of the membrane fractions. The mixed lysate was then 
applied to α-HA beads, washed and eluted. The eluates were analyzed for the respective 
 
Figure 7. AzuC copurifies with GlpD.  
A) GlpD co-purifies with AzuC-SPA. Cells expressing AzuC-
SPA (GSO351) or AcrZ-SPA (GSO350) from the 
chromosome were grown in M63 glucose medium to OD600~ 1 
or in LB to OD600~ 0.6, respectively. The cell lysates were 
split and passed over calmodulin beads. Eluants from each 
column were subjected to SDS/PAGE followed by Coomassie 
blue staining. The bands enriched in the eluant from the 
calmodulin beads and indicated by the arrows were excised 
from the gel and identified by mass spectrometry.  
B) AzuC-SPA co-purifies with GlpD-HA-His6. Cells expressing 
either AzuC-SPA (GSO351) or GlpD-HA-His6 (GSO1011) 
from the chromosome were grown in M63 glucose or M63 
glycerol media, respectively, to OD600~ 1 and mixed in a 1:1 
ratio. As a control, cells expressing MgtA-HA (GSO785) 
grown in N medium supplemented without added MgSO4 to 
OD600~ 0.5, were mixed with the AzuC-SPA (GSO351) cells 
in the same ratio. The mixed cells were homogenized, cell 
lysates (L) were applied to anti-HA beads and the flow-
through (FT) fractions were collected. The beads were washed 
(W), after which the bound proteins were eluted (E) and 
examined on immunoblots using either a-HA antibodies to 
detect MgtA-HA or GlpD-HA-His6 (top panel) or a-FLAG 
antibodies to detect AzuC (bottom panel). 
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Figure 8. AzuC increases GlpD activity and affects cell shape.  
A) Effect of AzuC overexpression on GlpD activity. WT or ∆azuC::kan cells (top panel), ∆azuC::kan 
(GSO193) (middle panel) or ∆azuC ∆glpD::kan (GSO1015) (bottom panel) cells transformed with pKK, 
pKK-AzuC, and pKK-AzuCL3STOP were grown in M63 glucose medium to OD600~1.0. Cells were washed 
and resuspended in M63 glycerol medium, pH 5.5 for 3 h prior to measurement of dehydrogenase activity 
based on the reduction of MTT to formazan.  
B) Effects of AzuC overexpression on E. coli cell morphology. ∆azuC::kan (GSO193) transformed with 
pKK, pKK-AzuC, pKK-AzuCL3STOP, or pKK-GlpD were grown in M63 glucose medium to OD600~1.0. 
Cells were washed and resuspended in M63 glycerol medium, pH 5.5 for 3 h prior to microscopy. 
 29 
tagged proteins by carrying out immunoblot analysis by using α-FLAG and α-HA antibodies 
(Fig 7B). As controls, similar purifications were carried out by mixing the AzuC-SPA cells with 
cells lacking tagged proteins grown in M63 glycerol medium (Fig 6B) or cells expressing 
chromosomally encoded MgtA-HA grown in N medium without added MgSO4 to induce MgtA 
expression (Fig 7B). Consistent with the first purification, AzuC-SPA co-purified with GlpD-
HA-His6 and not with MgtA-HA, supporting the conclusion that GlpD is an interacting partner 
of AzuC. As we predict for AzuC, GlpD has been reported to be a peripheral membrane protein 
which associates with the membrane through an amphipathic alpha helix (Walz, Demel et al. 
2002). 
 
AzuC protein increases GlpD activity  
Binding of AzuC to GlpD could potentially impact the stability, localization or activity of the 
enzyme as has been found for other small proteins (Hobbs, Yin et al. 2012, Wang, Yin et al. 
2017). To distinguish among these possibilities, we first examined the levels of chromosomally 
encoded GlpD-HA-His6 in cells carrying pKK, pKK-AzuC or pKK-AzuCL3STOP. In the latter two 
plasmids, the wild type or mutant (harboring a stop codon mutation of the third codon) azuC 
ORF was cloned downstream of the heterologous Ptac promoter and ribosome binding site on 
pKK. Cells were grown in M63 glucose medium to OD600~1.0 and then transitioned to glycerol 
(pH 5.5) for 3 h given that chromosomally expressed AzuC-SPA levels are elevated under these 
conditions (Fig 4B). The GlpD-HA-His6 levels were similar for all three strains grown under 
these conditions (Fig 9A).  
To test whether AzuC affects GlpD activity, we employed a dehydrogenase activity 
assay. In this assay, cellular dehydrogenase activity in cell extracts is measured by the reduction 
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of 2-(4,5-dimethyl-2-thiazolyl)-3,5-diphenyl-2H-tetrazolium bromide (MTT) to formazan, which 
accumulates and is detected at OD570 (Wegener, Vogtmann et al. 2016). Dehydrogenase activity 
was found to be almost 2-fold lower in the absence of AzuC when extracts were made from a 
WT and a ∆azuC strain grown in M63 glucose medium and shifted to glycerol (pH 5.5) for 3 h. 
In contrast, overexpression of wild type AzuC, but not AzuCL3STOP, led to an increase in the 
dehydrogenase activity for the extracts (Fig 8A, middle panel). To further verify that this 
increase was GlpD dependent, the assay was repeated in a ∆azuC ∆glpD double mutant. The 
double mutant did not show the increase in dehydrogenase activity upon AzuC overexpression 
 
Figure 9. Effect of AzuC overexpression on GlpD levels at pH 5.5 and on GlpD activity at pH 7.0. 
A) ∆azuC cells expressing GlpD-HA-His6 (GSO1013) were transformed with pKK, pKK-AzuC, and pKK-
AzuCL3STOP, grown in M63 glycerol medium to OD600~0.5 and examined on immunoblots using a-HA 
antibodies to detect GlpD-HA-His6. The membrane was stained with Ponceau S stain to control for loading. 
B) MG1655 or ∆azuC (GSO193) cells (top panel) or ∆azuC (GSO193) cells transformed with pKK, pKK-AzuC, 
or pKK-AzuCL3STOP (bottom panel) were grown in M63 glucose medium to OD600~0.5 and then washed and 
resuspended in M63 glycerol medium at pH 7.0. Cells were allowed to grow for an additional 3 h at which 
point the dehydrogenase activity assay was performed. 
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(Fig 8A, bottom panel), indicating that the interaction of the small protein AzuC with GlpD 
increases the dehydrogenase activity of the larger protein. Interestingly, the pKK-AzuCL3STOP 
plasmid gave rise to a GlpD-dependent decrease in dehydrogenase activity. We think this may be 
due to regulatory activity of the RNA (see below). The dehydrogenase assay also was carried out 
with these strains shifted to M63 glycerol, pH 7, where we observed similar, albeit somewhat 
smaller, effects of ∆azuC and AzuC overexpression on activity (Fig 9B).  
 
AzuC overexpression causes an increase in cell length  
The substrate for GlpD, glycerol-3-phosphate, is a precursor for phospholipid biosynthesis. Thus, 
we wondered whether increasing the activity of GlpD by AzuC might bias the flow of glycerol-
3-phosphate towards glycerol metabolism rather than phospholipid biosynthesis, which could 
impact cell morphology. To assess this, we carried out live-cell phase contrast microscopy of 
cells carrying the pKK vector control, pKK-AzuC or pKK-AzuCL3STOP (Fig 8B). We observed 
AzuC overexpressing cells, but not those carrying the vector or pKK-AzuCL3STOP, had an 
elongated morphology. The elongated morphology was similar to the morphology observed for 
cells upon GlpD overexpression (Fig 8B) as well as in cells lacking phosphatidylethanolamine, 
which comprises ~75% of the membrane phospholipid (Rowlett, Mallampalli et al. 2017).  
 
AzuC and GlpD protein levels are repressed by the FnrS small RNA  
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We previously reported that AzuC levels are higher under aerobic compared to anaerobic 
conditions (Hemm, Paul et al. 2010). Similarly, GlpD is required under aerobic conditions and is 
downregulated during anaerobic growth while a second glycerol dehydrogenase, GlpABC, is 
required under anaerobic 
conditions. Interestingly, 
interactions between the 
anaerobic-induced sRNA FnrS 
and both the azuC and glpD 
mRNAs were found in genome-
wide assays of RNA-RNA 
interactions on the Hfq 
chaperone (Melamed, Peer et al. 
2016, Melamed, Adams et al. 
2020). We also could predict 
base pairing between the 5´ end 
of FnrS and azuC as well as 
glpD (Fig 10A and 10C). These 
observations suggested possible 
FnrS-mediated repression of 
AzuC and GlpD synthesis. Consistent with this hypothesis, we observed higher AzuC-SPA 
levels in a ∆fnrS strain (Fig 11A) and lower AzuC-SPA levels upon overexpression of WT FnrS 
and previously generated FnrS-I and FnrS-II mutants (Durand and Storz 2010) but not FnrS-III 
for which base pairing is predicted to be disrupted (Fig 10B).  We similarly observed that WT 
 
Figure 10. FnrS sRNA represses synthesis of both AzuC and GlpD.  
A) Predicted base pairing between FnrS and azuC. The coordinates for 
both are relative to the +1 of the transcript.  
B) Effect of FnrS overexpression on AzuC-SPA levels. Cultures of the 
azuC-SPA::kan (GSO351) strain carrying pBR, pBR-FnrS, pBR-
FnrS-I, pBR-FnrS-II, or pBR-FnrS-III were grown in LB with 1 
mM IPTG to OD600~ 0.5. a-FLAG antibodies were used to detect 
the SPA tag.  
C) Predicted base pairing between FnrS and glpD. The predicted region 
of pairing in glpD is within the coding sequence. The coordinates 
for FnrS are relative to the +1 of the transcript, while the 
coordinates for glpD are relative to the first nucleotide of the start 
codon.  
D) Effect of FnrS overexpression on GlpD-HA-His6 levels. Cultures of 
the glpD-HA-His6 (GSO1011) strain carrying pBR, pBR-FnrS, 
pBR-FnrS-I, pBR-FnrS-II, or pBR-FnrS-III were grown in LB with 
1 mM IPTG to OD600~ 0.5. a-HA antibodies were used to detect 
GlpD-HA-His6. 
For (B) and (D), the membrane was stained with Ponceau S stain to 
control for loading. 
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FnrS, FnrS-I and FnrS-II, but not FnrS-III repressed an azuC-lacZ translational fusion expressed 
from the heterologous PBAD promoter (Fig 11B). Repression was restored for the FnrS-III mutant 
but not WT FnrS, FnrS-I, and FnrS-II by compensatory mutations in the azuC-lacZ-III mutant 
fusion demonstrating direct base-pairing between FnrS and the azuC mRNA. We also observed 
slightly lower levels of the GlpD-HA-His6 protein upon overexpression of WT FnrS, FnrS-I and 
FnrS-II, but not FnrS-III (Fig 10D). Together these results indicate that the 5´ end of FnrS base 
pairs with the azuC and glpD mRNAs to repress synthesis of AzuC and GlpD.  
 
 
Figure 11. FnrS sRNA represses AzuC expression. 
A) AzuC-SPA levels in strains lacking Hfq or FnrS. 
AzuC-SPA levels in WT (GSO351), ∆hfq 
(GSO1007) or ∆fnrS (GSO1023) strains grown in 
LB to OD600~ 0.5. a-FLAG antibody was used to 
detect the SPA tag. 
B) β-galactosidase activity was assayed for  PBAD-5´-
UTRazuC-lacZ  (GSO1024) or PBAD-5´-UTRazuC-
lacZ -III (GSO1025) cells carrying pBR, pBR-
FnrS or pBR-FnrS mutants (pBR-FnrS I, II or III). 
Cells were grown to OD600~0.4-0.5 and treated 
with either just arabinose (0.2%) (black bars) or 
arabinose (0.2%) and IPTG (1 mM) (white bars), 
and cells were grown another 40 min. The average 
of three independent trials is shown, and the error 
bars represent one SD. 
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AzuCR overexpression reduces growth in glycerol and galactose 
Given the AzuC effect on GlpD together with the different AzuC levels for cells grown in the 
presence of different carbon sources, we examined the consequences of AzuC overexpression 
from the pKK vector for growth in glucose and glycerol at pH 7.0 and 5.5 and galactose at pH 
7.0 (Fig 13 and Fig 12A). Consistent with the larger effect of AzuC on GlpD activity in M63 
glycerol pH 5.5 compared to pH 7.0, we observed a significant growth defect for cells grown 
under these conditions for 16 h but not for the pKK vector control and pKK-AzuCL3STOP strain 
(Fig 13). A similar phenotype was observed for overexpression of AzuC-SPA indicating that the 
 
Figure 12. Growth curves for AzuC 
and AzuCR overexpression.  
A) ∆azuC::kan strain (GSO193) 
transformed with pRI, pRI-
AzuCR, pRI-AzuCRL3STOP, pKK, 
pKK-AzuC, or pKK-AzuCL3STOP 
was grown in M63 medium with 
different carbon sources: glucose 
(pH 7.0), glycerol (pH 7.0 and 
5.5), and galactose (pH 7.0) and 
growth was tracked by OD600 over 
30 h. 
B) Growth of the ∆azuC::kan strain 
(GSO193) transformed with pKK, 
pKK-AzuC, pKK-AzuCL3STOP, or 
pKK-AzuC-SPA in M63 medium 
with glycerol pH 5.5 was 
measured at 16 h after dilution by 
OD600.   
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tagged derivative of AzuC is functional (Fig 12B). Growth in minimal medium with either 
glucose or galactose was not significantly changed by the pKK-AzuC plasmid. 
We also examined the effect of overexpressing the full-length azuC mRNA (pRI-AzuCR) 
without or with the L3STOP mutation (pRI-
AzuCRL3STOP) (Fig 13). Interestingly, we observed 
different effects on growth for these plasmids. 
While growth in minimal glucose was not affected, 
pRI-AzuCR led to a growth defect in glycerol pH 
7.0 and even more so in pH 5.5 as well as in 
galactose pH 7.0. Contrary to the detrimental effect 
of the L3STOP mutation when only the azuC 
coding sequence was included, the L3STOP 
mutation in the full-length transcript still blocked 
growth and, in glycerol pH 7.0, actually 
exacerbated the growth defect. This observation 
suggested the transcript could have a second role as 
a regulatory RNA, which we have denoted AzuR.  
 
AzuR functions as an sRNA to repress cadA and 
galE  
Based on our findings that the AzuCR transcript 
could have a second role as an sRNA, we 
investigated its potential as a base-pairing sRNA 
 
Figure 13. AzuC and AzuR 
overexpression leads to different 
growth phenotypes in different 
carbon sources.  
Growth of the ∆azuC::kan strain (GSO193) 
transformed with pKK, pKK-AzuC, pKK-
AzuCL3STOP, pRI, pRI-AzuCR, or pRI-
AzuCRL3STOP in M63 medium with different 
carbon sources, glucose (pH 7.0), glycerol 
(pH 7.0 and 5.5), and galactose (pH 7.0), 




Figure 14. AzuR represses cadA and galE expression.  
A) AzuCR-cadA base pairing predicted by TargetRNA2 (Kery, Feldman et al. 2014). Mutations introduced into 
AzuCR and cadA are indicated. The coordinates for AzuCR are relative to the +1 of the transcript, while the 
coordinates for cadA are relative to the first nucleotide of the start codon. 
B) Effect of AzuCR and AzuCRL3STOP overexpression on a cadA-gfp fusion in wild type and ∆azuC backgrounds. WT 
and ∆azuC::kan (GSO193) cells were co-transformed with a reporter plasmid expressing a cadA-gfp translational 
fusion and either the empty pRI vector, AzuCR or AzuCRL3STOP.  
C) Test of AzuCR-cadA base pairing. ∆azuC::kan (GSO193) cells were cotransformed with the WT cadA-gfp 
translational fusion reporter plasmid or a M1 derivative with mutations in the predicted region of base pairing along 
with the empty pRI vector, AzuCRL3STOP, or mutant AzuCRL3STOP-M1. The mutations in the cadA-gfp translational 
fusion and AzuCRL3STOP are indicated (A). 
D) AzuCR-galE base pairing predicted by IntaRNA (Mann, Wright et al. 2017). Mutations introduced into AzuCR and 
galE are indicated. The coordinates for AzuCR are relative to the +1 of the transcript, while the coordinates for galE 
are relative to the first nucleotide of the start codon. 
E) Effect of AzuCR and AzuCRL3STOP overexpression on a galE-gfp fusion in wild type and ∆azuC backgrounds. WT 
and ∆azuC::kan (GSO193) cells were co-transformed with a reporter plasmid expressing a galE-gfp translational 
fusion and either the empty pRI vector, AzuCR or AzuCRL3STOP.  
F) Test of AzuCR-galE base pairing. ∆azuC::kan (GSO193) cells were cotransformed with the WT galE-gfp 
translational fusion reporter plasmid or a M2 derivative with mutations in the predicted region of base pairing along 
with the empty pRI vector, AzuCRL3STOP, or mutant AzuCRL3STOP-M2. The mutations in the galE-gfp translational 
fusion and AzuCRL3STOP are indicated in (D). 
For (B), (C), (E) and (F), cells were grown in LB for 3 h before measuring the fluorescence corresponding to GFP 
expression. The the average of three independent trials is shown, and the error bars represent one SD. 
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by searching for possible base pairing targets using TargetRNA2 (Kery, Feldman et al. 2014) and 
IntaRNA (Fallmann, Will et al. 2017) prediction programs. Given the reduced growth associated 
with AzuCR overexpression in cells grown in galactose and low pH, we focused on potential 
targets encoding activities that might be important under these conditions. One predicted target 
with extensive potential base pairing was cadA, encoding lysine decarboxylase (Fig 14A). 
Consistent with AzuR-mediated regulation of cadA, we observe decreased expression of a cadA-
gfp fusion upon AzuCR overexpression (Fig 14B). Interestingly, the derivative with a stop codon 
at the third codon of AzuC (AzuCRL3STOP) had a stronger repressive effect than wild type 
AzuCR. Additionally, there were higher overall levels of cadA-gfp expression in the ∆azuC 
strain compared to the WT strain, suggesting that chromosomally encoded AzuC contributes to 
the repression. Consistent with the base pairing predicted in Fig 14A, the M1 mutations in 
AzuCRL3STOP reduced cadA-gfp repression, while regulation was restored when compensatory 
mutations were introduced in the cadA-gfp construct (Fig 14C). Another predicted target for base 
pairing with AzuR was galE (Fig 14D), the first gene in the galETKM galactose operon. The 
AzuCRL3STOP derivative also repressed a galE-gfp fusion in both the WT and ∆azuC 
backgrounds, with partial repression by AzuCR (Fig 14E). Again, there is direct base pairing 
between AzuCR and galE, as the M2 mutations in AzuCRL3STOP or galE alone reduced AzuCR-
mediated galE-gfp repression, while repression was restored when both compensatory mutations 
were present (Fig 14F). 
 
AzuCR RNA association with Hfq and ProQ is not required for cadA repression 
Consistent with the observation that ∆hfq impacts AzuC protein levels (Fig 4B), we found that 
the AzuCR mRNA co-immunoprecipitates with Hfq (Fig 15A). Another RNA chaperone that has 
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been found to bind to sRNA-mRNA pairs in E. coli and impacts the stability of some RNAs is 
ProQ (Melamed, Adams et al. 2020). As with Hfq, AzuCR co-purifies with ProQ (Fig 15A). 
However, in contrast to the increased AzuCR RNA levels in the ∆hfq background, AzuCR RNA 
levels were decreased in the ∆proQ background. We wondered whether AzuCR functions as an 
sRNA repressor were mediated by Hfq or ProQ and examined repression of the cadA-gfp in ∆hfq 
and ∆proQ single as well as ∆hfq ∆proQ double mutant backgrounds. GFP activity levels overall 
were lower when Hfq was absent, but we observed cadA-gfp repression by AzuCRL3STOP 
overexpression in all backgrounds (Fig 15B). These observations indicate that although both Hfq 
and ProQ bind to AzuCR, the RNA chaperones are not required for the repression of cadA when 
AzuCRL3STOP is overexpressed, possibly due to the long region of potential base pairing. 
 
AzuC translation and AzuR base pairing activity interfere  
The region of base pairing between AzuR and cadA and galE (89-107-nt relative to the 
transcription start) overlaps the azuC coding sequence (40-126 nt relative to the transcription 
start) raising the question of whether the mRNA and base pairing activities of the AzuCR RNA 
interfere which each other. This supposition that translation interferes with base pairing is 
supported by the observations that AzuCRL3STOP was more effective at repressing the cadA-gfp 
and galE-gfp fusions than AzuCR (Fig 14B and 14E). To determine if base pairing activity also 
interferes with translation, we examined the levels of chromosomally encoded AzuC-SPA upon 
overexpression of the base pairing regions of cadA and galE along with control regions of these 
genes not predicted to base pair with AzuCR. Interestingly, no repression was observed for cells 
grown in M63 glucose. In contrast, the base pairing fragments, but not the control fragments, led 
to decreased AzuC-SPA levels for cells grown in M63 with galactose (Fig 15C). These 
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observations suggest that base pairing can interfere with translation, particularly when AzuC 
protein levels overall are low as is the case for cells grown in M63 galactose.  
 
Figure 15. AzuCR mRNA and base pairing activities are differentially affected by Hfq and ProQ.  
A) AzuCR co-immunoprecipitation with Hfq and ProQ. Co-IP was carried out on cellular extracts from MG1655 
(GSO982), ∆hfq-cat::sacB (GSO954) and ∆proQ::kan (GSO956) cells using α-Hfq or α-ProQ antiserum. Total 
and RNA chaperone-bound RNA was extracted and subjected to Northern analysis using a primer specific for 
AzuCR.  
B) Effect of ∆hfq::kan (GSO955), ∆proQ::kan (GSO956) and ∆hfq ∆proQ::kan (GSO959) double mutant on AzuCR 
repression of cadA-gfp. cadA-gfp expression from pXG10-SF in the presence of AzuCR or AzuCRL3STOP in WT, 
∆hfq or ∆proQ backgrounds.The average of three independent trials is shown, and the error bars represent one 
SD. 
C) Effect of cadAbase pairing, cadAcontrol, galEbase pairing and galEcontrol on AzuC-SPA levels in cells (GSO351) transformed 
with the respective overexpression plasmid and grown in M63 medium supplemented with glucose or galactose. 
Samples were taken at OD600 ~ 0.5 and α-FLAG antibody was used to detect the SPA tag. The membranes stained 
with Ponceau S stain serves as a loading control. 
D) Model for the different functions of the AzuCR RNA. For growth in M63 glycerol, pH 5.5, the RNA can be 
translated to give the 28 amino acid amphipathic AzuC protein, which activates the activity of GlpD glycerol 
dehydrogenase.  Under anaerobic conditions this translation and the translation of GlpD is blocked by the FnrS 





Successful adaptation to varying environmental conditions requires regulation that can rapidly 
change metabolism. Along with transcription factors, sRNAs and small proteins are emerging as 
important regulators. While base-pairing sRNAs generally are not thought to be translated, a few 
have been reported to encode small proteins. Even fewer of these dual-function sRNAs have 
been characterized. Here we report that the 164-nt RNA previously reported to encode a 28 
amino acid small protein (AzuC) (Hemm, Paul et al. 2010) also functions as a regulatory RNA 
(AzuR). The AzuC protein binds and increases activity of GlpD, an enzyme at the junction of 
respiration, glycolysis, and phospholipid biosynthesis (Fig 7), while the RNA base pairs with and 
represses expression of the cadA and galETKM mRNAs (Fig 14).  
 
AzuCR is a unique dual-function sRNA 
There are a number of features of AzuCR that are unique compared to other dual-function 
sRNAs. First, while the regions involved in base pairing and protein coding are separate for the 
well-characterized E. coli SgrS-SgrT and Staphylococcus aureus RNAIII dual-function sRNAs, 
the region of AzuCR involved in base pairing with the cadA and galE targets overlaps the azuC 
coding sequence (Fig 4A). Another notable feature of this dual-function RNA is that while the 
gene is not broadly conserved, the levels of the RNA and protein are highly regulated. In our 
previous study, we observed the AzuC protein accumulates in minimal glucose medium as well 
as in response to low pH, high temperature and hydrogen peroxide, while the levels are low 
under anaerobic conditions (Hemm, Paul et al. 2010). The regulation in response to glucose 
availability was shown to be at the transcriptional level via Crp derepression. In our current 
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study, we show that AzuC repression under anaerobic conditions is mediated by the Hfq-
dependent sRNA FnrS, which base pairs near the AzuC ribosome binding site (Fig 10A). To the 
best of our knowledge, FnrS regulation of AzuCR is the first example of another sRNA 
regulating the translation of a dual-function sRNA. The observation that AzuC levels are higher 
in ∆hfq compared to ∆fnrS mutant cells (Fig 11A) suggests that still other Hfq-dependent sRNAs 
might repress AzuC synthesis. This is further emphasized by the discordance between RNA and 
protein levels under some conditions (Fig 4B).  
Consisted with the discordant expression of the AzuCR RNA compared to the AzuC 
protein, we found that the small protein and base pairing activities modulate overlapping but 
distinct pathways; AzuC plays a role in glycerol metabolism (Fig 7 and 8) and AzuCR impacts 
galactose and glycerol metabolism (Fig 13). The regulation of different pathways by the two 
activities of AzuCR contrasts with SgrST RNA where the SgrT protein and the base-pairing SgrS 
RNA both down-regulate the PtsG glucose transporter activity.  
 
AzuC stimulation of GlpD activity 
Although the functions of only a few small proteins have been described, most are inhibitory. 
Thus, AzuC is unique in that it increases GlpD activity. GlpD, one of the key flavin-linked 
primary dehydrogenases of the respiratory electron transport chain, catalyzes the oxidation of 
glycerol-3-phosphate to dihydroxyacetone phosphate (DHAP) (Yeh, Chinte et al. 2008). GlpD 
exists in in both soluble and membrane-bound forms and is only fully active when the enzyme is 
associated with the cytoplasmic membrane through lipid-enzyme interactions or when 
reconstituted with phospholipids in vitro (Schryvers, Lohmeier et al. 1978, Robinson and Weiner 
1980, Yeh, Chinte et al. 2008). Interestingly, GlpD activity was previously reported to be 
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increased by amphipaths (Robinson and Weiner 1980). Like GlpD, AzuC is also an amphipathic 
protein localized to the cytoplasmic membrane (Fig 5). Thus, it is possible that AzuC promotes 
GlpD binding to the cytoplasmic membrane. AzuC also could change the stability of GlpD, 
though we did not observe obvious differences in protein levels (Fig 9A). Alternatively, AzuC 
could increase GlpD by causing a conformational change of the protein upon binding. It is 
intriguing that expression of both AzuC and GlpD is repressed by the sRNA FnrS, which is 
expressed under anaerobic conditions. Under these conditions, GlpABC, the anaerobic glycerol-
3-phosphate dehydrogenase, serves the same role as GlpD. 
The physiological role of AzuC activation of GlpD, particularly at pH 5.5, is also an 
interesting question. We suggest AzuC binds GlpD under acidic conditions to modulate the 
levels of glycerol-3-phosphate. As a substrate for phospholipid biosynthesis, glycerol-3-
phosphate undergoes two acylation steps to form phosphatidic acid, which in turn is converted to 
the intermediate CDP-diacylglycerol (CDP-DAG), the precursor for the phospholipids 
phosphatidylethanolamine (PE), phosphatidylglycerol (PG) and cardiolipin (CL). E. 
coli membranes are composed of ∼75% PE, ∼20% PG, and ∼5% CL under normal growth 
conditions. Bacterial adaptation to environmental stress can be accompanied by cellular envelope 
remodeling, including changes in the LPS structure, and the protein content of the outer 
membrane and/or the inner membrane, as well as the phospholipid composition (Rowlett, 
Mallampalli et al. 2017). These changes in turn impact ell division, energy metabolism, 
osmoregulation as well as resistance to cationic antimicrobial peptides. In support of a 
hypothesis that AzuC activation of GlpD might affect membrane composition, we observed that 
cells overexpressing AzuC or GlpD grown in low pH showed increased cell length (Fig 8B) and 
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slow growth (Fig 13), phenotypes that have also been observed in cells lacking the phospholipids 
PE and CL (Rowlett, Mallampalli et al. 2017).   
 
AzuR repression of the cadA and the galETKM mRNAs 
We found that as a base pairing RNA, AzuR represses expression of CadA (Fig 11A, B and C), 
which is induced under acidic growth conditions and confers resistance to weak organic acids 
produced during carbohydrate fermentation under conditions of anaerobiosis and phosphate 
starvation. This regulation could partially explain the growth defect for cells growing in glycerol 
pH 5.5 observed upon AzuCR overexpression without and with a stop codon (Fig 13). We also 
identified galETKM mRNA as a direct AzuR target (Fig 14D, E and F). Consistent with this 
regulation, we see a drastic growth defect with galactose as the sole carbon source upon 
overexpression of AzuCR without and with a stop codon (Fig 13). While AzuR base pairs near 
the ribosome binding site of the cadA mRNA likely blocking ribosome binding, the base pairing 
with the galETKM mRNA interestingly is internal to the galE coding sequence. We suggest that 
for this mRNA, base pairing may lead to changes in mRNA stability or alternatively Rho-
dependent transcription termination reported for the galETKM mRNA (Wang, Ji et al. 2014). 
Since we also observe an RNA-dependent growth phenotype for cells grown in glycerol pH 7, 
we suggest that AzuR might target other genes, particularly genes related to glycerol 
metabolism. 
 
Competition between two AzuCR activities 
Several of our experiments indicate that there is competition between the mRNA and base 
pairing activities of AzuCR. We observed that a stop codon blocking translation improves AzuR 
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base pairing activity (Fig 14B and 14E) and overexpression of fragments of the base pairing 
targets cadA and galE inhibits AzuC translation (Fig 15). The conflict between base pairing and 
translation raises intriguing questions about what activity predominates under different growth 
conditions, whether the RNA can transition from one function to the other, what factors 
determine which activity predominates, and how the two activities evolved. We suggest that 
there are a number of scenarios for how AzuCR could act. There may be conditions where 
AzuCR acts solely a riboregulator, other conditions where AzuCR is solely an mRNA. Finally, 
there may be conditions where there are two populations of AzuCR, some transcripts acting as an 
sRNA and others being translated. It is also possible that AzuCR first acts as an mRNA, but 
subsequently goes on to act as a riboregulator.  
The factors that regulate the distribution of AzuCR between these regulatory roles are not 
fully understood but clearly depend on the levels of the sRNAs that repress AzuC translation, the 
levels of the mRNA targets of AzuCR, the levels of the Hfq and ProQ chaperones and likely 
other factors. The observed FnrS-dependent repression of AzuC synthesis is at least partially 
dependent on Hfq, while the stability of the RNA appears to depend on ProQ. The finding that 
AzuCR may only be a base-pairing RNA under specific conditions raises caveats for global 
approaches examining sRNA function by pulse overexpression or sRNA targets such as RIL-seq 
(Melamed, Peer et al. 2016). If these experiments are carried out under conditions where 
translation predominates, the effects of the base pairing activity may not be detected. These 
questions about AzuCR likely are relevant for other dual-function sRNAs and are an important 




Material and Methods 
 
Bacterial strains and plasmid construction 
Bacterial strains, plasmids, and oligonucleotides used in this study are listed in Appendix Tables. 
E. coli strains are derivatives of wild-type MG1655 (F- lambda- ilvG- rfb-50 rph-1). Tagged 
strains were generated by λ Red–mediated recombineering (Yu, Ellis et al. 2000) using NM400 
and the oligonucleotides listed in the Appendix. The chromosomal PBAD-5´UTRazuC-lacZ and 
PBAD-5´UTRazuC-lacZ III fusions (carrying the first 87-nt of the azuC mRNA fused to the 
seventh codon of the lacZ coding sequence) were created by carrying out PCR using primers 
listed in the Appendix to amplify the desired region of azuC followed by integration of the 
product into the chromosome of PM1205 (Mandin and Gottesman 2009). Alleles marked by 
antibiotic markers were moved between strains by P1 transduction. When necessary, kanamycin 
resistance cassettes were excised from the chromosome by FLP-mediated recombination 
(Cherepanov and Wackernagel 1995). All chromosomal mutations and fusions and plasmid 
inserts were confirmed by sequencing. 
 
Bacterial growth 
Cells were grown to the indicated OD600 in Luria-Bertani broth (LB) or M63 minimal media 
supplemented with 0.001% vitamin B1 and glucose, glycerol or galactose (0.2%, 0.4% or 0.2%, 
respectively) after a 1:100 dilution of the overnight culture. For some experiments, M63 medium 
was buffered to pH 5.5 with 100 mM MES. Where indicated, media contained antibiotics with 
the following concentrations: ampicillin (100 μg/ml), chloramphenicol (25 µg/ml) and 




The cell pellet from 1 ml of cells grown in the indicated medium was resuspended in 1X PBS 
(KD Medical), and 10 µl were loaded on a Mini-PROTEAN TGX 5%–20% Tris-Glycine gel 
(Bio-Rad) and run in 1X Tris Glycine-SDS (KD Medical) buffer. The proteins were electro-
transferred into nitrocellulose membranes (Invitrogen) for 1 h at 100 V. Membranes were 
blocked with 5% non-fat milk (BioRad) in 1X PBS with 0.1% of Tween 20 (PBS-T) for 1 h and 
probed with a 1:3,000 dilution of α-FLAG-HRP antiserum (Sigma), 1:1,000 dilution of α-AzuC 
antiserum (New England Peptide); 1:1,000 dilution of α-His-HRP antiserum (Qiagen), or 1:1,000  
dilution of α-OmpA antiserum (Antibody Research Corporation) in the same PBS-T buffer with 
5% milk for 1 h. After the incubation with the α-AzuC and α-OmpA antiserum, membranes were 
incubated with a 1:2,000 dilution of HRP-labelled anti-rabbit antibody (Life Technologies). All 
blots were washed 4X with PBS-T and then developed with an Amersham ECL Western Blotting 
Detection Kit (GE Healthcare).  
 
Total RNA isolation 
Cells corresponding to the equivalent of 10 OD600 were collected by centrifugation, and snap 
frozen in liquid nitrogen. RNA was extracted according to the standard TRIzol (Thermo Fisher 
Scientific) protocol. Briefly, 1 ml of room temperature TRIzol was add to cell pellets, 
resuspended thoroughly to homogenization, and incubated for 5 min at room temperature. After 
the addition of 200 µl of chloroform and thorough mixing by inversion, samples were incubated 
for 10 min at room temperature. After samples were centrifuged for 10 min at 4˚C on maximal 
speed, the upper phase (~0.6 ml) was transferred into a new tube and 500 µl of isopropanol was 
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added. Samples again were mixed thoroughly by inversion, incubated for 10 min at room 
temperature and centrifuged at maximal speed for 15 min at 4˚C. RNA pellets were washed 
twice with 75% ethanol and then dried at room temperature. RNA was resuspended in 20-50 µl 
of DEPC water and quantified using a NanoDrop (Thermo Fisher Scientific). 
 
Northern analysis 
Total RNA (5-10 µg per lane) was separated on denaturing 8% polyacrylamide gels containing 6 
M urea (1:4 mix of Ureagel Complete to Ureagel-8 (National Diagnostics) with 0.08% 
ammonium persulfate) in 1X TBE buffer at 300 V for 90 min. The RNA was transferred to a 
Zeta-Probe GT membrane (Bio-Rad) at 20 V for 16 h in 0.5X TBE, UV-crosslinked, and probed 
with 32P-labeled oligonucleotides (Listed in Table 1) in ULTRAhyb-Oligo buffer (Ambion Inc.) 
at 45˚C. Membranes were washed twice with 2X SSC/0.1% SDS at room temperature, once with 
0.2X SSC/0.1% SDS at room temperature, washed for 25 min with 0.2 × SSC/0.1% SDS at 
45˚C, followed by a final wash with 0.2X SSC/0.1% SDS at room temperature before 
autoradiography was performed with HyBlot CL film (Denville Scientific Inc.). 
 
Sub-cellular fractionation 
Cells with chromosomally encoded AzuC-SPA were grown in the indicated medium at 37˚C to 
an OD600~0.3, centrifuged at 20,000 × g for 10 min at 4˚C, resuspended in 1/20 vol of 20% 
sucrose, 50 mM Tris pH 8, 1 mM EDTA, and 0.1 mg/ml lysozyme, followed by a 1 h incubation 
at 25˚C with gentle shaking. After the cells were centrifuged at 20,000 × g for 15 min at 4˚C, the 
top periplasmic fraction was removed. The pellet fraction was resuspended in water to lyse the 
spheroplasts. The resulting crude lysate was passed through a 30-gauge syringe needle 6X to 
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homogenize the sample and reduce viscosity. The lysate was then clarified by centrifugation at 
20,000 × g for 5 min at 4˚C. This was repeated 3X. A 500 µl of the clarified lysate was layered 
on top of a 500 µl-sucrose cushion (5 mM EDTA and 1.4 M sucrose. Samples were centrifuged 
at 130,000 × g for 2 h at 4˚C in a TLA100.3 rotor (Beckman Optima TLX tabletop centrifuge). 
Following centrifugation, 425 µl was carefully removed from the top layer (soluble fraction). 
Then, the interface and remaining liquid were removed (inner membrane fraction). The pelleted 
material was resuspended in 500 µl of fractionation buffer (pellet fraction). SDS was added to all 
fractions (final concentration 1%) and the samples were incubated overnight at room 
temperature. Equal volumes of fractions were assayed by immunoblotting with a-FLAG-HRP 
and a-OmpA antibody.  
Cells expressing AzuC from a plasmid were grown as above, collected by centrifuged at 4K 
RPM for 10 min at 4˚C, resuspended as above but incubated 10 min on ice. After the lysate was 
incubated as above the periplasmic fraction removed, the pellet was resuspended in 1 ml of 20% 
sucrose/50mM Tris pH 8 and sonicated with a Sonic Dismembrator Model 100 (Fisher 
Scientific) 3X for 5 sec at power setting 4. Samples were centrifuged 3X at 12,000 × g for 5 min 
at 4˚C to remove unlysed cells. The supernatant was then centrifuged at 56k rpm for 1 h at 4˚C in 
a Beckman TLA100.3 rotor. The supernatant containing the cytoplasmic fraction was removed 
and the pellet containing the membrane fraction was resuspended in 1 ml of 20%sucrose/10mM 
Tris pH 8 by sonication. Equal volumes of fractions were assayed by immunoblotting with 




Cells grown as indicated were harvested, resuspended in phosphate buffered saline (PBS) (KD 
Medical) and placed on lysine-coated glass bottom dish (Mattek Corporation). Cells were fixed 
by applying a 1% agarose pad on top of the sample with gentle pressure. Cells were viewed with 
a DeltaVision Core microscope system (Applied Precision) equipped with an environmental 
control chamber. Bright field and fluorescence images were captured with a Photometrics 
CoolSnap HQ2 camera. Seventeen planes were acquired every 0.2 μm at 22˚C, and the data were 
deconvolved using SoftWorx software (GE Healthcare). 
 
Purification of chromosomally encoded SPA-tagged AzuC  
Cells expressing AzuC-SPA (GSO351) cells grown in LB at 37˚C overnight culture were diluted 
1:100 into 1 l of M63 glucose minimal media and incubated at 37˚C. At OD600 ~1, cells were 
collected by centrifugation (4,650 × g, 20 min). The pellet was resuspended in 20 ml of TNG 
buffer [10 mM Tris (pH 7.5), 100 mM NaCl, 10% glycerol] supplemented with Protease 
Inhibitor Cocktail (Roche). The cells were lysed using a microfluidizer processor (Microfluidics) 
at 20,000 psi, and the insoluble cellular debris was removed by centrifugation (20,000 × g, 30 
min). The cleared lysate was incubated with 50 mM dodecyl β-D-maltoside (DDM) at 4˚C for 2 
h. Next the lysate supplemented with DDM was split and added to either 500 µl of a-FLAG M2-
agarose beads from mouse (Sigma) or calmodulin-sepharose beads (Amersham Biosciences) 
overnight at 4˚C. The lysate and beads were applied to a Bio-Spin disposable chromatography 
column (Bio-Rad Laboratories) and allowed to drain by gravity. The α-FLAG columns were 
washed with 15 mL of TNG buffer with 2 mM DDM while the calmodulin column was washed 
15 mL of TNG buffer with 2 mM DDM, 5 mM β-ME, and 2 mM CaCl. Finally, proteins were 
eluted from the α-FLAG column with 1 ml of elution buffer (0.1M glycine pH 3.5, 100 mM 
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NaCl and 0.1% Triton X-100). The proteins from the calmodulin column were eluted in 1 ml 
TNG buffer supplemented with 4 mM EDTA, 5 mM β-ME, and 2.5% SDS. To analyze the 
protein samples, 7.5 μl of 2X Laemmli buffer was added to 21 μl of each sample. The samples 
were heated at 95˚C for 5 min, and aliquots were subjected to SDS/PAGE in a 10–20% Tris-
glycine gel (Invitrogen) at 12 V/cm. Proteins were visualized with Coomassie Blue Stain. Bands 
of interest were excised from the gel and analyzed by liquid chromatography-tandem mass 
spectrometry (LC-MS/MS). An identical purification was carried out for cells with chromosomal 
acrZ-SPA (GSO350) grown in 1 L of LB to OD600~0.6. 
 
Purification of chromosomally encoded HA-His-tagged GlpD 
MG1655 cells or cells expressing AzuC-SPA (GSO351), GlpD-HA-His (GSO1011) or the 
control MgtA-HA (GSO785) from the chromosome grown in LB at 37˚C for 16 h, were diluted 
1:100 into 1 L of M63 glycerol minimal medium, M63 glycerol minimal medium, M63 glucose 
minimal medium or 1 L of N medium with 500 µM MgSO4, respectively and incubated at 37˚C. 
The WT strain and strains expressing GlpD-HA-His6 and AzuC-SPA were grown to OD600~1. 
The strains expressing MgtA-HA were grown to OD600~0.4–0.6, collected, washed 2X in N 
medium without added MgSO4, resuspended in N medium without added MgSO4 and grown for 
another 2.5 h to induce MgtA-HA expression. For all cultures, cells were collected by 
centrifugation (4,650 × g, 20 min) and resuspended in 15 ml of TNG buffer supplemented with 
Protease Inhibitor Cocktail (Roche). Cells from the SPA tagged protein cultures were mixed with 
the control WT or HA-tagged protein cultures at a 1:1 ratio. To ensure thorough mixing, cells 
were shaken gently at 4˚C for 15 min. The cells were then homogenized as for the SPA-tagged 
protein purification and incubated with 50 mM DDM in 4˚C for 2 h. The insoluble cellular debris 
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was removed by centrifugation (20,000 × g, 20 min). Subsequently, the supernatant was applied 
to 100 µL of Pierce Anti-HA magnetic beads (Thermo Scientific) in a 50 ml tube and incubated 
overnight at 4˚C. Beads were collected with a MagneSphere technology magnetic separation 
stand (Promega) and resuspended in 1 ml of TNG buffer. The beads were washed with 1 ml of 
TNG buffer (10X). The beads were then resuspended in 1XPBS (50 µl) and 2X Laemmli buffer 
(50 µl) and heated at 95˚C for 5 min. Samples (15 µL) were analyzed on immunoblots using a-
His or M2 a-FLAG antibodies.  
 
Dehydrogenase activity assay 
Cells were grown in M63 glucose minimal medium to OD600 ~1. Cells were pelleted and 
washed with M63 glycerol medium, pH 7.0 or pH 5.5. Cells were then resuspended in same 
volume of the same medium and grown at 37˚C for 3 h. Cells (500 µl) were pelleted and 
resuspended in 500 µl of lysis buffer (25 mM Tris-HCl, 10 mM NaCl and 0.4% Triton X100). 
Cells were lysed by adding 0.6 g of glass beads and vortexing 30 s followed by 30 s incubation 
on ice, repeated 5X. The cells were then centrifuged at 20,000 × g for 2 min at 4˚C, and the 
lysate was used to measure the dehydrogenase activity. A method monitoring MTT reduction to 
quantitate the dehydrogenase activity of GlpD (Yeh, Chinte et al. 2008) was modified as follows. 
Each 225 µl microcuvette contained the following: 25 mM Tris/HCl pH 7.4, 100 mM NaCl, 1 
mM MTT (Sigma Aldrich), 3 mM phenazine methosulfate (PMS, Sigma Aldrich) and 100 µl of 
lysate. This was used as the blank, and the reaction was initiated by the addition of 3.7 mM 
DLglycerol-3-phosphate (Sigma Aldrich). The reduction of MTT at 570 nm was continuously 




Cultures were grown in LB to OD600~1.0 with arabinose (0.2%). 100 ul of cells were added to 
700 ul of Z buffer(60 mM Na2HPO4z7H2O, 40 mM NaH2PO4zH2O, 10 mM KCl, 1 
mMMgSO4z7H2O, 50 mMb-mercaptoethanol). After adding 15 ul of freshly prepared  0.1%  
SDS and 30 ul of chloroform to each sample the cells were vortexed for 30 s and then incubated 
at room temperature for 15 m to lyse the cells. At zero time, the assay is initiated by adding 100 
ul of ONPG (4 mg/ml) to each sample in 10 s intervals. The samples are incubated at room 
temperature before the reaction is terminated by the addition of 500 ul of 1M Na2CO3. Then, the 
A420 and A550 values are determined with a spectrophotometer and the absorbance data is 
transferred to a Microsoft Excel spreadsheet to calculate Miller units.  
 
Growth curves 
Colonies of ∆azuC::kan (GSO193) transformed with pRI, pRI-AzuCR, pRI-AzuCRL3STOP, 
pKK, pKK-AzuC or pKK-AzuCL3STOP grown on LB plates were inoculated into glucose (pH 
7.0), glycerol (pH 7.0 and 5.5), and galactose (pH 7.0) and allowed to grow overnight at 37˚C, at 
which point all cultures were in stationary phase. Cultures were diluted to OD600~0.05 (time 0) 
in 25 ml of the same media and grown at 37˚C. OD600 was measured at 16 h or growth was 
followed for 29 h. 
 
GFP reporter assay 
The GFP reporter assay was principally done as described previously (Urban and Vogel 2009, 
Corcoran, Podkaminski et al. 2012). ∆azuC::kan (GSO193) cells were transformed with a cadA-
gfp, cadA-gfp-M1, galE-gfp or galE-gfp-M2 reporter plasmid and a pRI-AzuCR, pRI-
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AzuCRL3STOP, pRI-AzuCRL3STOP-M1 or AzuCRL3STOP-M2 over-expressing plasmid or 
pRI as a control. Single colonies were grown overnight at 37˚C in LB supplemented with 
ampicillin and chloramphenicol. The cultures were diluted to OD600 = 0.05 in fresh medium and 
grown at 37˚C for 3 h in a 96 deep-well plate. An aliquot (1 ml) of each culture was centrifuged 
and the pellet was resuspended in 220 µl of 1X PBS. Fluorescence was measured using the 
CytoFLEX Flow Cytometer (Beckman Coulter). Three biological repeats were analyzed for 
every sample.  
 
Hfq and ProQ co-immunoprecipitation assays 
Cell extracts were prepared from MG1655 cells grown in M63 glucose medium to OD600~0.5. 
Cells corresponding to the equivalent of 20 OD600 were collected, and cell lysates were 
prepared by vortexing with 212-300 µm glass beads (Sigma-Aldrich) in a final volume of 1 ml 
lysis buffer (20 mM Tris-HC, pH 8.0, 150 mM KCl, 1 mM MgCl2, 1 mM DTT). 
Immunoprecipitations were carried according to (Zhang, Wassarman et al. 2002) using 100 µl of 
Hfq antiserum (Zhang, Wassarman et al. 2002) or 100 µl of ProQ antiserum (Melamed, Adams 
et al. 2020), 120 mg of protein-A-sepharose (Amersham Biosciences, Piscataway, NJ) and 950 
µl of cell extract per immunoprecipitation reaction. Immunoprecipitated RNA was isolated from 
immunoprecipitated pellets by extraction with phenol:chloroform:isoamyl alcohol (25:24:1, pH 
8), followed by ethanol precipitation. Total RNA was isolated from 50 µl of cell lysate by 
TRIzol (Thermo Fisher Scientific) extraction followed by chloroform extraction and isopropanol 
precipitation. Total and co-IP RNA samples were resuspended in 20 µl of DEPC H2O and 2 µg 





The AzuCR work has provided insights into the functions of the AzuC small protein and AzuR 
sRNA and revealed how the RNA and protein components of this dual-function RNA compete. 
There are still multiple interesting avenues of research to pursue for AzuCR. Given how transient 
membrane association of GlpD impacts activity of the protein, I think that further investigation 
of the subcellular localization of AzuC during interactions with GlpD could be intriguing. GFP 
and YFP tagged derivatives of AzuC and GlpD have been generated. I could move both proteins 
into the same background and examine their behavior before, during, and immediately after a 
shift from glucose to low pH (5.5) glycerol media. As AzuC translation is induced by this media 
I would expect to see changes in localization of either protein during these shifts.  
I also think it would be interesting to more fully characterize how AzuC modulates GlpD 
activity. Alanine mutagenesis could be carried out for the AzuC protein and mutants could be 
overexpressed in ∆azuC cells which would be analyzed by the MTT dehydrogenase activity 
assay. This assay would identify which residues of AzuC are important for altering GlpD 
activity. If this method is successful, the co-precipitation assays that were used to verify the 
interaction of AzuC with GlpD could be repeated with a promising alanine mutant compared 
against wild type AzuC to determine if the mutated residue was important for interaction or 
modulation of GlpD activity.  
This work did not fully explain the underlying mechanisms that control how these two 
overlapping components compete. The hypothesis that AzuCR interacts with ProQ as an sRNA 
and Hfq as an mRNA, based upon the co-immunoprecipitation data, could be pursued to answer 
this question. I think repeating the co-immunoprecipitation of AzuCR RNA with Hfq and ProQ 
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RNA binding proteins in different carbon sources could be valuable to identify conditions where 
AzuCR is potentially acting as an sRNA or an mRNA.  
Another interesting avenue of research is how AzuCR is regulating mRNA targets. An 
interesting experiment would be to overexpress AzuCR RNA and the stop codon control and 
examine the behavior of AzuCR and galE RNA levels by northern analysis. If there is evidence 
that RNA molecules co-degrade then RNA stability could be a guiding factor in determining 
when AzuCR functions as a regulatory RNA or an mRNA. To search for additional mRNA 
targets, I suggest carrying out RIL-seq using a chromosomal stop codon mutant of AzuCR to 
prevent translation of the small protein from disrupting base-pairing interactions. This genomic 
search could be done in many conditions, but I would start in glycerol to search for RNA 
interactions that may also contribute to regulation of glycerol metabolism, as with the small 
protein. I believe that the regulation of AzuCR by the anaerobic sRNA FnrS may not be the only 
regulatory RNA involved in interactions with this dual-function RNA. The RIL-seq analysis 
would also have the potential to identify other regulatory RNAs that interact with AzuCR. 
The work that has been undertaken on AzuCR has identified a novel dual-function RNA 
and characterized how it regulates targets using the RNA and protein functions. This project has 
potential to provide further understanding of the competition between activities of dual-function 





Spot 42 small regulatory RNA encodes a 15-amino acid protein that blocks 
Crp-mediated transcription activation  
 
Abstract 
The 109-nucleotide Spot 42 RNA is one of the best characterized base-pairing small RNAs 
(sRNAs) in E. coli. Transcription of Spot 42 is repressed by the cAMP receptor protein (Crp). 
Consistent with high levels of Spot 42 levels in glucose-grown cells, the RNA blocks the 
expression of transporters and enzymes involved in the utilization of non-preferred carbon such 
as galactose. We now document that Spot 42 also encodes a 15-amino acid protein denoted SpfP. 
Previous studies showed overexpression of Spot 42 reduces growth in galactose and other non-
preferred carbon sources. Overexpression of just the small protein from a Spot 42 derivative 
deficient in base pairing activity also prevented growth on galactose, revealing that the sRNA 
and protein impact the same pathway. Co-purification experiments showed that SpfP binds Crp. 
This binding blocks the ability of Crp to activate specific genes such as the galETKM operon, 
impacting the kinetics of induction when cells are shifted from glucose to galactose medium. 




Carbon catabolite repression (CCR) is a mechanism used by bacteria to promote the use of a 
preferred carbon source in an environment where non-preferred substrates are also available 
(reviewed in (Bruckner and Titgemeyer 2002)). In gram-negative bacteria, like Escherichia coli, 
this is generally achieved by preventing expression of genes involved in catabolism of non-
preferred carbon sources when the preferred carbon source such as glucose is available. In E. 
coli, the key components of the CCR pathway are the IIA component of the glucose-specific 
phosphotransferase system (PTS) [EIIAGlc; also called catabolite repression resistance (Crr) or 
EIIACrr], adenylate cyclase, cAMP, and the cyclic AMP (cAMP) receptor protein (Crp) 
(reviewed in (Kolb, Busby et al. 1993, Gorke and Stulke 2008). When glucose is limiting, the 
PTS proteins, including EIIAGlc, are predominantly phosphorylated. In this form, P-EIIAGlc binds 
to adenylate cyclase and activates cAMP synthesis. The high cAMP levels are sensed by Crp, 
which in turn binds and regulates hundreds of promoters of catabolic genes such as the galETKM 
operon for galactose metabolism and the malEFG operon for maltose metabolism (Zheng, 
Constantinidou et al. 2004). 
             Crp is a bifunctional regulator (reviewed in (Kolb, Busby et al. 1993)). As a 
transcriptional activator, cAMP-bound Crp binds to a sequence located upstream from (class I 
activation) or close to (class II activation) promoter DNA and participates in protein-protein 
interactions with RNA polymerase leading to transcription initiation (reviewed in (Busby and 
Ebright 1999)). Crp has also been shown to negatively regulate expression of several genes by 
inhibiting transcription initiation (Mallick and Herrlich 1979, Aiba 1983). 
In addition to regulating protein-coding genes, E. coli Crp modulates the transcription of 
small regulatory RNAs (sRNAs); repressing Spot 42 expression and activating CyaR expression  
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(Polayes, Rice et al. 1988, De Lay and Gottesman 2009). Spot 42 is a 109 sRNA encoded by 
the spf (spot forty-two) gene found in a-proteobacteria (reviewed in (Baekkedal and Haugen 
2015)). Spot 42 is highly expressed in glucose and its transcription is inhibited by the cAMP-Crp 
complex during growth in non-preferred carbon sources (Polayes, Rice et al. 1988). Many years 
after its first characterization (Ikemura and Dahlberg 1973, Sahagan and Dahlberg 1979), Spot 
42 was shown to bind the RNA chaperone Hfq and base pair with mRNA targets to regulate their 
expression (Moller, Franch et al. 2002). The third gene in the galactose operon, galK encoding 
galactokinase, was the first identified Spot 42 target; down regulation of this gene leads to 
discordant expression of the galactose operon (Moller, Franch et al. 2002). Later, Spot 42 was 
shown to base pair with and repress expression from a number of mRNAs encoding proteins 
involved in the uptake and catabolism of non-preferred carbon sources (Beisel and Storz 2011, 
Beisel, Updegrove et al. 2012). Consistent with this regulation, Spot 42 overexpression 
negatively impacts growth on a number of non-preferred carbon sources (Beisel and Storz 2011). 
            Apart from being an sRNA, Spot 42 RNA resembles a short mRNA. It contains a 
ribosome binding site followed by an AUG start codon, a 15 amino acid open reading frame 
(ORF) and a UGA stop codon (Fig 17A) (Sahagan and Dahlberg 1979). However, an early study 
examining the affinity between Spot 42 and the 70S ribosome showed that although the RNA 
bound to ribosomes, it did so inefficiently and nonproductively (Rice, Polayes et al. 1987). A 
fusion between the Spot 42 ORF to lacZ also did not support the synthesis of b-galactosidase. 
These studies led to the conclusion that Spot 42 does not function as a mRNA (Rice, Polayes et 
al. 1987). 
            Here we report that in fact, Spot 42 encodes a functional small protein (SpfP) in addition 
to acting as a regulatory sRNA and thus should be classified as a dual-function RNA. The small 
 59 
protein, whose levels are elevated at higher temperature, functions by binding to Crp. Binding of 
SpfP to Crp modulates Crp activity by blocking Crp-dependent activation thereby aiding in CCR 
by inhibiting the function of Crp in the presence of glucose and reinforcing the feedforward loop 




Spot 42 regulatory sRNA encodes a 15 amino acid protein 
Ribosome profiling in the presence of translation inhibitors (Onc112 and retapamulin) that trap 
ribosomes on start codons suggested the 15 amino acid ORF encoded by Spot 42 RNA might be 
translated (Fig 16) (Weaver, Mohammad et al. 2019). To directly test whether the protein 
 
Figure 16. Ribosome binding to and 
conservation of spf. 
A) Ribosome density on the spf gene detected 
by ribosome profiling in the presence of 
the translation inhibitors Onc112-treated 
(blue) (Weaver, Mohammad et al. 2019), 
retapamulin-treated (red) (Meydan, Marks 
et al. 2019) and an untreated control 
sample (gray) (Weaver, Mohammad et al. 
2019).  
B) The SpfP amino acid sequences from E. 
coli K12 and other bacterial species 
aligned with ClustalW. “*” indicates the 
residues are identical in all sequences, and 
“:” and “.”indicate that conserved and 
semi-conserved substitutions, respectively, 
as defined by ClustalW.  
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encoded by the predicted ORF is synthesized, we integrated the sequence for the sequential 
peptide affinity (SPA) tag onto the chromosome just upstream of the predicted stop codon. We  
then carried out immunoblot analysis with a-FLAG antibodies to assay for the protein. Given 
that the potential RBS and start codon might by sequestered by a stem-loop in the Spot 42 
structure, we hypothesized that higher temperatures might resolve the stem-loop promoting 
 
Figure 17. Spot 42 is a dual-function sRNA.  
A) Diagram of the Spot 42 RNA and sequence of the 
spf promoter and coding region.  Boxes and text 
in light blue denote SpfP coding sequence and 
yellow box and highlighted text denote region of 
Spot 42 base pairing with target mRNAs. The 
Spot 42 transcript is indicated in bold with the +1 
site of transcription (position 1988001 of the E. 
coli K-12 genome) in green font and the 3´ end of 
the transcript in red font. The ribosome binding 
site and the start (ATG) and the stop codons 
(TAA) of the AzuC ORF are indicated by black 
boxes. A potential σ70 -10 sequence is underlined 
and a predicted Crp binding site (Keseler, Mackie 
et al. 2017) is highlighted in light gray. 
B) Diagram of Spot 42 secondary structure (taken 
from (Updegrove, Shabalina et al. 2015)) with the 
Shine-Dalgarno sequence, start, and stop codon 
boxed. Single-stranded regions involved in base 
pairing with mRNAs are highlighted in yellow. 
The Hfq binding regions are indicated in dark 
blue and double stranded regions are indicated in 
red.  
C) Immunoblot analysis of SpfP-SPA cells 
(GSO1037) grown at 30˚C in LB and transferred 
to 42˚C and 45˚C. Samples collected before heat 
shock at OD600~0.4 and 5- and 10-min following 
heat shock. α-FLAG antibody was used to detect 
the SPA tag. The Ponceau S stain documents 
approximately equal loading of the samples. For 
total RNA isolated for WT cells grown under the 
same conditions, the Spot 42 and 5S RNAs were 
detected with probes specific to each of these 
transcripts. 
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translation (Fig 17B). Cells with the chromosomal SPA fusion grown to exponential phase in LB 
at 30˚C thus were shifted to 30˚C, 42˚C or 45˚C. The tagged protein was detected at all 
temperatures (Fig. 17C) indicating that Spot 42 is also an mRNA encoding a 15 amino acid 
protein, hereafter referred to as SpfP. Interestingly however, compared to the 30˚C samples, the 
levels of SpfP-SPA were higher at 42˚C and 45˚C, particularly at the 5 min time point, while the 
levels of the Spot 42 RNA assayed for cells grown under the same conditions were somewhat 
lower at 42˚C and 45˚C (Fig 17C).  
 
Spot 42 base pairing and protein coding activities can be genetically separated 
Upon documenting SpfP expression, we wondered whether SpfP might be responsible for some 
of the previously observed phenotypes attributed to Spot 42 (Beisel and Storz 2011). To separate 
the protein coding activity from the base pairing activities of spf, we constructed an 
overexpression plasmid encoding only the spfP ORF in which the sequence of two of the Spot 42 
base pairing regions were scrambled while maintaining the proper amino acid sequence of SpfP 
(pKK-SpfP-scram) (Fig 18A). 
To check whether the scrambled construct functioned as a regulatory sRNA, we assayed 
the effect of SpfP-scram overexpression on lacZ fusions to three mRNAs known to be direct 
targets of Spot 42 (Beisel and Storz 2011). β-galactosidase activity was assayed in cells 
expressing nanC-lacZ, srlA-lacZ, and glpF-lacZ translational fusions transformed with vector 
controls or the corresponding plasmids overexpressing either Spot 42 (from pRI, a derivative of 
pKK177-3 without the ribosome binding site) or SpfP-scram (from pKK177-3). Regulation of 
the targets was only observed when the full-length Spot 42 transcript was overexpressed 
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Figure 18. SpfP expression impacts growth on galactose.  
A) Sequence of region encoding 15 amino acid SpfP. Nucleotides changed in the scrambled derivative are 
indicated in blue, and nucleotides changed in the STOP mutants are indicated in red. 
B) β-galactosidase assay of ∆spf nanC-lacZ (GSO440), ∆spf srlA-lacZ (GSO441), and ∆spf glpF-lacZ (GSO519) 
expressing cells transformed with pRI, pRI-Spot 42, pKK, or pKK-SpfP-scram. The cells were grown to 
OD600~1.0 in LB supplemented with 0.2% arabinose. Bars depict average of three biological replicates and 
error bars correspond to the standard deviation. 
C) Growth assays of ∆spf::kan cells (GSO433) transformed with pKK or pKK-SpfP-scram in M63 minimal 
medium supplemented with the indicated carbon sources all at 0.2% except for glycerol, which was at 0.4%.  
D) Growth assays of ∆spf::kan cells (GSO433) transformed with pRI, pRI-Spot42, pRI-Spot42STOP, pKK, pKK-
SpfP-scram or pKK-SpfP-scramSTOP were grown in M63 minimal medium supplemented with either glucose 
(top panel) or galactose (bottom panel).  
For (C) and (D), cells grown overnight in LB with ampicillin were diluted to OD600~0.05 in M63 minimal medium 
with the indicated carbon sources and grown for 16 h, at which point OD600 was measured.  
For (B), (C) and (D), the average of three replicates is showed together with the standard deviation of the mean. 
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suggesting that these targets are regulated by Spot 42 but not by the scrambled construct (Fig 
18B). These data show that SpfP-scram does not function as a base pairing sRNA (Fig 18B). 
To test whether SpfP contributes to Spot 42 phenotypes, we examined how expression of 
SpfP impacts growth on non-preferred carbon sources as previously tested for Spot 42 (Beisel 
and Storz 2011). ∆spf cells were transformed with the overexpression plasmids and OD600 was 
measured after 16 h of growth in M63 minimal media supplemented with either glucose or other 
non-preferred carbon sources. Interestingly, as observed for Spot 42, overexpression of SpfP led 
to a growth defect in minimal medium with most of the non-preferred carbon sources, with 
galactose giving the greatest defect (Fig 18C).  
We also constructed stop mutants of Spot 42 and SpfP to further examine the effects of 
both the RNA and the small protein on growth on galactose. We observed that overexpression of 
full-length Spot 42 produces a growth defect in galactose that is not relieved by the stop codon 
control (Fig 18D). This indicates that overexpression of the sRNA alone is able to produce a 
growth defect. In contrast, a STOP codon mutation eliminated the growth phenotype associated 
with SpfP-scram overexpression. Taken together, these data demonstrate that spf functions as 
both an sRNA and mRNA. 
 
Histidine 10 is critical for SpfP function 
To determine which SpfP residues are important for its observed phenotype in galactose, we 
carried out alanine scan mutagenesis of the SpfP coding sequence in the scrambled-sequence 
context. The mutants were overexpressed in a ∆spf background and growth in M63 galactose 
was measured after 16 h. Cell density was approximately 4-fold less upon overexpression of the 
scrambled small protein (pKK-SpfP-scram) when compared to empty vector. The F2A and S5A 
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Figure 19. SpfP copurifies with Crp.  
A) Growth assays of ∆spf::kan cells (GSO433) expressing alanine-substitution mutants compared to WT pKK-
SpfP-scram in M63 minimal media supplemented with either glucose (top panel) or galactose (bottom panel).  
B) Growth assays of ∆spf::kan cells (GSO433) transformed expressing pKK-SpfP-scram derivatives with either 
an additional N-terminal Y or C-terminal Y in M63 minimal media supplemented with either glucose (top 
panel) or galactose (bottom panel).  
For (A) and (B), cells were assayed as in Fig 18, and the average of three replicates is showed together with the 
standard deviation of the mean. 
C) Crp copurifies with biotin-tagged SpfP. ∆spf::kan cells (GSO433) with the SpfP-scramN-terminal STOP or SpfP-
scramC-terminal STOP plasmids and the orthogonal tRNA and amino-acyl tRNA pair were grown in M63 glucose 
medium with 1mM p-azido phenylalanine to OD600~ 0.5 and induced with 0.2% arabinose for 3 h. Cell 
lysates were treated with biotin-PEGG-alkyne to biotinylate SpfP and passed over streptavidin beads. 
Fractions from the lysate (L), flow-through (FT), wash (W) and eluants (E) for each sample were subjected 
to SDS/PAGE followed by Coomassie blue staining. The unique ~25 kDa band enriched in the eluant from 
the SpfP expressing cells was excised from the gel and identified by mass spectrometry. 
D) N-terminally FLAG tagged SpfP copurifies with Crp-HA-His6 but not GalK-HA-His6. ∆spf cells expressing 
Crp-HA-His6 or GalK-HA-His6 from the chromosome (GSO1061 and GSO1060, respectively) were 
transformed with pKK-SpfP-scramN-FLAG and grown in LB until OD600~ 0.5. The cell lysate was incubated 
overnight with 50 µl of Pierce α-HA magnetic beads. The beads were collected using a magnet and proteins 
were eluted with Laemmeli buffer. Immunoblots of fractions from the lysate (L), flow-through (FT), wash 
(W) and eluants (E) separated by SDS/PAGE were probed α-FLAG (top panel) and α-His (bottom panel) 
antibodies. A cross-reacting band of high molecular weight is detected with α-FLAG antibodies. 
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derivatives produced a more severe effect on cell density when compared to pKK-SpfP-scram 
(Fig 19A). Conversely, Y3A, L8A, and F14A slightly relieved the growth defect while H10A 
almost completely relieved the effect of SpfP-scram overexpression (Fig 19A).    
 
SpfP associates with Crp 
To gain insight into the role of SpfP, we sought to identify co-associating proteins. As the SPA 
tag is almost three times the size of SpfP, we set out to generate a SpfP derivative with a non-
native amino acid azido-modified phenylalanine amino acid (p-AzF) that could be modified by 
biotin and is structurally somewhat similar to tyrosine. We first tested the possible effect of 
introducing p-AzF on SpfP activity by inserting a tyrosine at either the N-terminus of SpfP 
between the first and second amino acid or at the C-terminus just upstream of the stop codon, 
again in the context of the scrambled-sequence construct. The growth assay indicated that the N-
terminally tagged construct (pKK-SpfP-scramN-terminal Y) has wild type activity, while the C-
terminally tagged construct (pKK-SpfP-scramC-terminal Y) does not and could serve as a negative 
control in our subsequent co-purification experiments (Fig 19B).  
 To purify SpfP, we introduced a stop codon between the first and second amino acid or 
just upstream of the stop codon as a control. Each of the stop codon derivatives of SpfP was then 
expressed under conditions where p-AzF was incorporated at the stop codon by utilizing an 
engineered, orthogonal tRNA and aminoacyl-tRNA synthetase pair (pEVOL-p-AzF) (Chin, 
Santoro et al. 2002). The SpfP derivatives bearing p-AzF were biotinylated and purified on 
streptavidin beads. The eluant from each column was separated by SDS-PAGE. A prominent 
band of ~25 kDa was observed for the tagged protein expressed from the SpfP-scramN-terminal STOP 
construct but not the SpfP-scramC-terminal STOP construct (Fig 19C). In an independent experiment, 
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we also found this ~25 kDa protein enriched in the SpfP-scramN-terminal STOP sample compared to 
the sample for another small protein, YoaKN-terminal STOP, purified in the same way (Fig 20A). 
Mass spectrometric analysis revealed that Crp (23.6 kDa) was enriched in this ~25 kDa band in 
both experiments. We noted that an ~45 kDa band co-purified with the protein expressed from 
the SpfP-scramN-terminal STOP construct in both experiments but focused on Crp in this study given 




 To test for an interaction between SpfP and Crp, we carried out a reciprocal co-
purification experiment in which N-terminally FLAG-tagged SpfP was expressed in a ∆spf 
background with chromosomally tagged Crp-HA-His6 or GalK-HA-His6 as a cytosolic protein 
control. The inhibitory effect of SpfP on growth in minimal galactose medium was not altered in 
the Crp-HA-His6 strain (Fig 20B). The cells expressing the HA-His6-tagged proteins were grown 
in LB media to OD600~0.5, lysed and incubated with a-HA magnetic beads. Immunoblot analysis 
of the fractions from this purification was carried out using a-FLAG and a-His antibodies (Fig 
19D). The immunoblot probed with the α-His antiserum showed that the tagged derivatives of 
GalK and Crp were clearly enriched by incubation with the α-HA beads. The immunoblot probed 
with α-FLAG showed one prominent band of ~25 kDa. FLAG-tagged SpfP should be of ~ 2 
Figure 20. Lack of SpfP-FLAG association in ∆crp mutant background.  
A) Crp copurifies with biotin-tagged SpfP but not YoaK. WT cells (GSO433) carrying the SpfP-scramN-terminal STOP 
(left), or YoaKN-terminal STOP (right) plasmids were both transformed with pEVOL-p-AzF, a plasmid that 
expresses an orthologous aminoacyl-tRNA and tRNA pair. Cells grown in LB to OD600~ 0.5 were lysed and 
applied to streptavidin beads. After the beads were washed, the bound protein was eluted in two steps (E1 and 
E2). The samples were separated by SDS-PAGE and stained with Coomassie blue. Unique bands in the eluate 
were sent for mass spectrometric analysis and Crp was identified in the indicated band. 
B) Same repressive effect of SpfP is observed in crp+ and crp-HA-His6 backgrounds. Growth assays of ∆spf::kan 
(GSO433) and cells ∆spf crp-HA-His6::kan (GSO1061) transformed with pKK, pKK-SpfP-scram or pKK-
SpfP-scramSTOP were grown in M63 minimal medium supplemented with either glucose (top panel) or 
galactose (bottom panel). Cells were grown overnight in LB with ampicillin were diluted to OD600~0.05 in 
M63 minimal medium with the indicated carbon sources and grown for 16 h, at which point OD600 was 
measured. The average of three replicates is showed together with the standard deviation of the mean. 
C) N-terminally FLAG tagged SpfP associates with ~25 kDa band in Crp-HA-His6 but not ∆crp background. ∆spf 
crp-HA-His6::kan (GSO1061) or ∆spf::kan ∆crp::cm (GSO1063) cells expressing N-terminally FLAG-tagged 
SpfP-scram from the pKK plasmid were grown in LB to OD600~ 0.5. Cells were lysed (L) and applied to anti-
HA beads, and the flow through (FT) fraction was collected. Beads were washed (W) and the bound protein 
was eluted (E). The samples were examined on immunoblots using α-FLAG antibodies to detect SpfP-
scramNFLAG (top) or a-His antibodies to detect CRP-HA-His6 (bottom panel). A cross-reacting band of high 
molecular weight is detected with the α-FLAG antibodies, and a cross-reacting band of the same size as CRP 
is detected with the α-His antibodies. 
D) Synthetic SpfP associates with ~25 kDa band in Crp-HA-His6 but not ∆crp background. Extracts prepared 
from ∆spf crp-HA-His6::kan (GSO1061) or ∆spf::kan ∆crp::cm (GSO1063) cells grown LB to OD600~ 0.5 
were incubated with N-terminally biotinylated SpfP (biotin-MFYLSDLLLHVIGFG-COOH, Thermo Fisher 
Scientific) for 2 h. The lysates (L) were applied to anti-HA beads, and the flow through (FT) fraction was 
collected. Beads were washed (W) and the bound protein was eluted (E). The samples were examined on 
immunoblots using streptavidin-HRP to detect biotin-SpfP (top panel) or α-His antibodies to detect CRP-HA-
His6 (bottom panel). A number of cross-reacting bands are detected with streptavidin-HRP, and a cross-
reacting band of the same size as CRP is detected with the α-His antibodies. 
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kDa. We hypothesized that this ~25 kDa cross-reacting band was FLAG-SpfP complexed with 
Crp. To test this hypothesis, we carried out a similar co-purification with the chromosomally 
tagged Crp-HA-His6 compared to a ∆crp control strain (Fig 20C). Again FLAG-tagged SpfP 
migrated as a ~25 kDa band, the same molecular weight as Crp-HA-His6, while the band was not 
detected for the ∆crp strain. As a further assay of the SpfP-Crp interaction, we mixed synthetic 
SpfP peptide biotinylated at the N-terminus with extracts from Crp-HA-His6 ∆spf and ∆crp ∆spf 
cells and incubated the extracts with α-HA magnetic beads to isolate Crp-HA-His6 with 
associated proteins (Fig 20D). When we probed an immunoblot of this fractionation with 
streptavidin, we again observed a band that specifically co-migrated with Crp-HA-His6. Together 
these results indicate that SpfP associates with Crp and this association is sufficiently tight that 
the 15 amino acid SpfP protein remains bound to Crp during SDS-PAGE. Interestingly, despite 
being non-functional in the growth assay, the H10A derivative of the FLAG-SpfP still co-
purified with Crp (Fig 20E). 
 
SpfP overexpression blocks activation of some Crp-dependent operons 
We hypothesized that SpfP binding to Crp could affect the activity of this transcription regulator. 
To test this possibility, we examined the effects of pKK-SpfP-scram or pKK-SpfP-scramSTOP, the 
stop mutant control, on the levels of proteins encoded by various Crp-activated or -repressed 
operons. The strains with chromosomally tagged operons were grown with carbon sources that 
activated the expression of the specific operons. These experiments showed that pKK-SpfP-
scram, but not pKK nor pKK-SpfP-scramSTOP, led to decreased levels of GalM-SPA and GalK-
HA-His6 for cells grown in M63 with galactose (Fig 21A) and decreased levels of MalE-SPA 
and MalK-SPA for cells grown in M63 with maltose (Fig 21B). Consistent with the reduced 
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growth defect observed for the SpfP-scramH10A mutant, this derivative did not reduce GalM-SPA 
and MalE-SPA levels (Fig 22A). In contrast, the levels of SrlA-SPA encoded in another Crp-
activated operons were not affected by overexpression of SpfP-scram for cells grown in M63 
medium with sorbitol (Fig 21C), nor did SpfP overexpression lead to reduced β-galactosidase 
levels from lacZ for cells grown in M63 with lactose (Fig 21D). We also did not detect 
differences in the levels of the AzuC-SPA small protein (Fig 22B) whose expression is repressed 
 
Figure 21. SpfP overexpression leads to downregulation of Crp-activated genes.  
A) Immunoblot blot analysis of GalM-SPA and GalK-HA-His6 levels in ∆spf strains with chromosomal galM-
SPA::kan or galK-HA-His6::kan (GSO1066 and GSO106, respectively) transformed with pKK, pKK-SpfP-
scram, or pKK-SpfP-scramSTOP. Cells were grown in M63 galactose to OD600 ~  0.5. α-FLAG (top panel) or α-
His antibody (bottom panel) were used to detect GalM-SPA or GalK-HA-His6, respectively.  
B) Immunoblot blot analysis of MalE-SPA and MalK-SPA levels in ∆spf strains with chromosomal malE-
SPA::kan or malK-SPA::kan (GSO1067 and GSO1068, respectively) transformed with pKK, pKK-SpfP-
scram, or pKK-SpfP-scramSTOP. Cells were grown in M63 maltose to OD600 ~  0.5. α-FLAG antibody were 
used to detect both proteins. 
C) Immunoblot blot analysis of SrlA-SPA levels in ∆spf strains with chromosomal srlA-SPA::kan (GSO449) 
transformed with pKK, pKK-SpfP-scram, or pKK-SpfP-scramSTOP. Cells were grown in M63 sorbital to OD600 
~  0.5. α-FLAG antibody was used to detect the protein. 
D) Immunoblot blot analysis of LacZ levels in the ∆spf strain (GSO1059) transformed with pKK, pKK-SpfP-
scram, or pKK-SpfP-scramSTOP. Cells were grown in M63 lactose to OD600 ~  0.5. α-β-galactosidase antibody 
was used to detect the protein. 
For all panels, the Ponceau S stained membrane documents approximately equal loading of the samples. 
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by Crp or in the levels of Crp itself (Fig 22C) whose expression is both positively and negatively 
autoregulated.  
 These assays showed that SpfP blocks the activation of some but not all Crp-dependent 
genes. Since SpfP did not affect all Crp-target genes equally, we hypothesize SpfP does not 
affect either the cAMP effector binding to Crp or Crp binding to DNA, but rather modulates the 
Crp interaction with RNA polymerase at specific promoters. Given that malE and galE, Class I 
 
Figure 22. No effect of SpfP overexpression on AzuC or Crp levels and no effect of SpfPH10A overexpression. 
A) SpfP-scramH10A is less effective at repressing GalM-SPA and MalE-SPA. Panels show same blots depicted in 
Fig 4A and 4C but with an additional lane for cells transformed with pKK-SpfP-scramH10A.  
B) Immunoblot blot analysis of expression of chromosomally tagged AzuC-SPA (GSO351) from cells 
transformed with pKK, pKK-SpfP-scram, or pKK-SpfP-scramSTOP and grown in LB to OD600~0.5. α-FLAG 
antibody was used to detect the SPA tag.  
C) Immunoblot blot analysis of expression of chromosomally-tagged Crp-HA-His6 in ∆spf crp-HA-His6::kan 
(GSO1061) cells transformed with pKK, pKK-SpfP-scram, or pKK-SpfP-scramSTOP. Cells were grown in M63 
galactose to OD600~0.5. α-His antibody was used to detect Crp.  
D) SpfP-scramH10A is less effective at repressing galE P1-lacZ. β-galactosidase activity assay of galE P1-lacZ 
Dspf (GSO1071) cells transformed with pKK, pKK-SpfP-scram, pKK-SpfP-scramSTOP, and pKK-SpfP-
scramH10A. β-galactosidase assays were performed for cells grown to OD600~0.5 in LB. Bars depict average of 
three biological replicates and error bars correspond to the standard deviation. 
D 
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and Class II-activated genes, respectively, are both repressed by SpfP, while lacZ and srlA, also 
Class I and Class II-activated genes, respectively, are both unaffected by SpfP, the regulation is 
not based on the position of Crp binding relative to RNA polymerase. 
  
SpfP blocks Crp-dependent transcription from the galE P1 promoter  
To further test whether SpfP modulated Crp-mediated transcription activation, we assayed a 
transcriptional fusion of the P1 promoter of the galactose operon to lacZ (DM0021) 
(Geanacopoulos, Vasmatzis et al. 1999) for cells 
with pKK, pKK-SpfP-scram, or pKK-SpfP-
scramSTOP. This β-galactosidase activity assay 
showed that SpfP-scram but not SpfP-scramSTOP 
down regulates transcription from the P1 promoter 
(Fig 23). SpfP-scram did not repress the levels of 
β-galactosidase activity for a galE P1-lacZ fusion 
with a C to G mutation at the -35 position in the 
Crp binding site, though, as expected. β-
galactosidase was significantly lower for this 
derivative. These observations indicate that SpfP 
affects the ability of Crp to activate transcription of 
the galactose operon. As seen for GalM-SPA and 
MalE-SPA, the SpfP-scramH10A mutant did not 
repress the galE P1-lacZ fusion (Fig 22E) 
 
 
Figure 23. SpfP blocks Crp-dependent 
transcriptional activation. 
β-galactosidase activity assay of transcriptional 
fusion of the P1 promoter of the galactose operon 
to lacZ (galE P1-lacZ) (GSO1069) and the same 
fusion with a C35G mutation (GSO1070). Both 
fusion strains carrying Dspf (GSO1071 and 
GSO1072, respectively) were transformed with 
pKK, pKK-SpfP-scram, and pKK-SpfP-scramSTOP, 
and β-galactosidase assays were performed for 
cells grown to OD600~0.5 in LB. Bars depict 
average of three biological replicates and error bars 
correspond to the standard deviation. 
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Relative importance of Spot 42 base pairing activity and SpfP protein activity varies with 
temperature 
Given the somewhat higher levels of SpfP at 42˚C and 45˚C (Fig 17C), we wondered whether 
the relative importance of the sRNA and mRNA activities of spf varied depending on the growth 
temperature. To test this possibility, we repeated the β-galactosidase assay of the srlA-lacZ 
fusion for cells grown at 30˚C, 37˚C, and 42˚C. This assay showed that Spot 42 overexpression 
resulted in less repression at 42˚C compared to the lower temperatures (Fig 24). In contrast, 
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Spot 42STOP overexpression led to the same repression at all temperatures resulting in less 
repression than WT Spot 42 at 30˚C and more repression than WT Spot 42 at 42˚C.  
 We also examined how the same constructs affected GalK-HA-His6 levels at the different 
temperatures. Consistent with the β-galactosidase activity assay, we observed that full length 
Spot 42 was less effective at reducing GalK-HA-His6 levels at 42˚C, while Spot 42STOP 
overexpression led to strong repression at all temperatures (Fig 25A). Overexpression of SpfP-
scram led to similar, but slightly less GalK-HA-His6 repression at all temperatures, while SpfP-
scramSTOP had no effect on GalK-HA-His6 levels (Fig 25B). We interpret these results to mean 
that Spot 42 levels are higher or base pairing is more effective at repression at lower 
temperatures and that translation of Spot 42 can interfere with base pairing activity at higher 
temperatures.  
 Previous studies showed that Spot 42-repressed targets were induced more rapidly in ∆spf 
cells compared to WT cells upon a shift from glucose to a non-preferred carbon, source such that 
cells were primed to utilize glucose for as long as possible (Beisel and Storz 2011). We repeated 
this experiment with a shift from glucose to galactose at 30˚C and 42˚C and similarly observed a 
more rapid induction of GalK-HA-His6 (Fig 25C) and GalE (Fig 24B) in the ∆spf background 
when comparing the same point between the WT and ∆spf strain at both temperatures. A similar 
comparison between WT cells and cells in which the chromosomal version of spf carried the 
scrambled sequence (spf-scram), and thus only expressed SpfP, showed less of a difference 
Figure 24. Spot 42 and Spot 42STOP have different effects at different temperatures. 
A) β-galactosidase assay of ∆spf::kan srlA-lacZ expressing cells (GSO441) transformed with pRI, pRI-Spot 42, and 
pRI-Spot 42STOP. The cells were grown to OD600~1.0 at 30˚C, 37˚C, and 42˚C in LB supplemented with 0.2% 
arabinose. Bars depict average of three biological replicates and error bars correspond to the standard deviation. 
B) Immunoblot analysis of GalE levels in galK-HA-His6::kan (GSO1057), Dspf galK-HA-His6::kan (GSO1060), 
spf-scram galK-HA-His6::kan (GSO1077), and spfSTOP::kan galK-HA-His6 (GSO1075). Blots in 25C were stripped 
and probed with α-GalE polyclonal antiserum.  The stripping did not completely remove the GalK-HA-His6 
signal, and some nonspecific bands are detected with the α-GalE antibodies.  The Ponceau S stain documents 
approximately equal loading of the samples. 
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Figure 25. Spot 42 and SpfP have different effects at different temperatures. 
A) Immunoblot analysis of GalK-HA-His6 levels in a Dspf galK-HA-His6::kan strain (GSO1060) transformed 
with pRI, pRI-Spot 42, and pRI-Spot 42STOP and grown in LB at 30˚C, 37˚C, and 42˚C.  
B) Immunoblot analysis of GalK-HA-His6 levels in a Dspf galK-HA-His6::kan strain (GSO1060) transformed 
with pKK, pKK-SpfP-scram, and pKK-SpfP-scramSTOP and grown in LB at 30˚C, 37˚C, and 42˚C. 
For (A) and (B), samples were collected at OD600~0.5. α-His antibody was used to detect the HA-His6 tag. The 
Ponceau S stained membrane documents approximately equal loading of the samples. 
C) Immunoblot analysis of GalK-HA-His6 levels in galK-HA-His6::kan (GSO1057), Dspf galK-HA-His6::kan 
(GSO1060), spf-scram galK-HA-His6::kan (GSO1077), and spfSTOP::kan galK-HA-His6 (GSO1075) grown in 
M63 glucose to OD600~0.4 at 30˚C or 42˚C, collected and then resuspended in M63 galactose at 30˚C or 
42˚C, respectively with samples collected at the indicated times. 
D) The small protein SpfP reinforces the multi-output feedforward loop between Crp and Spot 42. For cells 
grown in the absence of glucose, Crp directly increases transcription of targets and represses Spot 42. In 
medium with glucose, Spot 42 represses Crp-activated targets through base pairing and the small protein 
SpfP blocks Crp-dependent activation, particularly at high temperature.  
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indicating that the small protein is functioning to repress transcription at 30˚C and 42˚C.  It is 
worth noting that due to the scramble sequence, the spfP ribosome binding site and start codon 
likely are no longer in a stem-loop structure, probably allowing equal translation at all 
temperatures. When the chromosomal version of spf had the same stop codon mutation as in Spot 
42STOP, we also observed very little difference between the WT and spfSTOP strain at 30˚C, 
probably due to Spot 42STOP function as an sRNA. However, we detected more rapid induction 
for the spfSTOP strain compared to WT at 42˚C. This observation shows that the lack of small 




While bacterial cells encounter environments with mixed nutrients, they selectively metabolize 
the most energetically favorable carbon sources in order to maximize growth. To accomplish 
this, bacteria employ transcription factors, regulatory sRNAs, as well as small proteins to control 
gene expression to specifically synthesize the appropriate transporters and enzymes. In this 
study, we have demonstrated that the base pairing sRNA Spot 42 is also translated to produce a 
15 amino acid protein, SpfP, that plays a role in catabolite repression. Previous work showed that 
the Crp-repressed Spot 42 RNA represses numerous targets, including galK, srlA, fucI, and 
nanC, involved in secondary metabolism and the uptake and use of non-preferred carbon sources 
(Beisel and Storz 2011, Beisel, Updegrove et al. 2012). Through copurification analysis we 
showed that SpfP interacts with Crp. We suggest that this interaction functions to block Crp-
mediated activation of gene expression. Our discovery that Spot 42 can act as an mRNA 
demonstrates that this sRNA is a dual-function sRNA whose base pairing and small protein both 
impact carbon source utilization. 
 
Impact of dual-function RNAs on carbon metabolism 
The findings reported here add another layer to the Spot 42 modulation of catabolite repression. 
It was already shown that Spot 42 coordinates with Crp in a multioutput feedforward loop to 
repress genes from auxiliary metabolic pathways when the preferred carbon source glucose is 
available delaying induction of these genes until the preferred carbon source disappears and thus 
prioritizing use of glucose as the most effective carbon source (Beisel and Storz 2011). As shown 
in Fig 25D, we suggest that SpfP reinforces this regulatory loop by directly blocking Crp-
mediated activation when cells are growing in glucose, particularly at high temperatures.  
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 Interestingly, we found the regions of Spot 42 involved in base pairing overlap the SpfP 
coding sequence raising the question of whether the sRNA or mRNA activity predominates 
under specific conditions. Given the potential to open the secondary structure overlapping the 
SpfP ribosome binding site and the slightly higher levels of SpfP at 42˚C, we hypothesized that 
SpfP-mediated effects may be more predominant at higher temperatures when base pairing may 
be less efficient. Consistent with this hypothesis, we found Spot 42 repression of the srlA-lacZ 
translation fusion was less effective at higher temperatures. If Spot 42 base pairing activity is 
decreased at temperatures where SpfP translation increases, perhaps SpfP continues the 
regulatory role of Spot 42 in carbon metabolism when Spot 42 is no longer functioning as 
effectivity as an sRNA.  
 Given that only a handful of dual-function sRNAs have been characterized in bacteria, it 
is noteworthy that all of the dual-function sRNAs studied thus far in E. coli impact carbon 
utilization. The SgrST sRNA is specifically activated by the SgrR transcription factor when cells 
encounter glucose phosphate stress (Vanderpool and Gottesman 2004). As with Spot 42, where 
both the base pairing function and small protein target the same pathway, the sRNA activity and 
small protein encoded by SgrS both regulate glucose phosphate utilization metabolism by 
targeting the PtsG transporter (Vanderpool and Gottesman 2004, Lloyd, Park et al. 2017). In a 
parallel study, we characterized another dual-function sRNA with connections to carbon 
metabolism. This 164-nt RNA, AzuCR, whose transcription also is repressed by Crp, base pairs 
with galE, a gene that contributes to galactose metabolism in E. coli (Raina, Aoyama et al. 
2020). The RNA is also translated to give the 28 amino acid small protein AzuC which binds to 
and increases the activity of GlpD, a protein essential for glycerol catabolism during growth in 
stationary phase. Thus, in contrast to SgrS-SgrT and Spot 42-SpfP, AzuR-AzuC modulates 
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different aspects of metabolism and glycerol metabolism. While the small protein and base 
pairing activities are encoded in separate parts of the 227-nt long SgrST RNA, for both spfP and 
azuC the ORF overlaps the base pairing region, leading to competition between the activities of 
these dual-function sRNAs. The perceived enrichment for dual-function sRNAs that modulate 
carbon metabolism may be a reflection of the fact that they are relatively abundant and thus 
readily detected. Alternatively, the strong selection imposed by metabolism may be a driving 
force for the evolution of dual-function sRNA regulators. 
 
SpfP interaction with Crp 
Another interesting question is the mechanism of how SpfP impacts Crp activity, a global 
transcription factor with ~300 regulated genes (Shimada, Fujita et al. 2011). The functions of 
only a limited number of small proteins less than 50 amino acids have been identified in E. coli. 
The majority of these characterized small proteins have been found to be localized to the inner 
membrane (reviewed in (Hemm, Weaver et al. 2020)). At 15 amino acids, SpfP is among the 
smallest proteins to be characterized. We suggest the hydrophobic protein acts as a small 
molecular inhibitor to affect the ability of Crp to bind RNA polymerase, thus blocking Crp-
dependent transcription activation at specific promoters. The mutational studies indicate that the 
H10 residue of SpfP is needed for this activity, which is interesting given that two of the 
activation regions (AR1 and AR2) of Crp have histidine residues required for the interaction with 
RNA polymerase (Evangelista, Dong et al. 2019). Given how extensively Crp has been studied, 
it is intriguing that SpfP was not detected previously. Fortunately, the existing tools and 
approaches to study Crp should help facilitate further mechanistic studies.    
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 SpfP is also unique among the small proteins characterized in E. coli because it binds and 
modulates a transcription factor. Intriguingly, a few other very small proteins or peptides have 
been found to modulate transcription factor activity. For example, the small signaling peptides of 
5-10 amino acids that are secreted by Bacillus and Streptococcus are recognized by sensory 
receptors from the RRNPP protein family (named for the representative proteins Rap, Rgg, 
NprR, PlcR, and PrgX) (reviewed in (Neiditch, Capodagli et al. 2017)). Binding of these 
peptides to the RRNPP proteins induces conformational changes that favor oligomerization, 
DNA binding and transcriptional activation of target genes. Similarly, the 6-10 amino acid 
Arbitrium peptide released by phages modulates the lysis-lysogeny decision by interacting with 
the AimR transcription factor (Erez, Steinberger-Levy et al. 2017). We predict that other very 
small proteins likely will be found to target other transcription factors and possibly other 
components of the transcriptional machinery. It is worth considering whether derivatives of these 
small proteins, which are easy to synthesize, could be exploited to control bacterial cell growth 






Material and Methods 
Bacterial strains and plasmids 
Bacterial strains, plasmids, and oligonucleotides used in this study are listed in Appendix Tables. 
E. coli strains are derivatives of wild-type MG1655 (F- lambda- ilvG- rfb-50 rph-1). Tagged 
strains were generated by λ Red–mediated recombineering (Yu, Ellis et al. 2000) using NM400 
and the oligonucleotides listed in the Appendix. Alleles marked by antibiotic markers were 
moved between strains by P1 transduction. When necessary, kanamycin resistance cassettes were 
excised from the chromosome by FLP-mediated recombination (Cherepanov and Wackernagel 
1995). All mutations and fusions were confirmed by sequencing. Descriptions of plasmids used 
in this study are listed in the Appendix. All SpfP derivatives were overexpressed from pKK177-3 
(a derivative of pKK223-3 lacking the region between at BamHI at 256 and PvuII at 1,945), 
while Spot 42 WT and the Spot 42STOP mutant were overexpressed from the pRI derivative of 
pKK177-3 in which an EcoRI site was introduced at the Ptac +1 site (Opdyke, Kang et al. 2004). 
The Spot 42 and SpfP derivatives were ordered as primers listed in Table S3, annealed and 
cloned into pKK177-3 or pRI digested with the EcoRI and HindIII restriction enzymes. All 
inserts were confirmed by sequencing. 
 
Bacterial growth 
Unless indicated otherwise, bacterial strains were grown with shaking at 250 rpm at 37˚C in 
either LB rich or M63 minimal medium supplemented with 0.001% vitamin B1 and glucose, 
galactose or maltose at 0.2%, and sorbitol at 0.4%. Where indicated, media contained antibiotics 
with the following concentrations: ampicillin (100 μg/ml), chloramphenicol (25 µg/ml), and 




Aliquots (1 ml) of cells were grown in the indicated medium were collected and the cell pellet 
was resuspended in 1XPBS and 10 ul were loaded on a Mini-PROTEAN TGX 5%–20% Tris-
Glycine gel (Bio-Rad) and run in 1X Tris Glycine SDS buffer (KD biomedical). The gel was 
electro transferred into nitrocellulose membranes (Invitrogen) for 1 h at 100 volts. Membranes 
were blocked with 5% non-fat milk (Bio-rad, ) in 1X PBS 0.1% of Tween 20 (PBS-T) for 1 h 
and probed with a 1:3,000 dilution of a-FLAG antibody (Sigma), 1:1,000 dilution of a-His 
antibody (Qiagen), 1:1,000 dilution of a-β-galactosidase antibody (Abcam) or 1:1,000 dilution 
of a-GalE antibody (kind gift of S. Adhya) in PBS-T for 1 h. Incubation with the a-GalE 
antibodies was followed by an incubation with a 1:20,000 dilution of peroxidase-labelled a-
rabbit antibodies. After three washes with PBS-T, the membrane was developed with an 
Amersham ECL Western Blotting Detection Kit (GE Healthcare).  
 
RNA isolation 
Cells corresponding to the equivalent of 10 OD600 were collected by centrifugation, and snap 
frozen in liquid nitrogen. RNA was extracted according to the standard TRIzol (Thermo Fisher 
Scientific) protocol. Briefly, 1 ml of room temperature TRIzol was added to cell pellets, 
resuspended thoroughly to homogenization, and incubated for 5 min at room temperature. After 
the addition of 200 µl of chloroform and thorough mixing by inversion, samples were incubated 
for 10 min at room temperature. After samples were centrifuged for 10 min at 4˚C on maximal 
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speed, the upper phase (~0.6 ml) was transferred into a new tube and 500 µl of isopropanol was 
added. Samples again were mixed thoroughly by inversion, incubated for 10 min at room 
temperature and centrifuged at maximal speed for 15 min at 4˚C. RNA pellets were washed 
twice with 75% ethanol. After the second wash, the ethanol was aspirated, and the RNA pellet 
was left to dry at room temperature. RNA was resuspended in 20-50 µl of DEPC water and 
quantified using a NanoDrop (Thermo Fisher Scientific). 
 
Northern analysis 
Total RNA (5- 10 µg per lane) was separated on denaturing 8% polyacrylamide gels, urea gels 
containing 6 M urea (1:4 mix of Ureagel Complete to Ureagel-8 (National Diagnostics) with 
0.08% ammonium persulfate) in 1X TBE buffer at 300V for 90 min. The RNA was transferred to 
a Zeta-Probe GT membrane (Bio-Rad) at 20 V for 16 h in 0.5X TBE, UV-crosslinked, and 
probed with 32P-labeled oligonucleotide  (Listed in Appendix Tables) in ULTRAhyb-Oligo 
buffer (Ambion Inc.) at 45˚C. Membranes were washed twice with 2X SSC/0.1% SDS at room 
temperature, once with 0.2X SSC/0.1% SDS at room temperature, washed for 25 min with 0.2 × 
SSC/0.1% SDS at 45˚C, followed by a final rinse with 0.2X SSC/0.1% SDS at room temperature 




Colonies of ∆spf::kan (GSO433) transformed with indicated plasmids were grown overnight in 
LB with ampicillin and diluted to OD600=0.05 in M63 minimal medium supplemented with 
0.001% vitamin B1 and either 0.2% glucose or 0.2% galactose. OD600 was measured after 16h.  
 
Purification of scrambled SpfP 
The ∆spf::kan strain (GSO433) transformed with pKK-SpfP-scramN-terminal tag or pKK-SpfP-
scramC-terminal tag and pEVOL-p-AzF was grown in LB at 37˚C overnight. The overnight culture 
was diluted 1:100 into 1 l of M63 glucose minimal media and incubated at 37˚C. At OD600 ~0.5, 
0.2% arabinose was added to induce the orthologous aaRS and tRNA pair along with 1 mM p-
azido phenylalanine (Chem-Impex Int’l. Inc.) and incubated for another 3 h. Cells were collected 
by centrifugation (4,650 × g, 20 min) and the pellet was resuspended in 30 ml of TNG buffer [10 
mM Tris (pH 7.5), 100 mM NaCl, 10% glycerol] supplemented with Protease Inhibitor Cocktail 
(Roche). The cells were lysed using a microfluidizer processor (Microfluidics) at 20,000 psi, and 
the insoluble cellular debris was removed by centrifugation (20,000 × g, 30 min). The cleared 
lysate was incubated with 5 µM CuCl2, 1 mM ascorbic acid (pH adjusted to 7 by NaOH) and 5 
µM of Biotin-PEG4-Alkyne (Click Chemistry Tools) dissolved in DMSO at room temperature 
by nutating for 30 min. The lysate was then supplemented with 25 mM DDM and incubated 
overnight at 4˚C with 500 ul of streptavidin agarose beads (Thermo Scientific). The lysate and 
beads were applied to a Bio-Spin disposable chromatography column (Bio-Rad Laboratories) 
and allowed to drain by gravity. The streptavidin column was washed with 15 ml TNG buffer 
with 2 mM DDM. Finally, proteins were eluted from the column with 1 ml of elution buffer (0.1 
M glycine pH 3.5, 100 mM NaCl and 0.1% Triton X-100) and TCA precipitation was carried out 
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to concentrate the protein samples. The pellet was resuspended in 30 µl of 2X Laemmli buffer. 
The samples were heated at 95˚C for 10 min, and aliquots were subjected to SDS/PAGE in a 10–
20% Tris-glycine gel (Invitrogen) at 12 V/cm. Proteins were visualized with Coomassie Blue 
Stain. Bands of interest were excised from the gel and analyzed by liquid chromatography-
tandem mass spectrometry (LC-MS/MS). 
 
Reciprocal purification 
∆spf cells expressing Crp-HA-His6 or GalK-HA-His6 from the chromosome (GSO1061 and 
GSO1060, respectively) or ∆spf::kan ∆crp::cm cells GSO1063 were transformed with pKK-
SpfP-scramN-terminal FLAG and grown in LB at 37˚C for 16h, diluted 1:100 into 1L of LB and 
incubated at 37˚C. At ~OD=0.5 cells were collected by centrifugation (10,000 x g, 20min) and 
resuspended in 15 ml of TNG buffer supplemented with Protease Inhibitor cocktail (Roche). The 
cells were homogenized and incubated with Pierce a-HA magnetic beads (Thermo Scientific) in 
a 50 ml tube and incubated overnight at 4˚C. Beads and the bound protein were collected using a 
MagneSphere magnetic separation stand (Promega) and washed with 1 ml of TNG buffer (10X). 
The beads were resuspended in 1X PBS (25 ul) and 2X Laemmli buffer (25 ul) and heated at 
95˚C for 5 min. Samples were analyzed on immunoblots using a-His and a-FLAG antibodies. 
Synthetic N-terminally biotin tagged SpfP (produced by Thermo Scientific) was added to lysates 
of ∆spf cells expressing Crp-HA-His6 or ∆spf ∆crp cells prior to incubation with Pierce a-HA 




Cultures were grown in LB to OD600~1.0 with arabinose (0.2%). 100 ul of cells were added to 
700 ul of Z buffer (60 mM Na2HPO4z7H2O, 40 mM NaH2PO4zH2O, 10 mM KCl, 1 
mMMgSO4z7H2O, 50 mM β-mercaptoethanol). After adding 15 ul of freshly prepared 0.1%  
SDS and 30 ul of chloroform to each sample the cells were vortexed for 30 s and then incubated 
at room temperature for 15 m to lyse the cells. At zero time, the assay is initiated by adding 100 
ul of ONPG (4 mg/ml) to each sample in 10 s intervals. The samples are incubated at room 
temperature before the reaction is terminated by the addition of 500 ul of 1M Na2CO3. Then, the 
A420 and A550 values are determined with a spectrophotometer and the absorbance data is 




While expanding the known function of the well-studied Spot 42, this study illuminates some 
interesting avenues for additional research. I think the most interesting question is the 
mechanism by which SpfP affects Crp. SpfP does not alter Crp levels, so SpfP must be affecting 
how Crp is acting 
One possibility is that SpfP is altering the effects of Crp on transcription. My work on 
Spot 42 suggests that SpfP interferes with activation of some, but not all, Crp regulated genes. 
Using an in vitro transcription assay with purified RNAP, Crp, and the promoter DNA from 
differentially regulated genes, lacZ and galE, as template I could assess if SpfP is modulating 
how Crp increases RNAP transcription. This assay could also be used to determine how the 
H10A mutant is impacting the function of SpfP.  
 My co-purification experiments have demonstrated that SpfP interacts with Crp, but the 
actual nature of this interaction has not been uncovered. I could gain further insights into the 
interaction by characterizing additional SpfP and Crp mutants to define the interaction surfaces. 
One method is to take advantage of the growth phenotypes on nonpreferred carbon sources when 
SpfP is overexpressed. I would use error prone PCR on a plasmid expressing Crp in a ∆crp 
background and grow cells on galactose while simultaneously overexpressing SpfP. Mutants 
would suppress the growth defect, and I could sequence both SpfP and Crp from their respective 
plasmids to attempt to identify mutations that are important for the functional interaction 
between these proteins. I could also use chemical mutagenesis to achieve a similar result. 
Additionally, I could carefully purify Crp and SpfP and utilize nuclear magnetic resonance 
(NMR) to assess the structural interaction between the two proteins. This would identify how 
SpfP is interacting with Crp. As Crp has been well studied and the structure has been solved, 
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visualizing the interaction with SpfP could also provide important insights into how SpfP affects 
Crp. 
 Finally, I have demonstrated that temperature is important for modulating the regulatory 
activities of Spot 42. Using structure probing experiments such as enzymatic cleavage we could 
examine how temperature is able to disrupt base pairing interactions. It would also be interesting 
to search for other methods by which the Spot 42 structure could be resolved to permit 
translation of the SpfP ORF. I would like to MS2 tag the Spot 42 RNA and then conduct an 
immunoprecipitation in an attempt to identify other proteins that may be interacting with the 
Spot 42 RNA to increase translation of SpfP. I would expect to identify proteins and RNA 
molecules that are capable of altering the Spot 42 structure to permit SpfP translation under 
conditions where temperature is not responsible for the same effect. We could then repeat the 
structure probing experiment suggested above to test how these proteins and RNAs are altering 
Spot 42 structure. 
The finding that Spot 42 encodes a 15 amino acid protein has added a new layer of 
regulation to a well-studied network controlled by an RNA regulator. The translation of the small 
protein SpfP reinforces the effects of Spot 42 on carbon catabolite repression. The identification 
of SpfP has provided an interesting opportunity to study how regulation by Spot 42 changes 




Critical features of a synthetic dual-function RNA 
 
Abstract 
Small base pairing RNAs (sRNAs) and small proteins have emerged as components of numerous 
regulatory networks. Both of these classes of regulators allow bacterial cells to rapidly adapt to a 
wide variety of growth conditions through post-transcriptional regulation. Dual-function RNAs 
regulate mRNA expression by base pairing and also encode a small protein. Thus, the products 
of a single gene can regulate targets at the level of mRNA stability or translation as well as at the 
level of protein activity or stability. While an increasing number of these molecules are being 
identified and characterized, little is known about the interplay between their two regulatory 
functions. To investigate the competition between the two activities of dual-function RNAs, we 
constructed hybrid RNAs encoding the Escherichia coli sRNA MgrR and small protein MgtS, 
hereafter referred to as MgtSR or MgtRS. Expression of MgrR and MgtS is normally induced by 
low magnesium (Mg2+) by the PhoQP two-component system. MgrR is a 98-nt sRNA that 
negatively regulates ygdQ (unknown function) and eptB (phosphoethanolamine transferase). 
MgtS is a 31 amino acid small inner membrane protein that is required for the accumulation of 
MgtA, the Mg2+ transporter. By generating various versions of this synthetic dual-function RNA, 
we probed how the organization of components is important for proper function of both activities 
of a dual-function RNA and how the organization affects competition between the two activities. 
By understanding these features of synthetic and natural dual-function sRNA, future synthetic 
molecules can be constructed to maximize their regulatory impact.  
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Introduction 
Small RNAs (sRNAs) play an important role in shaping and regulating the cellular responses to 
changing environmental conditions. Hundreds of sRNAs have been identified through various 
deep sequencing methodologies. Most of these 50-300 nucleotide molecules regulate target 
mRNAs through base pairing (reviewed in (Storz, Vogel et al. 2011) (Adams and Storz 2020)). 
In many bacteria, sRNAs depend on the RNA binding protein Hfq (host factor for bacteriophage 
Qβ) for stability and base pairing with target mRNAs (Updegrove, Zhang et al. 2016). The 
functional outcomes of sRNA base pairing with the target mRNA are an inhibition of translation, 
a change in mRNA degradation or an increase in translation.   
While generally assumed to be noncoding, some sRNAs have been found to contain 
small ORFs and for a small subset of the RNAs, this ORF has been shown to be translated. These 
sRNAs capable of base pairing regulation while also encoding a protein are called dual-function 
RNAs (reviewed in (Raina, King et al. 2018)). The limited number of dual-function RNAs that 
have been identified and characterized is because they tend to be overlooked due to the difficulty 
in distinguishing a translated ORF from small ORFs that are randomly present in the genome. 
Furthermore, traditional biochemical methods for identifying and purifying proteins commonly 
miss proteins that are 10-50 amino acids (Storz, Wolf et al. 2014).  
Despite the difficulties inherent in the study of dual-function RNAs, several E. coli dual 
function sRNAs have been examined in sufficient depth to clearly describe both the base pairing 
and protein coding activities: SgrST, Spot 42-SpfP and AzuCR. All three of these RNAs are 
involved in regulating carbon metabolism.  
The 227-nt SgrS sRNA was originally identified in a computational screen for sRNAs in 
E. coli (Wassarman, Repoila et al. 2001). Subsequently, SgrS was studied for the role it plays in 
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the cellular response to glucose-phosphate stress and found to base pair with the ptsG and 
manXYZ mRNAs encoding important sugar transporters (Rice and Vanderpool 2011).  In the 
course of these studies, it was found that SgrS is translated to give the 43 amino acid small 
protein SgrT, which inhibits the transport activity of the glucose permease PtsG (Wadler and 
Vanderpool 2007). Together SgrS and SgrT counteract the accumulation of sugar phosphates in 
the cell by reducing the translation and activity of sugar transporters and increasing 
dephosphorylation of sugar phosphates.  
The 109-nt Spot 42 RNA identified in 1973 is one of the first sRNA described (Ikemura 
and Dahlberg 1973) and represses the synthesis of many transporters and enzymes for the 
utilization of non-preferred carbon sources. Many of the mRNA targets repressed by Spot 42 are 
activated by the transcription factor cAMP receptor protein (Crp) (Beisel and Storz 2011). 
Recently, it was shown that Spot 42 also encodes a small ORF that is translated to give a 15 
amino acid protein, SpfP. Translation of SpfP is increased following heat shock, and the small 
protein has been demonstrated to interact with Crp to disrupt transcriptional activation of some 
Crp targets. This additional function means Spot 42 is a dual-function RNA with the small 
protein reinforcing Spot 42 RNA control over carbon catabolite repression (CCR). 
Another recently identified dual-function RNA is AzuCR. This 164-nt RNA was initially 
identified in a bioinformatic search for novel sRNA genes but then was reclassified as an mRNA 
when it was found to encode a 28 amino acid protein, AzuC (Chen, Lesnik et al. 2002, Hemm, 
Paul et al. 2010). AzuC, interacts with aerobic glycerol 3-phosphate dehydrogenase (GlpD) to 
increase its activity. However, overexpression of AzuCR produces growth defects in galactose 
and glycerol medium that persist even when an AzuCR derivative carrying a stop codon 
mutation in the small ORF is expressed, suggesting that AzuCR also functions as an sRNA. 
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Consistent with this observation, AzuCR is capable of direct base pairing regulation of cadA, 
lysine decarboxylase, and galE, a gene involved in galactose metabolism. Together, the sRNA 
and mRNA activities contribute to the modulation of carbon utilization in E. coli. 
One question that arises for dual-function RNAs is whether the two functions can be 
carried out simultaneously by the same molecule. The base pairing region of SgrS is 15-
nucleotides downstream of the SgrT ORF. Mutations to inhibit sgrT translation do not impede 
SgrS regulation of mRNA targets, but mutations that restrict base-pairing increase SgrT 
translation indicating that the base-pairing function interferes with translation. Furthermore, 
translation of the small protein lags behind transcription of SgrS RNA by approximately 30 
minutes (Balasubramanian and Vanderpool 2013). Based on these observations, it was suggested 
that the base pairing function predominates, and SgrST molecules that base pair with target 
mRNAs are unavailable for use as an mRNA as they are degraded. Once the pool of targeted 
mRNA has been sufficiently degraded, SgrST accumulates and is translated.  
For Spot 42 and AzuCR, there is direct overlap between the base pairing region and small 
ORF such that one function necessarily interferes with the other. In both of these dual-function 
RNAs, the introduction of a stop codon, which presumably reduces ribosomal occupancy of the 
transcript increases base pairing activity. For Spot 42, the start of the encoded ORF is 
sequestered in secondary structure, and translation of the small protein increases at high 
temperatures that may partially resolve the secondary structure and may coincide with a 
temperature-dependent reduction in base pairing regulation.  For AzuCR, translation of the small 
protein is repressed by the anaerobic-growth induced sRNA FnrS suggesting sRNAs are another 
mechanism by which the competition between the base pairing and protein coding activities can 
be controlled.  
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 To further explore the features of dual-function RNAs that impact what activity 
predominates, we chose to construct synthetic dual-function RNAs using parts of the transcripts 
encoding the sRNA MgrR and small protein MgtS. The sRNA component, MgrR, was identified 
through Hfq co-immunoprecipitation followed by genome-wide RNA detection on microarrays. 
The sRNA negatively regulates eptB, a lipopolysaccharide (LPS) modifying enzyme, and ygdQ, 
a protein of unknown function (Moon and Gottesman 2009). The small protein MgtS was first 
identified as a potential ORF using microarray analysis (Wassarman, Repoila et al. 2001). 
Further study confirmed that MgtS is a 31 amino acid small protein that interacts with MgtA, a 
P-type ATPase Mg2+ importer (Hemm, Paul et al. 2008, Wang, Yin et al. 2017). This interaction 
with MgtA serves to increase levels of the importer and increase intracellular concentration of 
Mg2+. Expression of both components, MgrR and MgtS, is dependent on the two-component 
system, PhoQ/PhoP. In low Mg2+ conditions, the sensor kinase PhoQ becomes activated. Once 
active, PhoQ phosphorylates PhoP which in turn activates transcription of a number of different 
genes including Mg2+ transporters and proteins that modify the LPS (Prost and Miller 2008). 
In this study, we demonstrate that it is possible to create a synthetic dual-function RNA 
from existing separate components. Additionally, we discover that the composition of the 
sequence between the functional elements impact their activities. Interestingly, despite 
construction of a functional dual function MgtSR RNA from two separate genes, reversing the 





Construction of a synthetic dual-function RNA  
We set out to design a synthetic dual-function RNA built from two components that could be 
easily tested for their regulatory activity. We chose MgtS as the small protein component and 
MgrR as the sRNA component. The corresponding two genes are convergently transcribed in a 
PhoPQ-dependent manner in response to low Mg2+ conditions (Fig 26A). The design of this first 
synthetic dual-function RNA denoted MgtSR was modeled after the characterized dual-function 
RNA, SgrS, whose small ORF precedes the base pairing region by 15-nt (Raina and Storz 2017). 
Our design included the 96-nt of the MgtS ORF, from the start codon to the stop codon, 
 
Figure 26. Regulatory activity of the synthetic 
dual-function RNA.  
A) Diagram of the endogenous location of mgtS 
(blue) and mgrR (red). 
B) Schematic of the hybrid dual-function RNA, 
MgtSR. Plasmid sequences are in gray, mgtS 
sequences are in blue and mgrR sequences 
are in red.  The ARN, seed, and terminator 
sequences are indicated by distinct patterns 
as indicated.  
C) Effect of pBR, pBR-MgrR, pBAD, pBAD-
MgtSR, pBAD-MgtSRSTOP, and pBAD-
MgtSRBP overexpression on an eptB-lacZ 
fusion in ∆mgrR background. Data 
represents triplicate biological replicates 
with error bars of standard deviation.  
D) Immunoblot analysis of MgtA-HA cells in a 
∆mgtS transformed with pBAD, pBAD-
MgtSR, pBAD-MgtSRSTOP, and pBAD-
MgtSRBP grown to OD600 0.4 in N-media 
supplemented with 500 uM Mg2+, washed, 
and then resuspended and grown in N-media 
supplemented with arabinose but without 
Mg2+. Samples collected after 20 minutes 
and visualized with a-HA antibodies to 
detect MgtA-HA.  
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immediately followed by 77-nt of native mgrR sequence. The pBAD24 plasmid carrying the 
construct provided the ribosome binding site (RBS) for MgtS. The sequence from mgrR includes 
a 9-nt Hfq A-R-N (where A = adenine, R = adenine or guanine, N = any nucleotide) binding 
motif, the seed sequence for base pairing interactions with MgrR targets, and an intrinsic 
terminator with a polyU stretch also bound by Hfq (Updegrove, Zhang et al. 2016, Kwiatkowska, 
Wroblewska et al. 2018). Thus, the MgtS ORF and the seed sequence of MgrR are separated by 
30-nt of native sequence from MgrR (Fig 26B). The hybrid gene was cloned behind an arabinose 
inducible promoter to allow for controllable expression.  
We also designed controls to be able to specifically eliminate the activity of one 
component or the other. To this end we constructed a stop codon control, pBAD-MgtSRSTOP, to 
prevent translation of the small protein component while maintaining the integrity of the base 
pairing region, and pBAD-MgtSRBP, a construct with base pairing mutations to prevent sRNA 
activity while maintaining translation of the small protein. 
 
MgtSR is a functional dual-function RNA 
To establish whether each component of MgtSR maintained regulatory activity, we first assayed 
the effect of MgtSR overexpression on expression of an eptB-lacZ fusion. β-galactosidase 
activity was assayed in DmgrR cells expressing eptB-lacZ translational fusions transformed with 
pBR322, pBR-MgrR, pBAD, pBAD-MgtSR, pBAD-MgtSRSTOP, and pBAD-MgtSRBP. 
Regulation of eptB-lacZ was observed upon overexpression of MgtSR to a similar extent as 
overexpression of MgrR (Fig 26C). Furthermore, the pBAD-MgtSRSTOP derivative was still able 
to regulate, but pBAD-MgtSRBP no longer repressed eptB-lacZ expression. This result 
demonstrates that the MgrSR RNA has the capability to act as a base pairing regulatory RNA.  
 96 
We similarly tested for functional expression of the MgtS component by carrying out 
immunoblot analysis to examine the levels of MgtA, a membrane protein that is stabilized by 
MgtS (Wang, Yin et al. 2017). DmgtS cells expressing chromosomally expressed HA-tagged 
MgtA were transformed with pBR, pBR-MgrR, pBAD, pBAD-MgtSR, pBAD-MgtSRSTOP, and 
pBAD-MgtSRBP. Overexpression of MgtSR stabilizes MgtA-HA in conditions of Mg2+ 
limitation similar to MgtS (Fig 26D). As expected, pBAD-MgtSRSTOP did not stabilize levels of 
MgtA-HA while pBAD-MgtSRBP did, demonstrating that a functional small protein is translated 
from mgtSR (Fig 26D). The β-galactosidase data taken together with the immunoblot analysis 
indicate that we have successfully constructed a synthetic dual-function RNA that can express a 
functional small protein and also act as a base pairing sRNA. 
 
Translation of MgtS is the dominant activity in the absence of an intervening sequence 
To examine how the intervening sequence impacts the activities of the two MgtSR components, 
we removed the 30-nt of intervening sequence to generate the pBAD-MgtSR-no spacer construct 
(Fig 27A). We hypothesized that in the absence of the spacer, the two functions may interfere 
with each other resulting in the loss of one or both of the activities. To test this hypothesis, we 
assayed the eptB-lacZ fusion and MgtA-HA levels for cells transformed with pBR, pBR-MgrR, 
pBAD, pBAD-MgtSR, and pBAD-MgtSR-no spacer. We discovered that removing the 
intervening sequence between the components of MgtSR eliminates the regulation of the eptB-
lacZ fusion (Fig 27B) but not stabilization of MgtA (Fig 27C). These results suggest that 
translation of MgtS predominates and may sterically block MgrSR base pairing activity (Takyar, 
Hickerson et al. 2005). To test this prediction, we introduced a stop codon into the pBAD-
MgtSR-no spacer construct. This construct, pBAD-MgtSR-no spacerSTOP, rescued eptB-lacZ 
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regulation consistent with translation of the small protein MgtS disrupting base pairing 
regulation by MgtSR (Fig 27B).  It is interesting to note, that pBAD-MgtSR-no spacerSTOP is still 
functional despite the upstream Hfq binding site being removed and that the levels of this sRNA 
are higher than MgtSR (Fig 28).  As expected, MgtSR-no spacerSTOP, which should not be 
translated, was unable to stabilize the larger protein. These results demonstrate that for dual-
function RNAs with non-overlapping components, the presence of a 30-nt intervening sequence 
helps to maintain the independent function of each component. 
 
 
Figure 27. MgtS translation is the dominant 
activity absent the intervening sequence.  
A Schematic of the hybrid dual-function RNA 
with the intervening sequence removed. 
Labeling of plasmid, mgtS, mgrR, ARN, 
seed and terminator sequences are indicated 
as in Fig 26B.  
B Effect of pBR, pBR-MgrR, pBAD, pBAD-
MgtSR, pBAD-MgtSRNO SPACE, and pBAD-
MgtSRBP overexpression on an eptB-lacZ 
fusion in a ∆mgrR background. Data 
represents triplicate biological replicates 
with error bars of standard deviation.  
C Immunoblot analysis of MgtA-HA cells in a 
∆mgtS transformed with pBAD, pBAD-
MgtSR, pBAD-MgtSRNO SPACE, and pBAD-
MgtSRNO SPACE MUT grown to OD600 0.4 in N-
media supplemented with 500uM Mg2+, 
washed, and then resuspended and grown in 
N-media supplemented with arabinose but 
without Mg2+. Samples collected after 20 
minutes and visualized with a-HA 
antibodies to detect MgtA-HA. 
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Truncating the intervening sequence disrupts regulation by each component 
To better understand how the 
composition of the intervening sequence 
contributes to regulation by each 
component, we next examined the effects 
of truncations from either end of the 
intervening sequence to determine if the 
5´ or 3´ end played a more prominent role 
in maintaining the functions of the synthetic dual-function RNA. We thus constructed derivatives 
with five and ten nucleotide truncations from either the 5´ or 3´ ends of the synthetic dual-
function RNA: pBAD-MgtSR-5´∆5nt, pBAD-MgtSR-5´∆10nt, pBAD-MgtSR-3´∆5nt, and 
pBAD-MgtSR-3´∆10nt (Fig 29A). Expression of these MgtSR deletion derivatives is similar to 
the full length MgtSR RNA (Fig. 28). We carried out β-galactosidase assays for eptB-lacZ 
strains carrying each of these plasmids or the control pBAD and pBAD-MgtSR plasmids. 
Interestingly, the derivatives with truncations near the 3´ end of the RNA completely lost the 
ability to regulate eptB-lacZ, while the constructs with truncations near the 5´ end retained some 
ability to repress eptB-lacZ (Fig 29B).  When stop codons were introduced into each of the 
truncation constructs, the RNAs all repressed eptB-lacZ demonstrating that the truncated 
constructs still have the potential to base pair and translation of the small ORF is responsible for 
disrupting regulatory activity.   
In contrast, the truncations towards the 5´ end of the intervening sequence prevented 
stabilization of MgtA-HA, while the 3´ truncation derivatives still were still capable of 
increasing MgtA-HA levels similar to MgtSR (Fig 29C).  Thus, while removal of portions of the 
 
Figure 28. RNA levels of synthetic constructs. 
Northern analysis of ∆mgrR cells transformed with pBAD, 
pBAD-MgtSR, pBAD-MgtSRNO SPACE, and all truncation 
variants. Cells grown in LB to OD=1.0. Probed for the 3’ 
region of mgrR 
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intervening sequence from the 5´ end did not affect the base pairing activity, these deletions 
prevented stabilization of MgtA-HA.  In contrast, the 3´ end truncation derivatives which lacked 
base pairing activity still stabilized MgtA-HA indicating translation of MgtS. It is possible that 
Hfq binding proximal to the ORF in the 5´∆5nt and 5´∆10nt derivatives has a negative effect on 
translation by competing with ribosome binding (Moon and Gottesman 2009). Another 
possibility is that the truncations at either the 5´ or 3´ end produce changes in RNA structure that 
disrupt translation or base pairing, respectively. These results highlight show that the specific 
sequence between the ORF and seed region has an impact on the functions of the chimeric RNA.  
 
Figure 29. Analysis of the regulatory 
contributions of the intervening 
sequence.  
A) Schematic of the 5-nt and 10-nt 
truncation mutants of MgtSR. 
Labeling of plasmid, mgtS, mgrR, 
ARN, seed and terminator 
sequences are indicated as in Fig 
26B. 
B) Effect of pBAD, pBAD-MgtSR, 
pBAD-MgtSR truncations and 
truncation stop construct 
overexpression on an eptB-lacZ 
fusion in a ∆mgrR background. 
Data represents triplicate 
biological replicates with error 
bars of standard deviation.  
C) Immunoblot analysis of MgtA-HA 
cells in a ∆mgtS transformed with 
pBAD, pBAD-MgtSR, pBAD-
MgtSRNO SPACE, and pBAD-
MgtSRNO SPACE MUT grown to 
OD600 0.4 in N-media 
supplemented with 500uM Mg2+, 
washed, and then resuspended and 
grown in N-media supplemented 
with arabinose but without Mg2+. 
Samples collected after 20 minutes 
and visualized with a-HA 
antibodies to detect MgtA-HA.  
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Reversing the organization of the components of MgtSR disrupts regulatory capability 
To test whether the order of the encoded functions of the synthetic dual-function RNA impacted 
the activities, we placed the coding sequence of mgtS together with its RBS and 30-nt of 
intervening sequence between the base pairing region and terminator sequence of mgrR (Fig 
30A). However, we found that this did not result in a functional construct. When cells expressing 
an eptB-lacZ fusion were transformed with pBR, pBR-MgrR, pBAD, and pBAD MgtRS and 
then assayed for β-galactosidase activity, we did not observe regulation (Fig 30B). Furthermore, 
pBAD-MgtRS was incapable of stabilizing MgtA-HA when compared against pBAD-MgtSR 
and a vector control (Fig 30C). We have several hypotheses to explain why the reverse construct 
displays no regulatory activity from either component, while the original MgtSR construct 
regulates targets effectively. First, it is possible that the reverse construct produces secondary 
 
Figure 30. Reversing the organization of the 
components produces a nonviable 
synthetic dual-function RNA.  
A Schematic of the inverse hybrid construct, 
MgtRS. Labeling of plasmid, mgtS, mgrR, 
ARN, seed and terminator sequences are 
indicated as in Fig 26B.  The stippled blue 
region corresponds to mgtS sequence 
outside of the coding region. 
B Effect of pBR, pBR-MgrR, pBAD, and 
pBAD-MgtRS overexpression on a eptB-
lacZ fusion in a ∆mgrR background. Data 
represents triplicate biological replicates 
with error bars representing standard 
deviation.  
C Immunoblot analysis of MgtA-HA cells in 
a ∆mgtS transformed with pBAD, pBAD-
MgtRS, and pBAD-MgtSR grown to OD600 
0.4 in N-media supplemented with 500uM 
Mg2+, washed, and then resuspended and 
grown in N-media supplemented with 
arabinose but without Mg2+. Samples 
collected after 20 minutes and visualized 
with a-HA antibodies to detect MgtA-HA.  
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structure that sequester the RBS and seed sequence to prevent regulation. Another explanation is 
that the process of reversing the organization of the components has moved the ARN motif of 
MgrR too distant from the terminator to disrupt interactions with the RNA binding protein, Hfq. 
Finally, as can occur with mutations in any RNA, it is very possible that by altering the original 
construct we have destabilized the RNA to the point that is unable to function as either an sRNA 
or an mRNA. Taken together, these data suggest that the organization of a dual-function RNA is 





Dual-function RNAs are an intriguing yet largely unexplored class of RNA regulatory 
molecules. Given the underidentification of small proteins, these RNA transcripts are likely more 
prevalent than has currently been reported. To better understand the organization and 
competition between the components of a dual-function RNA, we designed and constructed a 
synthetic dual-function RNA from the MgrR sRNA and MgtS small protein (Fig 26B). This 
hybrid RNA is capable of regulating by base pairing and is translated to give rise to a functional 
MgtS protein. We used derivatives of this synthetic construct to examine the how the 
organization of the components affects the regulatory activities of this RNA molecule. 
 
Elements necessary for dual function activity  
The MgtSR chimera and its derivatives point to some of the elements necessary to construct a 
dual-function RNA. First, translation of the small ORF likely requires an unobstructed ribosome 
binding site.  For sRNA function, required elements include an unobstructed seed sequence for 
base pairing along with Hfq binding sites including a Rho-independent terminator. Where these 
elements are relative to one another has a significant impact on the two activities. While the 
MgtSR construct was completely functional, reversing the order of the two genetic elements 
eliminated activity (Fig 30).  In the MgtRS construct, when the sRNA sequence for MgrR was 
moved to the 5’ end the ARN motif it contained was displaced from the Rho-independent 
terminator, potentially eliminating Hfq activity.  
 The length of the sequence that genetically separates the components of dual-function 
RNA also is important for maintaining the independent regulatory activity of each component. 
Most deletions that reduced the sequence separating the smORF and the seed sequence, 
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eliminated base pairing activity (Fig 27 and 29).  The observation that all of these derivatives 
regained base pairing activity upon the introduction of a stop codon suggests the main block to 
base pairing is occlusion by ribosome binding although some of the deletions might also affect 
Hfq binding. For most of these deletion constructs, the MgtS activity predominated, possibly 
because this activity is encoded first.  Interestingly however, with a limited distance between the 
two genetic elements, base pairing can also interfere with translation as illustrated for the 5´∆5-nt 
and 5´∆10-nt derivatives. 
In other dual-function RNA such as AzuCR or Spot 42, the overlap of the ORF and base 
pairing regions causes competition between the activities. Mutations that prevent translation of 
the ORF have been found to enhance regulation by the sRNA component. In contrast, for SgrS, 
where the components are separated by 15-nt, the introduction of mutations to disrupt translation 
of the encoded small protein, SgrT, do not change base pairing regulation of mRNA targets by 
SgrS (Balasubramanian and Vanderpool 2013). Furthermore, mutants with disrupted base pairing 
actually led to an increase in SgrT levels (Balasubramanian and Vanderpool 2013). This is 
consistent with the model that the stability of SgrS RNA dictates that translation will occur after 
base pairing regulation is completed. Overall, however, it is expected that separation of the parts 
of a dual-function RNA by an intervening sequence gives each component more autonomy 
despite existing on the same RNA molecule. 
  
Evolution of dual-function RNAs 
In thinking about the components of dual-function sRNAs, it is interesting to consider how these 
regulatory molecules evolve (Dutcher and Raghavan 2018) and whether there are more barriers 
to evolution of base pairing or a smORF as the second feature. Phylogenetic analyses of SgrST 
 104 
and the RNAIII dual-function RNA from Staphylococcus aureus suggests that evolution in both 
directions is possible.  For example, all SgrST homologs across enteric species carry the highly 
conserved 13-nt seed sequence complementary to the ptsG RNA near the 3’ end of the RNA, 
while some species with a SgrS homolog, such as Yersinia, lack a functional SgrT ORF 
suggesting that the sRNA served as the precursor RNA which ultimately developed an mRNA 
function. In contrast, the 26 amino acid δ-hemolysin encoded by RNAIII appears to be more 
broadly conserved than the base pairing regions (Verdon, Girardin et al. 2009).  For Spot 42-
SpfP, the overlapping base pairing and SpfP-encoding regions are so well conserved that it is 
difficult to determine which function is more broadly conserved. 
 
Possibility of exploiting dual-function RNAs 
Dual-function RNA have the potential to be a useful tool for synthetic biology.  Given that these 
molecules can regulate both the translation and activity of a protein, they are capable of efficient 
control of a specific process. Furthermore, if the two activities regulate different pathways, a 
single dual-function RNA can provide a regulatory link between the two pathways. By 
modulating when each component is active, these molecules could be used to regulate two 
pathways under mutually exclusive conditions. It is hoped that the observations gained from this 
study will guide future investigations into dual-function RNA function and construction. 
Ultimately, there is much to be explored about the regulatory potential of natural and synthetic 




Material and Methods 
 
Bacterial strains and plasmid construction 
Bacterial strains, plasmids, and oligonucleotides used in this study are listed in Appendix Tables. 
E. coli strains are derivatives of wild-type MG1655 (F- lambda- ilvG- rfb-50 rph-1). Alleles 
marked by antibiotic markers were moved between strains by P1 transduction. When necessary, 
kanamycin resistance cassettes were excised from the chromosome by FLP-mediated 




Cells were grown to the indicated OD600 in Luria-Bertani broth overnight (LB) or N media after 
a 1:100 dilution of the overnight culture (Nelson and Kennedy 1971). Where indicated, media 
contained antibiotics with the following concentrations: ampicillin (100 μg/ml), chloramphenicol 
(25 µg/ml) and kanamycin (30 µg/ml). 
 
Immunoblot analysis 
The cell pellet from 1 ml of cells grown in the indicated medium was resuspended in 1X PBS 
(KD Medical) and 10 µl were loaded on a Mini-PROTEAN TGX 5%–20% Tris-Glycine gel 
(Bio-Rad) and run in 1X Tris Glycine-SDS (KD Medical) buffer. The proteins were electro-
transferred into nitrocellulose membranes (Invitrogen) for 1 h at 100 V. Membranes were 
blocked with 5% non-fat milk (BioRad) in 1X PBS with 0.1% of Tween 20 (PBS-T) for 1 h and 
probed with a 1:1,000 dilution of α-HA antiserum (Abcam) in the same PBS-T buffer with 5% 
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milk for 1 h. After the incubation with the α-HA antiserum, membranes were incubated with a 
1:20,000 dilution of HRP-labelled goat α-rabbit antibody (Pierce). All blots were washed 4X 
with PBS-T and then developed with an Amersham ECL Western Blotting Detection Kit (GE 
Healthcare).  
 
Total RNA isolation 
Cells corresponding to the equivalent of 10 OD600 were collected by centrifugation, and snap 
frozen in liquid nitrogen. RNA was extracted according to the standard TRIzol (Thermo Fisher 
Scientific) protocol. Briefly, 1 ml of room temperature TRIzol was add to cell pellets, 
resuspended thoroughly to homogenization, and incubated for 5 min at room temperature. After 
the addition of 200 µl of chloroform and thorough mixing by inversion, samples were incubated 
for 10 min at room temperature. After samples were centrifuged for 10 min at 4˚C on maximal 
speed, the upper phase (~0.6 ml) was transferred into a new tube and 500 µl of isopropanol was 
added. Samples again were mixed thoroughly by inversion, incubated for 10 min at room 
temperature and centrifuged at maximal speed for 15 min at 4˚C. RNA pellets were washed 
twice with 75% ethanol and then dried at room temperature. RNA was resuspended in 20-50 µl 
of DEPC water and quantified using a NanoDrop (Thermo Fisher Scientific). 
 
Northern analysis 
Total RNA (5-10 µg per lane) was separated on denaturing 8% polyacrylamide gels containing 6 
M urea (1:4 mix of Ureagel Complete to Ureagel-8 (National Diagnostics) with 0.08% 
ammonium persulfate) in 1X TBE buffer at 300 V for 90 min. The RNA was transferred to a 
Zeta-Probe GT membrane (Bio-Rad) at 20 V for 16 h in 0.5X TBE, UV-crosslinked, and probed 
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with 32P-labeled oligonucleotides (Listed in Table 1) in ULTRAhyb-Oligo buffer (Ambion Inc.) 
at 45˚C. Membranes were washed twice with 2X SSC/0.1% SDS at room temperature, once with 
0.2X SSC/0.1% SDS at room temperature, washed for 25 min with 0.2 × SSC/0.1% SDS at 
45˚C, followed by a final wash with 0.2X SSC/0.1% SDS at room temperature before 
autoradiography was performed with HyBlot CL film (Denville Scientific Inc.). 
 
β-galactosidase assays 
Cultures were grown in LB to OD600~1.0 with arabinose (0.2%). 100 ul of cells were added to 
700 ul of Z buffer (60 mM Na2HPO4z7H2O, 40 mM NaH2PO4zH2O, 10 mM KCl, 1 
mMMgSO4z7H2O, 50 mM β-mercaptoethanol). After adding 15 ul of freshly prepared 0.1%  
SDS and 30 ul of chloroform to each sample the cells were vortexed for 30 s and then incubated 
at room temperature for 15 m to lyse the cells. At zero time, the assay is initiated by adding 100 
ul of ONPG (4 mg/ml) to each sample in 10 s intervals. The samples are incubated at room 
temperature before the reaction is terminated by the addition of 500 ul of 1M Na2CO3. Then, the 
A420 and A550 values are determined with a spectrophotometer and the absorbance data is 




My assays of MgtSR has shown that it is possible to construct functional synthetic dual-function 
RNAs and that these artificial constructs can be used to successfully probe how dual-function 
RNA work. However, there are other interesting aspects of dual-function RNA that this construct 
could help to study. The successful creation of the reverse construct with the small ORF 3’ of the 
base-pairing region would be very informative. I think that issue with the first attempt could have 
been due to moving the entire MgrR sequence to the 5’ end and using native MgtS sequence to 
separate the two components. This may have resulted in too much separation between the two 
elements in the original construct, the A-R-N motif important for binding Hfq, and the 
terminator. I would like to replace the original A-R-N sequence with one from ChiX, another 
sRNA with a very strong Hfq binding site, and then assess both regulatory capability of the 
construct as well as RNA levels using northern analysis. This would test if alterations to the Hfq 
binding site within the intervening sequence contribute to regulation of targets as well as the 
inherent stability of the molecule. I predict that stronger Hfq binding sites would assist in 
regulation and stability. 
Another subject I would like to address with MgtSR is if translation of the smORF is 
altering the RNA structure. To test this, I would like to create different constructs with stop 
codons placed throughout the ORF and use enzymatic cleavage to probe the structure of these 
different constructs. Structural analysis of constructs that were defective for base-pairing and 
small protein activity should also be undertaken. MgtSR is not particularly large, and it is 
possible that the truncations and mutations may have disrupted the original structure to inhibit 
translation of the smORF or base-pairing. 
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The experiments that I have proposed to further explore this synthetic construct and dual-
function RNA at large could certainly be expanded beyond what I have created. What happens if 
a new ORF or base pairing sRNA are incorporated? The creation of this initial construct will 












Prior to the current study only five dual-function RNAs had been described in bacteria. The 
characterization of two additional dual-function RNAs and a synthetic dual-function RNA 
greatly contributes to our understanding of these regulatory molecules. 
 
Roles of dual-function RNAs in regulating carbon metabolism 
Bacteria maximize growth by selecting the most energetically viable carbon source to metabolize 
that is available in the environment. My work has demonstrated that the base pairing sRNA Spot 
42 also encodes a 15 amino acid protein, SpfP, that interacts with Crp to block Crp mediated 
activation of gene expression. I have also characterized the novel dual-function RNA, AzuCR. 
AzuCR base pairing regulates galactose metabolism while the translated small protein impacts 
glycerol metabolism. My work suggests that AzuCR and Spot 42 use both sRNA and mRNA 
activity to exert control over carbon catabolite repression. It is intriguing to note that in addition 
to Spot 42 and AzuCR, two other dual-function RNAs, E. coli SgrST and B. subtilis SR1, have 
been found to play a role in carbon metabolism. SgrS mediates the cellular response to glucose-
phosphate stress in enterobacteria by base pairing with target mRNAs to reduce accumulation of 
sugar phosphates while the translated small protein specifically inhibits the transport activity of 
the major glucose permease PtsG (Wadler and Vanderpool 2007). SR1 base pairs with mRNA 
targets to inhibit arginine metabolism and is translated to give the small protein SR1P that 
stabilizes gapA mRNA and modulates the ability of GapA protein to recruit RNases (Gimpel, 
Heidrich et al. 2010). 
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The question of whether there is some evolutionary pressure that encourages the use of 
dual-function RNA to regulate carbon metabolism is intriguing. A base pairing RNA uses less 
energy and less complicated machinery to regulate mRNA and protein targets than is required by 
translation of a protein to fulfill the same role. However, translated proteins can withstand 
reversible modifications to alter their own function. Perhaps it is desirable for an energy 
generating pathway to be regulated in an efficient and flexible manner by molecules that can 
translate a protein and also riboregulate other mRNAs. The flexibility provided by having two 
distinct regulatory mechanisms within a single molecule allows for diverse combinations of 
regulation that may be beneficial for such a complicated system. 
 
Competition between base pairing and translation 
The competition between components has previously been documented for SgrS and briefly 
explored for RNAIII. The work presented in this dissertation characterizes the competition 
inherent in two additional dual-function RNAs, AzuCR and Spot 42. My work explores the 
features that are important for controlling competition using a synthetic construct.  
The base pairing region of SgrS is 15 nucleotides downstream of the SgrT ORF. 
Mutations that inhibit sgrT translation do not impede SgrS regulation of mRNA targets, but 
mutations that restrict base-pairing increase SgrT translation, indicating that the base-pairing 
function interferes with translation (Balasubramanian and Vanderpool 2013). Furthermore, 
translation of the small protein lags behind transcription of SgrS RNA by approximately 30 
minutes (Balasubramanian and Vanderpool 2013). Based on these observations, it was suggested 
that the base pairing function predominates and that SgrST molecules that base pair with target 
mRNAs are unavailable for use as an mRNA as they are degraded. Once the pool of targeted 
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mRNA has been sufficiently degraded, SgrST accumulates and is translated. Given that co-
degradation of a sRNA with mRNA targets has been shown for other sRNAs, this type of 
competition may be present in other dual-function RNAs.  
 The primary effector molecule of the S. aureus agr quorum sensing system is the 514-nt 
RNAIII. This dual-function RNA contains fourteen stem-loop motifs and has been demonstrated 
to directly regulate 12 mRNA targets. RNAIII also contains an ORF for the 26 amino acid δ-
hemolysin (hld) which targets host cell membranes to lyse cells (Verdon, Girardin et al. 2009). 
Interestingly, the production of hld is delayed by 1 hour following RNAIII transcription (Balaban 
and Novick 1995). Analysis of RNAIII structure demonstrated that the 5’ and 3’ ends of the 
RNA are in close proximity, perhaps suggesting that the delay in δ-hemolysin levels are due to 
this interaction partially occluding the RBS of hld (Benito, Kolb et al. 2000). In support of this 
hypothesis, it has been shown that deletion of the 3’ end of RNAIII eliminates the delay between 
hld protein levels and RNAIII RNA levels (Balaban and Novick 1995). The method by which 
 
Figure 31. Temperature can control competition between elements of a dual-function RNA.  
The dual-function RNA (red) contains a secondary structure that sequesters a small ORF. At a permissive 
temperature the dual-function RNA regulates target mRNA (blue) via base pairing interactions. An increase in 
temperature can disrupt base pairing and internal structure to permit and translation of the small protein. 
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RNAIII mediates a conformational change in structure to permit δ-hemolysin translation are 
unknown. 
The work on Spot 42-SpfP and AzuCR has provided additional mechanisms for how 
competition can control the activities of the two components of a dual-function RNA. For Spot 
42-SpfP and AzuCR, there is direct overlap between the base pairing region and smORF which 
causes the activities to interfere with one another. In both dual-function RNAs, the introduction 
of a stop codon to reduce ribosomal occupancy of the transcript increases base pairing activity 
and exacerbates growth defects caused by overexpression of the full-length RNA.  
For Spot 42, the ribosome binding site and smORF are sequestered in secondary 
structure. Levels of the small protein increase following heat shock, perhaps due to partially 
resolving this structure. Additionally, the increase in levels of SpfP coincide with a temperature 
dependent reduction in base pairing regulation. Taken together, the data demonstrated sRNA 
activity of Spot 42 is inhibited by the increase in temperature. I hypothesize that the temperature 
dependent increase in SpfP levels reinforces the repression of Crp targets by Spot 42 RNA. As 
many studied sRNA have some form of secondary structure it is possible that additional 
undiscovered dual-function RNAs are subject to temperature guided competition between their 
components as illustrated in Figure 7.  
The work on the dual-function RNA AzuCR has uncovered many hints as to how this 
molecule regulates the activity of its components. AzuCR encodes the small protein AzuC which 
specifically interacts with glycerol-3-phosphate dehydrogenase, GlpD, to increase activity. This 
work also demonstrated that the anaerobically expressed sRNA FnrS represses both AzuC and 
GlpD, AzuCR RNA co-immunoprecipitates with Hfq, and SPA tagged AzuC levels were 
elevated in a ∆hfq strain. Finally, introduction of a stop codon to prevent translation of the 
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smORF within AzuCR produces a stronger repressive effect on target mRNAs than the wild type 
transcript alone. The processes that control the regulatory roles of AzuCR are not fully 
understood, but they clearly depend on the levels of sRNAs that target the dual-function RNA 
(FnrS), the levels of RNA chaperones (Hfq), and the levels of mRNA targets. 
As suggested in the work on AzuCR, a mechanism by which the activities of a dual-
function RNA can be regulated is through an external factor, either an RNA binding protein or a 
regulatory RNA.  In this scenario, the factor could block or expose an RBS or affect access to the 
base pairing region or binding of an RNA chaperone. This control over translation could also be 
achieved if the dual-function RNA contained a riboswitch that would alter levels of translation in 
response to binding with a metabolite or small molecule. Finally, it is possible that a dual-
function RNA could undergo a maturation or activation phase where the transcript is processed 
so that only one or the other activity is functional. 
Generation of the synthetic dual-function RNA, MgtSR, has also provided some insight 
into the competition that is inherent to these molecules. The work with MgtSR focused on 
understanding how the sequence between separate components contributes to the regulatory 
integrity of the entire molecule. Different permutations of the construct were made to study this 
intervening sequence. This study concluded that for MgtSR the separating sequence prevented 
the translation of the smORF from disrupting riboregulation by the base pairing region. In 
addition, this intervening sequence was found to play an important role in the proper function of 
both activities. The work demonstrated how the creation of a dual-function RNA is both possible 
and has the potential to aid in the research of these molecules. 
This dissertation has identified a new method by which dual-function RNA regulate their 
components and attempted to provide additional insights into the inherent competition within 
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these molecules by constructing and studying a synthetic dual-function RNA. We hypothesize 
that there are other types of competition that can impact translation of the smORF as a method to 
control when sRNA or mRNA activity is predominate. As more of these molecules are identified 
we anticipate a more comprehensive understanding of how translation and RNA function 
compete within dual-function RNA. 
 
Where do we go from here? 
Application of what has been learned about dual-function RNAs in E. coli to other bacteria 
The majority of currently identified dual-function RNA are in bacteria but have not been 
examined in terms of how their separate components compete. All of the dual-function RNA 
presented in this dissertation have been studied in sufficient depth to begin describing how the 
RNA and protein functions are coordinated. The Spot 42 project described how at higher 
temperatures the smORF that is sequestered in a hairpin is translated more effectively and at 
lower temperatures base pairing regulation is more efficient. The analysis of competition 
between components should be undertaken for all future characterized dual-function RNA as it is 
the core mechanism that dictates how and when these molecules exert their regulatory impact. 
Additionally, the methods we have used to study the molecules characterized in this dissertation 
can be utilized to fully understand the RNA and protein functions of future dual-function RNA 
and how these elements compete. 
 
Application of what has been learned about dual-function RNAs in E. coli to eukaryotes 
Although the work in this dissertation has studied dual-function RNA in bacteria, the conclusions 
and discoveries could potentially be applied to eukaryotes. As previously explained, the many 
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different types of ncRNA in eukaryotes undergo a variety of different maturation steps, are of a 
wide range of sizes, and regulate a large number of different cellular process. Given the variety 
of ncRNA in eukaryotes it is reasonable to assume that there are many more dual-function RNA 
species that have functions outside what has been identified in bacteria.  
As mentioned in the introduction, one subset of dual-function RNA in eukaryotes are 
those whose RNA perform a role during embryonic development. The examples that we have 
previously discussed are from different organisms, Oskar in Drosophila and Squint in zebrafish 
(Kloc, Wilk et al. 2005, Jenny, Hachet et al. 2006, Lim, Kumari et al. 2012). All three of these 
RNAs assist in cell patterning during early embryogenesis. The early embryo is a unique and 
short-lived regulatory environment. What are the advantages of dual-function RNA regulators in 
this unique cellular ecosystem? Many mRNA are translationally inhibited when they are 
localized to oocytes in order to translate their protein product at a specific interval important for 
proper development (Evans and Hunter 2005, Lasko 2009). Perhaps RNA that can have 
additional functions while translationally dormant are selected for in this early developmental 
environment. By having a translation independent RNA function while mRNA activity is 
suppressed these molecules would serve to increase the regulatory capacity of the early embryo 
while reducing the need to deliver additional regulatory RNA molecules. 
Another potential dual-function RNA type consists of those that could arise from 
lncRNAs. lncRNAs are defined as RNA molecules that are longer than 200-nt and do not encode 
a protein. More than 16,000 lncRNAs have been annotated with some estimates being even 
higher (Derrien, Johnson et al. 2012). Despite the enormous numbers of these large RNA 
molecules less that 1% have actually been experimentally validated (Quek, Thomson et al. 
2015). Given the vast amount of uncharacterized RNA it stands to reason that some of these may 
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contain viable ORFs, have a ncRNA function, or both. We have already discussed the example 
of the small protein, sarcolipin, that was found to be translated from a formerly characterized 
lncRNA (Singh, Dalton et al. 2019). I believe that further examination of eukaryotic genomes to 
search for ORFs located in what are currently classified as lncRNAs may uncover many novel 
dual-function RNAs. 
 
The search for more dual-function RNAs 
Multiple computational searches and genetic screens have been carried out to identify potential 
ncRNAs in bacteria and eukaryotes. These experiments have provided evidence of function for 
these RNA molecules and represent an important first step in identifying novel dual-function 
RNA. In bacteria, RNA interaction by ligation and sequencing (RIL-seq) has been used to 
identify Hfq-bound sRNA:mRNA pairs (Melamed, Peer et al. 2016, Melamed, Adams et al. 
2020). In eukaryotes, Argonaute binding information can be generated from crosslinking and 
immunoprecipitation followed by sequencing (CLIP-seq) and has greatly increased the resolution 
of potential miRNA interactions (Wessels, Lebedeva et al. 2019). Both of these methods 
leverage next generation sequencing to produce large numbers of potential RNA:RNA 
interactions which can then be examined in greater detail.  
Perhaps one of the most significant obstacles to the search for dual-function RNAs is the 
difficulty in identifying smORFs that are translated. A powerful approach for the identification 
of small protein-coding regions is ribosome profiling. This method uses deep sequencing of 
ribosome protected mRNA fragments to globally monitor ribosome binding in vivo. In bacteria, 
ribosome profiling has been employed to identify potential small proteins (Weaver, Mohammad 
et al. 2019). In this method, antibiotics were used to arrest initiating 70S ribosomes over start 
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codons followed by ribosome profiling to produce an accurate database of initiation sites 
throughout the E. coli genome (Meydan, Marks et al. 2019).  In eukaryotes, ribosome profiling 
has been leveraged in numerous ways to identify protein variants from alternative start codons 
and small proteins translated from RNAs that were previously considered noncoding (Brar and 
Weissman 2015). Determining what smORFs are translated will be valuable for identifying 
potential dual-function RNAs in bacteria and eukaryotes.  
By combining data sets of potential ncRNAs with potential small proteins it should be 
possible to create databases of potential dual-function RNAs for bacteria and eukaryotes. Based 
on what is currently understood about dual-function RNA, we suggest that the search for novel 
molecules be constrained to below 600 nucleotides and the minimum size for the smORF should 
be set to 10 amino acids in order to prevent the inclusion of nonviable ORFs in this analysis. 
This database could then be examined for dual-function RNAs whose components are non-
overlapping, as with SgrS, or whose components overlap, as with AzuCR or Spot 42. 
 Once databases of potential dual-function RNAs have been established, a critical step 
will the documentation of both functions. The gold standard for demonstrating direct base 
pairing interaction is mutational analysis of the putative base pairing region. Some regulatory 
RNAs interact with target proteins. An example of this is the sRNA CsrB binding the carbon 
storage regulator, CsrA, to inhibit CsrA-mediated acceleration of glg mRNA degradation (Liu, 
Gui et al. 1997). Verification of this interaction can be assessed using a co-purification for a 
tagged derivative of the potential protein and then identifying the interacting RNA using 
northern analysis. This purification can also be done using mutants to identify residues that are 
important for the interaction. Structure probing can also be used to demonstrate that the protein 
makes relevant contacts with the RNA. The documentation of protein function can be achieved 
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through copurification assays to determine interacting proteins followed by mass spectrometric 
analysis. Often an initial purification with a tagged derivative of the small protein of interest is 
conducted to identify potential large interacting proteins. After a possible protein partner for the 
small protein of interest is determined, the larger protein is purified to attempt to identify the 
original small protein of interest to confirm the result. Following identification of a potential 
interaction an in vitro analysis of purified components can provide further evidence of this 
interaction.  
 
Generation of synthetic dual-function RNAs to regulate desired processes 
Dual-function RNAs represent an interesting opportunity for synthetic biology applications. As 
we have demonstrated in this work, the creation of an artificial dual-function RNA from existing 
ncRNA and small protein components can provide valuable information on how these molecules 
are constructed and how they behave. Using specific truncation mutants, we were able to more 
carefully describe how alterations to the intervening sequence between components contribute to 
the regulatory integrity of the entire molecule. However, synthetic constructs could be employed 
to examine other aspects of dual-function RNA. For example, one could introduce an adenylate-
uridylate-rich element (ARE) into the 3’ UTR of a eukaryotic synthetic dual-function RNA to 
destabilize the molecule in order to test how reduced RNA half-life impacts the competition 
between components of the molecule. In contrast, an RNA chaperone binding site could be 
introduced to greatly increase the stability of the molecule to determine if this predisposes the 
molecule towards the regulatory RNA function. By controlling when each element of a dual-
function RNA is active, these molecules have the potential to regulate two separate pathways 
under separate conditions making them a versatile regulatory tool. 
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Finally, understanding how to design dual-function RNAs could provide an efficient 
method to regulate RNA and protein using the same molecule. As these molecules can regulate 
both mRNA and protein, they could be employed to specifically control a single process. 
Another interesting use would be to design a dual-function RNA to regulate two different 
pathways at the same time. Ultimately, dual-function RNAs represent an opportunity to design 




Despite the work in bacteria and eukaryotes to characterize and understand dual-function RNAs, 
it is evident that much remains to be learned about these RNA molecules. As we continue to 
study these RNA transcripts, we will uncover more about their functions, competition, and 
evolution. Expanding the numbers of characterized dual-function RNA would be a significant 





Appendix 1: Strain List 
Name Genotype Source 
MG1655 E. coli F- λ- ilvG- rfb-50 rph-1 lab stock 
TOP10 F- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ∆lacX74 nupG 
recA1 araD139 ∆(ara-leu)7697 galE15 galK16 rpsL(StrR) endA1 λ- 
Invitrogen 
NM400 MG1655 mini-λ:cat N. Majdalani 
PM1205 
 
Mandin and Gottesman, 
2009 
GSO351 MG1655 azuC-SPA::kan Hemm et al. 2008 
GSO955 MG1655 ∆hfq::kan Melamed et al. 2020 
GSO1006 MG1655 azuC-SPA This study 
GSO1007 MG1655 azuC-SPA ∆hfq::kan This study 
GSO1008 MG1655 azuC-gfp::kan This study 
GSO1009 MG1655 azuCIL6,7EE-gfp::kan This study 
GSO1010 MG1655/pAZ3-AzuC This study 
GSO350 MG1655 acrZ-SPA::kan Hemm et al. 2008 
GSO1011 MG1655 glpD-HA-His6::kan This study 
GSO193 MG1655 ∆azuC::kan Hobbs et al. 2010 
GSO1012 MG1655 ∆azuC This study 
GSO1013 MG1655 ∆azuC glpD-HA-His6::kan This study 
GSO785 MG1655 mgtA-HA::kan ∆mgtS Wang et al. 2017 
JW3389 ∆glpD::kan Keio collection 
GSO1014 MG1655 ∆glpD::kan This study 
GSO1015 MG1655 ∆azuC ∆glpD::kan This study 
GSO1016 MG1655 ∆azuC::kan/pKK177-2  This study 
GSO1017 MG1655 ∆azuC::kan/pKK-AzuC This study 
GSO1018 MG1655 ∆azuC::kan/pKK-AzuCL3STOP This study 
GSO1019 MG1655 ∆azuC::kan/pKK-GlpD This study 
GSO1020 MG1655 ∆azuC::kan/pRI  This study 
GSO1021 MG1655 ∆azuC::kan/pRI-AzuCR This study 
GSO1022 MG1655 ∆azuC::kan/pRI-AzuCRL3STOP This study 
GSO402 MG1655 ∆fnrS::kan Durand and Storz, 2010 
GSO1023 MG1655 azuC-SPA ∆fnrS::kan  This study 
GSO1024 PM1205 azuC::lacZ  This study 
GSO1025 PM1205 azuC-III::lacZ  This study 
GSO1026 MG1655 ∆azuC::kan/pXG10-SF-cadA-gfp This study 
GSO1027 MG1655 ∆azuC::kan/pXG10-SF-cadA-M1-gfp This study 
GSO1028 MG1655 ∆azuC::kan/pR1-AzuCRL3STOP-M1 This study 
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GSO1029 MG1655 ∆azuC::kan/pXG10-SF-galE-gfp This study 
GSO1030 MG1655 ∆azuC::kan/pXG10-SF-galE-M2-gfp This study 
GSO1031 MG1655 ∆azuC::kan/pR1-AzuCRL3STOP-M2 This study 
GSO1032 MG1655 azuC-SPA::kan/pRI-cadA This study 
GSO1033 MG1655 azuC-SPA::kan/pRI-cadAcontrol This study 
GSO1034 MG1655 azuC-SPA::kan/pRI-galE This study 
GSO1035 MG1655 azuC-SPA::kan/pRI-galEcontrol This study 
GSO982 MG1655 (crl+) Melamed et al. 2020 
GSO954 MG1655 ∆hfq-cat::sacB Melamed et al. 2020 
GSO956 MG1655 ∆proQ::kan Melamed et al. 2020 
GSO959 MG1655 ∆hfq ∆proQ::kan Melamed et al. 2020 
GSO1037 MG1655 spfP-SPA::kan This study 
GSO441 MG1655 srlA-lacZ ∆spf::kan Beisel and Storz, 2011 
GSO440 MG1655 nanC-lacZ ∆spf::kan Beisel and Storz, 2011 
GSO519 MG1655 glpF-lacZ ∆spf::kan Beisel and Storz, 2011 
GSO433 MG1655 ∆spf::kan Beisel and Storz, 2011 
GSO1038 MG1655 ∆spf::kan/pRI This study 
GSO1039 MG1655 ∆spf::kan/pRI-Spot 42 This study 
GSO1040 MG1655 ∆spf::kan/pRI-Spot 42STOP This study 
GSO1041 MG1655 ∆spf::kan/pKK177-3 This study 
GSO1042 MG1655 ∆spf::kan/pKK177-3-SpfP-scram This study 
GSO1043 MG1655 ∆spf::kan/pKK177-3-SpfP-scramSTOP This study 
GSO1044 MG1655 ∆spf::kan/pKK177-3-SpfP-scramF2A This study 
GSO1045 MG1655 ∆spf::kan/pKK177-3-SpfP-scramY3A This study 
GSO1046 MG1655 ∆spf::kan/pKK177-3-SpfP-scramS5A This study 
GSO1047 MG1655 ∆spf::kan/pKK177-3-SpfP-scramD6A This study 
GSO1048 MG1655 ∆spf::kan/pKK177-3-SpfP-scramL8A This study 
GSO1049 MG1655 ∆spf::kan/pKK177-3-SpfP-scramH10A This study 
GSO1050 MG1655 ∆spf::kan/pKK177-3-SpfP-scramV11A This study 
GSO1051 MG1655 ∆spf::kan/pKK177-3-SpfP-scramF14A This study 
GSO1052 MG1655 ∆spf::kan/pKK177-3-SpfP-scramN-terminal Y This study 
GSO1053 MG1655 ∆spf::kan/pKK177-3-SpfP-scramC-terminal Y This study 
GSO1054 MG1655 ∆spf::kan/pKK177-3-SpfP-scramN-terminal STOP This study 
GSO1055 MG1655 ∆spf::kan/pKK177-3-SpfP-scramC-terminal STOP This study 
GSO1056 MG1655 ∆spf::kan/pKK177-3-SpfP-scramN-terminal FLAG This study 
GSO1057 MG1655 galK-HA-His6::kan This study 
GSO1058 MG1655 crp-HA-His6::kan This study 
GSO1059 MG1655 ∆spf This study 
GSO1060 MG1655 ∆spf galK-HA-His6::kan This study 
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GSO1061 MG1655 ∆spf crp-HA-His6::kan This study 
GSO1062 MG1655 ∆spf::kan/pKK177-3-YoaKN-terminal STOP This study 
GSO388 MG1655 ∆crp::cm  Durand and Storz, 2010 
GSO1063 MG1655 ∆spf::kan ∆crp::cm  This study 
GSO1064 galM-SPA::kan SPA collection 
GSO1065 malE-SPA::kan SPA collection 
GSO1066 MG1655 ∆spf galM-SPA::kan This study 
GSO1067 MG1655 ∆spf malE-SPA::kan This study 
GSO1068 MG1655 ∆spf malK-SPA::kan This study 
GSO449 MG1655 ∆spf srlA-SPA::kan Beisel and Storz, 2011 
GSO351 MG1655 azuC-SPA::kan Hemm et al. 
GSO1069 PM1205 galE P1-lacZ This study 
GSO1070 PM1205 galE P1C35G-lacZ This study 
GSO1071 PM1205 galE P1-lacZ ∆spf This study 
GSO1072 PM1205 galE P1C35G-lacZ ∆spf This study 
GSO1073 MG1655 ∆spf galK-HA-His6 This study 
GSO1074 NM400 spfSTOP::kan This study 
GSO1075 MG1655 spfSTOP::kan galK-HA-His6 This study 
GSO1076 NM400 spf-scram::kan This study 
GSO1077 MG1655 spf-scram::kan galK-HA-His6 This study 
KM100 mal∷lacI q, ΔaraBAD, leu +, araC+, araE Moon et. al., 2013 
KM132 ΔmgrR ::kan Moon et. al., 2014 
KM238 eptB-lacZ ΔmgrR::kan positions -150 to +94 of eptB 
promoter 
Moon et. al., 2015 
GSO229 MG1655 ΔmgtS::kan Wang et. al., 2017 




Appendix 2: Plasmid List 
Name Relevant features Source 
pAZ3 pBAD18 with an EcoRI site at +1, CmR Kawano et al. 
2005 
pRI pKK177-3 with an EcoRI site at transcription start site, AmpR PMID:15466020 
pKK177-3 pRI with a ribosome binding site PMID: 6390428 
pBR Derivative of the pBR322-derived pBRplac vector PMID: 16359331 
pJL148 Template for amplification of SPA tag together with the 
adjacent kanamycin-resistance cassette flanked by FRT sites 
PMID: 15253427 
pCP20 Temperature-sensitive vector that expresses FLP recombinase. 
Used to excise antibiotic resistance cassettes flanked by FRT 
sites 
PMID: 7789817 
pXG-0 Superfolder GFP plasmid negative control PMID: 17264113 
pXG10-SF Superfolder GFP plasmid PMID: 22458297 
pAZ3-AzuCR pAZ3 with AzuCR cloned into EcoRI site This study 
pRI-AzuCR pRI with AzuCR cloned into  EcoRI and HindIII, AmpR This study 
pRI-AzuCRSTOP pRI-AzuCR with the third codon mutated to TAG, AmpR This study 
pKK-AzuC pKK with AzuC open reading frame cloned into EcoRI and 
HindIII, AmpR 
This study 
pKK-AzuCSTOP pKK-AzuC with the third codon mutated to TAG, AmpR This study 
pKK-GlpD GlpD coding region cloned into EcoRI and HindIII, AmpR This study 
pBR-FnrS FnrS sequence cloned in pBR322 Durand and 
Storz 
pBR-MicA MicA sequence cloned in pBR322 PMID: 25030700 
pBR-FnrS-I FnrS sequence cloned in pBR322 containing truncation as 
described in Durand and Storz 
Durand and 
Storz 
pBR-FnrS-II FnrS sequence cloned in pBR322 containing truncation as 
described in Durand and Storz 
Durand and 
Storz 
pBR-FnrS-III FnrS sequence cloned in pBR322 containing truncation as 
described in Durand and Storz 
Durand and 
Storz 
pXG10-SF-cadA cadA sequence from the transcription start to 20 codons into 
the open reading frame cloned between NheI and NsiI 
This study 
pXG10-SF-cadA-M1 pXG10-SF-CadA sequence  mutated from CGTTATTGCA to 
ttTgATTttg 
This study 
pXG10-SF-galE galE sequence cloned into PXG10-SF This study 
pXG10-SF-galE-M2 galE sequence with mutations to prevent AzuCR base pairing This study 
pRI-AzuCRSTOP-M1 pRI-AzuCRSTOP sequence  mutated from 
TATTGCAAGACGTTC to GATCGCGACACA 
This study 
pRI-AzuCRSTOP-M2 pRI-AzuCRSTOP sequence  mutated from TGCAAGACG to 
caaAAGACa 
This study 
pRI-cadA frag cadA coding sequence from nucleotide 1 to 46 with 50 




pRI-cadA-frag control cadA coding sequence from nucleotide 1965 to 2061 cloned 
into pRI between EcoRI and HindIII, AmpR 
This study 
pRI-galE frag galE coding sequence from nucleotide 679 to 778 cloned into 
pRI between EcoRI and HindIII, AmpR 
This study 
pRI-galE-frag control galE coding sequence from nucleotide 881 to 964 cloned into 
pRI between EcoRI and HindIII, AmpR 
This study 
pRI-galR-frag GalR coding sequence from nucleotide 209 to 290 cloned into 
pRI between EcoRI and HindIII, AmpR 
This study 
pXG10-SF-CadA-M3 pXG10-SF-CadA sequence  mutated from CGTTATTGCA to 
tGTTATTttg 
This study 
pEVOL-p-AzF Orthologous aminoacyl-tRNA and tRNA pair PMID: 12148987  
pRI-Spot 42 pRI with spf cloned into  EcoRI and HindIII, AmpR This study 
pRI-Spot 42STOP pRI-Spot 42 with T27G mutation, AmpR This study 
pKK-SpfP-scram pKK with SpfP open reading frame scrambled and cloned into 
EcoRI and HindIII, AmpR 
This study 
pKK-SpfP-scramSTOP pKK-SpfPscram with the third codon mutated to TAG, AmpR This study 
pKK-SpfP-scramF2A pKK-SpfPscram with the second codon mutated to GCG, 
AmpR 
This study 
pKK-SpfP-scramY3A pKK-SpfPscram with the third codon mutated to GCG, AmpR This study 
pKK-SpfP-scramS5A pKK-SpfPscram with the fifth codon mutated to GCG, AmpR This study 
pKK-SpfP-scramD6A pKK-SpfPscram with the sixth codon mutated to GCG, AmpR This study 
pKK-SpfP-scramL8A pKK-SpfPscram with the eighth codon mutated to GCG, 
AmpR  
This study 
pKK-SpfP-scramH10A pKK-SpfPscram with the tenth codon mutated to GCG, AmpR This study 
pKK-SpfP-scramV11A pKK-SpfPscram with the eleventh codon mutated to GCG, 
AmpR  
This study 
pKK-SpfP-scramF14A pKK-SpfPscram with the fourteenth codon mutated to GCG, 
AmpR  
This study 
pKK-SpfP-scramNY pKK-SpfP-scram with tyrosine (TAC) introduced after the 
start codon, AmpR  
This study 
pKK-SpfP-scramCY pKK-SpfP-scram with tyrosine (TAC) introduced before the 
stop codon, AmpR  
This study 
pKK-SpfP-scramNSTOP pKK-SpfP-scram with stop (TAG) introduced after the SpfP 
start codon, AmpR  
This study 
pKK-SpfP-scramCSTOP pKK-SpfP-scram with stop (TAG) introduced before the SpfP 
stop codon, AmpR  
This study 
pKK-N-FLAG-SpfP pKK-SpfP with an N terminal 3X FLAG tag This study 
pBR-MgrR pBR with mgrR cloned into  EcoRI and HindIII, AmpR Moon, et. al., 
2013 
pBAD-MgtSR Initial construct with MgtS ORF 30-nt upstream of mgrR This study 
pBAD-MgtSRSTOP pBAD-MgtSR with TAG stop mutant as second amino acid This study 




pBAD-MgtSRNO SPACE pBAD-MgtSR with 30-nt intervening sequence removed This study 
pBAD-MgtSRNO SPACE 
MUT  
pBAD-MgtSRNO SPACE MUT with TAG stop mutant as second 
amino acid 
This study 
pBAD-MgtSR5´∆5nt pBAD-MgtSR with 5-nt removed from 5' end of intervening 
sequence 
This study 
pBAD-MgtSR5´∆10nt pBAD-MgtSR with 10-nt removed from 5' end of intervening 
sequence 
This study 
pBAD-MgtSR3´∆5nt pBAD-MgtSR with 5-nt removed from 3' end of intervening 
sequence 
This study 
pBAD-MgtSR3´∆10nt pBAD-MgtSR with 10-nt removed from 3' end of intervening 
sequence 
This study 
pBAD-MgtSR5´∆5nt STOP pBAD-MgtSR with 5-nt removed from 5' end of intervening 
sequence and stop mutant 
This study 
pBAD-MgtSR5´∆10nt STOP pBAD-MgtSR with 10-nt removed from 5' end of intervening 
sequence and stop mutant 
This study 
pBAD-MgtSR3´∆5nt STOP pBAD-MgtSR with 5-nt removed from 3' end of intervening 
sequence and stop mutant 
This study 
pBAD-MgtSR3´∆10nt STOP pBAD-MgtSR with 10-nt removed from 3' end of intervening 
sequence and stop mutant 
This study 
pBAD-MgtRS Reverse construct This study 
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Appendix 4: Oligonucleotides for Plasmid Construction 
Name Sequence 
pRI-AzuCRSTOP-M1F GAAAAGTATGTTCAATAACGATCGCGACACATTCAAAGACGTACCGCC
























pXG10-SF-GalEF GTTTTTTATGCAT ATCGCGCATAAAAAACGGCT 
pXG10-SF-GalER GTTTTTTGCTAGC GCCTACGCCAGCGCCGAGGT 
cadA frag F AATTCCATTTTGTCCCATGTGTTGGGAGGGGCCTTTTTTACCTGGAGATA
TGACTatgAACGTTATTGCAATATTGAATCACATGGGGGTTTATTTTAAA
GA 
cadA frag R agcttCTTTAAAATAAACCCCCATGTGATTCAATATTGCAATAACGTTcatAG
TCATATCTCCAGGTAAAAAAGGCCCCTCCCAACACATGGGACAAAATG
G 
cadA ctrl frag F AATTCAGTTCCTCTGGTAATGCCGGGTGAAATGATCACCGAAGAAAGCC
GTCCGGTTCTGGAGTTCCTGCAGATGCTGTGTGAAATCGGCGCTCACTA
TCCGA 
cadA ctrl frag R agcttCGGATAGTGAGCGCCGATTTCACACAGCATCTGCAGGAACTCCAGA
ACCGGACGGCTTTCTTCGGTGATCATTTCACCCGGCATTACCAGAGGAA
CTG 
galE frag F AATTCGGTACTGGCGTACGCGATTACATCCACGTAATGGATCTGGCGGA
CGGTCACGTCGTGGCGATGGAAAAACTGGCGAACAAGCCAGGCGTACA
CATCTACAA 
galE frag R agcttTGTAGATGTGTACGCCTGGCTTGTTCGCCAGTTTTTCCATCGCCACG
ACGTGACCGTCCGCCAGATCCATTACGTGGATGTAATCGCGTACGCCAG
TACCG 
galE ctrl frag F aattcGCGACCTTCCGGCCTACTGGGCGGACGCCAGCAAAGCCGACCGTG
AACTGAACTGGCGCGTAACGCGCACACTCGATGAAATGGa 
galE ctrl frag R agcttCCATTTCATCGAGTGTGCGCGTTACGCGCCAGTTCAGTTCACGGTC
GGCTTTGCTGGCGTCCGCCCAGTAGGCCGGAAGGTCGCg 
galR frag F AATTCccgatccgtttttcggtgcaatggtgaaagcggtcgaacaggtggcttatcacaccggtaattttttattgatt
ggcaccggA 
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galR frag R agcttccgttgccaatcaataaaaaattaccggtgtgataagccacctgttcgaccgctttcaccattgcaccgaaaaac
ggatcggG 
pRI FnrS F AATTCGCAGGTGAATGCAACGTCAAGCGATGGGCGTTGCGCTCCATATT
GTCTTACTTCCTTTTTTGAATTACTGCATAGCACAATTGATTCGTACGAC
GCCGACTTTGATGAGTCGGCTTTTTA 




































































P1galElacZ F GCGGATCCTACCTGACGCTTTTTAT 











MgtSR stop f GGGCTAGCAGGAGGAATTCatgtaGGGTAATATGAATGTTTTTATG 






















Appendix 5: Oligonucleotides for Chromosomal Tagging 
Name Sequence 
MG1655 azuC-GFP 5' primer TATTGCAAGACGTTCAAAGACGTACCGCCAGGCAATATGTTCCGA
atgagtaaaggagaagaacttttca 
MG1655 azuC-GFP 3' primer CACCGTCATCAGGACACAAAAAAACCTGCCGGAGCAGGTTTTTTG
attccggggatccgtcgacc 




PM1205 azuC::lacZ  5' primer ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATaaagacaata
acacctgtata 
PM1205 azuC::lacZ  3' primer TAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACtcggaaca
tattgcctggcgg 














































Appendix 6: Oligonucleotides for Sequencing 
Name Sequence 
lacZ F GCAATGACCATTGAACAGGCAGC 
lacZ R GCGATCGGTGCGGGCCTCTTCGCTA 
pRI Seq F CTGGCAAATATTCTGAAATGAGCTG 
pKK Seq R CACTACCATCGGCGCTACGGCGTTT 
pBAD f AAACCAGAAAATAAAATTAT 
pBAD r GTTTTTATGGCCGTACTGGG 
MgtSR seq f GTCACACTTTGCTATGCCAT 
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